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1. General introduction 
 
1.1.  Background 
 
1.1.1. Ageing and chronic illness among the older population   
 
An increase in life expectancy along with a dramatic drop in the fertility rate contribute to the 
ageing of our Western population
1
. It is expected that the number and proportion of older 
people will increase sharply in the years ahead; by 2050, more than one quarter of the 
population of the European region will be 65 or older
2
. The fastest growing age group in most 
European countries is the group of people aged 85 and older. This group is even predicted to 
double in size in the next 20 years
2
. As a result of the population ageing, the number of deaths 
has also begun to increase with a majority of deaths occurring after the age of 65 years
3
. The 
population of older people thus comprises a substantial proportion of those patients who are 
approaching the end of life. 
 
As more people live to older ages, the pattern of disease at the end of life is changing and 
more people are living with frailty and serious chronic and degenerative diseases such as 
chronic heart disease, cerebrovascular disease, respiratory disease, dementia and cancer
2,4,5
. In 
addition, increased longevity is associated with the increased prevalence of co-morbidity, ie 
people living with two or more diseases at the same time. An increasing number of older 
people will therefore live with the consequences of one or more of these diseases. Moreover, 
older people often experience medical problems towards the end of life (e.g. pneumonia or hip 




These demographic and epidemiological changes increasingly confront societies with 
challenges regarding the organization of end-of-life care. As a consequence, the World Health 
Organization (WHO) has identified palliative care and end-of-life care as one of the public 
















End-of-life care is the clinical approach to the patient at the end of his/her life, which includes 
the months, days or hours before death
9
. In contrast to conventional medical care, in which the 
focus is on curation or on life-prolongation, palliative and end-of-life care put emphasis on 
improving and sustaining the quality of life. 
 
End-of-life care for older people encompasses more than the mainstream palliative medicine 
principles and has therefore been defined as “the medical care and management of older 
patients with health-related problems and progressive, advanced disease for which the 
prognosis is limited and the focus of care is quality of life
10




- combines the principles and practice of geriatric medicine and palliative care; 
- focuses on comprehensive geriatric assessment; relief from pain and other symptoms; 
and management of physical and psychological problems, integrating social, spiritual, 
and environmental aspects; 
- recognizes the unique features of symptom and disease presentation, the interaction 
between diseases, the need for safe drug prescribing, and the importance of a tailored 
multidisciplinary approach for older patients receiving palliative care and their family; 
- emphasizes the importance of autonomy, the involvement in decision-making, and the 
existence of ethical dilemmas; 
- calls for good communication skills when discussing and giving information to older 
patients and their families; 
- addresses the needs of older patients and their families across all settings - home, long-
term care, hospices, and hospital; 
- pays special attention to transitions within and between settings of care; and 









End-of-life care and quality of dying 
 
The ultimate goal of end-of-life care is to pursue a good and dignified death for every person
4
. 
Hence it is increasingly accepted that end-of-life care should focus on symptom management, 




As older people may have specific and challenging needs towards the end of life, they may 
respond well to the expertise offered by specialist palliative care providers across all setting
7
. 
It is for instance known that the role of a palliative care consultation supports the optimization 
of the medication profile, tailoring each decision to the individual’s preferences, comorbidities 
and prognosis
11
, though, end-of-life care should not be something that only specialized 
palliative care teams, palliative care services or hospices offer when other treatments have 
been withdrawn. It should be an integral part of care, be provided by any health professional 




According to older people, adequate pain and symptom management, appropriate social, 
spiritual and emotional support, avoiding inappropriate prolongation of dying and providing 
best quality of life for their families are important aspects of optimal end-of-life care which 
may contribute to a ‘good death’
4,12
. Adequate care during the last days of life may also 
include an appropriate pharmacological management such as medication reviews, anticipatory 
prescription of medication for optimal symptom control and deprescription of potentially 
inappropriate medication
11,13,14
. A medication review aims to optimize pharmacologic 
treatments, reduce polypharmacy and minimize medication-induced adverse effects and acute 
complications, which are particularly common in frail individuals
11
. It is also recognised that 
appropriate care for the dying consists of symptom management, performing mouth care and 




In perfect conditions, end-of-life care is in accordance with the patient’s individual needs and 
wishes. Exploring and acknowledging individual needs at the end-of-life and appropriately 
addressing them is therefore crucial when striving for optimal end-of-life care.  
However, delivering optimal end-of-life care in older people is challenging since older people 
often have complex and multifaceted needs due to the multiple chronic health problems they 
are experiencing. In addition, an increasing proportion of this older population is cognitively 
impaired which may also contribute to the challenging nature of end-of-life care 
provision
2,4,16–19
. Moreover, delivering appropriate end-of-life care for older people implies 
that health care professionals recognize the dying phase, which is particularly challenging in 
13 
 





Main goal of treatment 
An important indicator for the quality of end-of-life care is the main goal of treatment at the 
end-of-life
21
. The absence of a palliative or comfort care goal at the time of death in patients 
suffering from chronic life-limiting diseases is generally associated with poor quality end-of-
life care. A main goal of treatment aimed at comfort or quality of life may thus become more 




Although a number of studies have been performed to investigate the quality of end-of-life 
care for older people, among others in hospitals
22,23
, little is known about the main goal of 
treatment in older dying people as well as the type of care that older people of different ages 
receive at the end of life. 
 
1.1.3. Acute geriatric hospital wards 
 
An important place of end-of-life care and death 
 
Another important principle of achieving a good death is having choice and control over 
where death occurs
24,25
. Unfortunately, these choices and wishes are not always met. 
The proportion of older people dying in a hospital setting remains persistently high in many 
high-income countries while most people prefer to be cared for and die at home
26–29
. 
Although a more recent study of trends in place of death in Belgium has found a slight 
decrease in hospital deaths, still a majority of older patients die in hospital
30
 and it is estimated 




Patients on acute geriatric wards 
In Flanders (Belgium), specialized acute care units for older people, i.e. acute geriatric wards, 
are an important place within the acute hospital setting where older patients are hospitalized 
and end-of-life care may be provided. These wards were installed since 1984 for specialized 
acute geriatric care, with a multidisciplinary approach and supervised by a geriatrician, i.e. a 
specialist with a three year training in internal medicine and a supplementary three year 
training in geriatric medicine
32
. Geriatric patients, generally 75 years or older, are often 
admitted to these wards as a result of acute events such as falls, infections, acute 
cardiovascular problems, drug interactions. However, the geriatric patient is not defined on the 
14 
 
basis of age; the geriatric profile is rather determined by age-related vulnerability with 
associated co-morbidities. This geriatric profile associated with acute events poses various 
challenges to health care staff on acute geriatric wards; complex and multifaceted needs have 
to be addressed
33,34
. In line with a recently published resolution by the World Health 
Organization, geriatric medicine will particularly focus on improving the quality of life of 
older people and simultaneously centre on the improvement and rehabilitation of a patient’s 
functional status
8
. However, some patients admitted to acute geriatric hospital wards may die 
in this specific setting and should thus benefit from appropriate end-of-life care where cure or 
life-prolongation is no longer a priority. 
 
End-of-life care and quality of dying  
 
While we are aware of a substantial proportion of older people dying in acute geriatric hospital 
wards, we lack reliable data on what care they receive at the end-of-life and what the quality 
of the dying process is.  
 
What we actually do know is that acute hospital care in general is considered to be inadequate 
to the needs of dying patients. Care in hospitals is mainly focused on cure or life-prolongation 
and studies have indicated that communication between health care professionals and patients 
and their families is often poor or contradictory in hospitals
22,23,35
.  Moreover, studies show 
that many hospitalized patients often do not die a peaceful death
36–38
. Key findings of a study 
evaluating the dying experience at home and in institutional settings found that bereaved 
family members whose relatives died in a hospital, reported higher rates of concerns around 
dying in comparison to family members whose relatives died at home. For example, higher 
rates were found for unmet needs for symptom management, for concerns with physician 
communication about medical decision making, for the lack of emotional support for family 




Moreover, studies are showing that care at the end of life for the older person in the acute 
hospital ward is often suboptimal, resulting in poor symptom control during the last days of 
life and poor quality of dying
22,23,39,40
. For older patients in the hospital, pain control at the 
end-of-life seems to be less intensive than for younger patients
5,41
, the chance to receive 
optimal end-of-life care is lower compared to younger patients
41
 and burdensome interventions 
aimed at prolonging life instead of interventions to promote their comfort are more often 
started or continued
8
. Furthermore, the patient population with dementia is especially prone to 





1.1.4. Barriers to providing optimal end-of-life care in older hospitalized patients 
 
Several studies have already been carried out in order to identify barriers to providing optimal 
end-of-life care in older people
4,45,46
. Although the evidence is limited regarding barriers to 
optimal end-of-life care for older people in acute hospitals
47
, the findings are consistent with 
other study results not restricted to the hospital setting.   
 
Three types of barriers can be identified from the literature to providing optimal end-of-life 
care for older hospitalized patients
4,45–47 
(Table 1). These barriers are related to the 
patient/family, to the clinicians and to the institution. 
 
Table 1 Three types of barriers to providing optimal end-of-life care  
 
Patient/family related barriers 
 
Clinician related barriers 
 





Inability of patients to participate 
in discussions 
Lack of advance directives 




Differing understandings of whose 
responsibility it was to provide palliative 
care 
Failure to implement a timely end-of-life 
plan of care  
Reluctance to acknowledge treatment 
failure or to relinquish end-of-life patient 
care to other specialists  
Lack of generic palliative care skills and 
knowledge amongst healthcare 
professionals 
Reluctance to engage in and difficulties 
with conversations about death and dying 
with patients and their families 
Possible reluctance in prescribing opioids 
to the oldest old people 
 
Suboptimal space for family 
meetings 
Inadequate staffing levels 
Lack of a palliative care service 
A focus on interventionist care 
with curative intent 








An essential finding is that older age in itself can be a barrier to providing optimal end-of-life 
care
4,47
. It was for instance found in a study that health professionals sometimes believe that 
older patients less often require palliative care than younger people, because death is more 
expected in an older persons, and the perception that older people find it easier to come to 
terms with a terminal diagnosis
47
. This thinking may influence the allocation of scarce 
resources to the care of older dying people and may also lead to a weak emphasis on quality of 





1.1.5. Initiatives to improve end-of-life care in older hospitalized patients 
 
Dealing with the abovementioned barriers is an important but challenging step when striving 
to improve end-of-life care in older hospitalized patients. Various initiatives have been 
developed and introduced worldwide in order to address and surpass these barriers
2,50,51
. Most 
of the initiatives such as educational programmes, symptom-specific interventions, advance 
care planning, and integrated care pathways aim to improve the provision of general palliative 
care for all and to prompt referral to specialist palliative care services when needed
2,4
. With 
respect to improving end-of-life care for older patients in hospitals, education of the staff 
members, identifying and assessing the people who need end-of-life care, good collaboration 
between all involved parties, e.g. geriatricians, oncologists, cardiologists, palliative care 
clinicians, pharmacists, psychologists, social workers, dieticians, nursing staff and chaplains, 
implementing care pathways and ensuring access to specialist palliative care teams are 
strongly recommended
2,52
. To our knowledge, no care pathways have been developed or 
implemented mainly aimed at improving end-of-life care in acute geriatric hospital wards. 
 
Over many years several end-of-life care pathways have been developed to improve the 
quality of end-of-life care of which the Liverpool Care Pathway (LCP) for the Dying Patient is 
the most well-known
13,50,53,54
. The LCP was developed in 1997 in the United Kingdom (UK) 
as a multi-professional document that provides a template of care for the final days and hours 




Although the LCP as developed in the UK was meant to be implemented in every health care 
setting and population, individual patient characteristics and needs may differ as well as the 
health care setting in which they are cared for
7
. It is for instance known that the recognition of 
the dying phase is more challenging in older non-cancer patients
53
 and that around half of 
older patients in hospital are cognitively impaired
55
. Furthermore, although studies suggest 
that the LCP can improve the quality of end-of-life care in a cancer population
56–59
, its 
effectiveness in people dying of causes other than cancer, especially older people, has not yet 
been investigated. Therefore, if we want to introduce and use such a care programme in acute 
geriatric hospital wards, we should be careful that the context is taken into account, especially 
during the process of implemention. Moreover, as the LCP has been widely criticized since 
June 2012 for leading to physicians and nurses not providing appropriate care, the 
development of an adapted care programme for the last days of life should also take into 
account the concerns that have been raised in the UK. Raised concerns regarding the LCP 
arise mainly from inappropriate implementation and use and not the principles of the LCP 
17 
 
itself. This was also recently highlighted in an independent review which recommended 





































1.2.  Research aims, methodology and outline of this dissertation 
   
1.2.1. Research aims 
 
The aims of our research project are threefold: (1) to evaluate the main goal of treatment at the 
end of life in older patients, (2) to describe end-of-life care for patients in acute geriatric 
hospital wards and (3) to develop and evaluate the effectiveness of the Care Programme for 
the Last Days of Life in improving end-of-life care in acute geriatric hospital wards.  
 
Research aim 1: To evaluate the main goal of treatment at the end of life in older patients 
The research objectives are: 
1) To provide a population-based evaluation of the main goal of treatment that older people 
of different ages receive at the end of life (chapter 2) 
 
Research aim 2: To describe end-of-life care for patients in acute geriatric hospital wards 
The research objectives are: 
2) To describe end-of-life care in terms of performed nursing and medical interventions in 
the last 48 hours of life and quality of dying of patients in acute geriatric hospital wards 
(chapter 3) 
3) To describe the policy of prescription and deprescription of medication in the last 48 
hours of life of patients in acute geriatric hospital wards (chapter 4)  
 
Research aim 3: To develop and evaluate the effectiveness of the Care Programme for 
the Last Days of Life in improving end-of-life care in acute geriatric hospital wards 
The research objectives are: 
4) To develop the Care Programme for the Last Days of Life for older patients in acute 
geriatric hospital wards (chapter 5) 
5) To test the feasibility of the implementation of the Care Programme for the Last Days of 
Life in an acute geriatric hospital ward and explore its preliminary effects (chapter 6) 
6) To describe the research protocol of a cluster Randomized Controlled Trial (RCT) to 
evaluate the effectiveness of the Care Programme for the Last Days of Life in acute 









I. Death certificate study in Flanders 
 
In order to compare the main goal of treatment in the last week of life of people aged 86 and 
older with those between 75 and 85 years, and thus address the first research objective, a 
secondary analysis of a previously published death certificate study was performed.  
This death certificate study was conducted in the Flemish speaking part of Belgium in 2007. A 
random sample (N = 6927) of all death certificates of people aged one year or older and dying 
between June 1 and November 30, 2007 was received by the Flemish Agency for Care and 
Health. For each sampled death certificate the certifying physician was sent an anonymous 
structured questionnaire, identifying non-sudden deaths and medical end-of-life decisions that 
preceded death.  
Prior to the analysis, cases were weighted to be representative of all deaths in Flanders in 
2007. In the questionnaire, the treating physician was asked whether the death was sudden and 
unexpected (yes/no). The questionnaire included the question: ‘What was the main goal of 
treatment in the last week of life?’ with answer categories ‘cure’, ‘life-prolonging’ or 
‘comfort’. All non-sudden deaths of persons aged 75 years and older were selected as being in 
principle eligible for comfort care in the final week of life. 
 
More details on the methodology of this study are described in the published study protocol
61
. 
Positive recommendations for the anonymity procedure and study protocol were obtained from 
the Ethical Review Board of the University Hospital of the Vrije Universiteit Brussel, the 
Ethics Committee of the University Hospital of Ghent University, the Belgian National 
Disciplinary Board of Physicians and the Belgian Federal Privacy Commission. 
 
II. Retrospective cross-sectional descriptive study  
 
To address research objectives 2 and 3, namely describing end-of-life care in terms of 
performed nursing and medical interventions, quality of dying and the policy of prescription 
and deprescription of medication in the last 48 hours of life of patients in acute geriatric 
hospital wards, we analyzed data collected through a retrospective cross-sectional descriptive 
study.  
This cross-sectional study is the baseline assessment as part of the cluster RCT to evaluate the 
effectiveness of the Care Programme for the Last Days of Life. The cross-sectional study or 
baseline assessment was conducted from October 1
st
 2012 to September 30
th
 2013 in 23 acute 
20 
 
geriatric wards in 13 Flemish hospitals. For each deceased patient who has been hospitalized 
for more than 48 hours and has given informed consent at admission for the use of their 
personal information from medical or nursing records, the following characteristics were 
collected by the researcher via administrative files of the participating hospitals: age, sex and 
length of hospital stay. Structured after-death questionnaires were filled out by the nurse, the 
physician and the family carer most involved in end-of-life care for the patient who died on 
the geriatric ward. After-death questionnaires surveyed socio-demographic characteristics, 
clinical characteristics, end-of-life care in terms of the performed  nursing and medical 
interventions in the last 48 hours of life, the physician’s policy of prescribing and 
deprescribing medication in the last 48 hours of life and quality of dying.  
 
More details on the methodology of this study as part of the cluster RCT are described in 
chapter 7 or the published study protocol of the cluster RCT
62
. The study was approved by the 
Central Ethics Committee of the Vrije Universiteit Brussel (VUB) (Belgium) and by the Local 
Ethics Committees of the participating hospitals in Flanders.  
 
III. Medical Research Council (MRC) Framework for developing and evaluating 
complex interventions 
 
In order to address the third research aim with research objectives 4 to 6, the development and 
evaluation of the Care Programme for the Last Days of Life was conducted using the Medical 
Research Council (MRC) Framework for the Evaluation of Complex Interventions
63
. The 
MRC Framework follows a five phase iterative approach, i.e. pre-clinical phase (phase 0), 
modeling phase (phase I), exploratory phase (phase II), explanatory phase (phase III) and 
large-scale implementation (phase IV), and has proved to be valuable in guiding the 
development, modelling and evaluation of complex interventions (Figure 1)
63–65
. Each phase 
suggests the use of appropriate quantitative and/or qualitative methodologies depending on the 
specific objectives of the phase, and requires a specific study design taking into account the 
theoretical basis, any evidence on the issue and the context’s specificity
63
. In this thesis we 











First, phases 0-I according with the MRC Framework were completed in order to accomplish 
research objective 4. Phase 0 consisted of a review of existing LCP programmes from the UK, 
Italy and the Netherlands, a literature review to identify key factors for a successful LCP 
implementation and an analysis of the concerns raised in the UK regarding the LCP. In phase 
I, we developed the Care Programme for the Last Days of Life for older patients dying in 
acute geriatric wards based on the results of phase 0. The Care Programme was reviewed and 
refined by two nurses and two physicians working in an acute geriatric ward and by two 
experts from Italy and the Netherlands. More information about the phase 0-I study can be 
found in chapter 5. 
 
Phase II of the MRC Framework was completed in order to accomplish research objective 5, 
i.e. testing if the implementation of the Care Programme for the Last Days of Life is feasible 
and exploring which preliminary effects may be achieved. This phase II encompassed a mixed 
methods study including participant observation and the use of a quantitative evaluation tool 
measuring the success of implementation. More information about the phase 2 study can be 
found in chapter 6. 
 
According to the MRC Framework, a thorough evaluation of a complex intervention is needed 
before implementing it in practice
63
. We developed a study protocol for a cluster RCT (phase 
III of the MRC Framework) to evaluate the effectiveness of the Care Programme for the Last 
Days of Life
62
. The study protocol can be found in chapter 7. The development of this phase 
III study protocol addressed our last research objective.  
 
With respect to phase II and III, we received approval of the Central Ethics Committee of the 
University Hospital of the Vrije Universiteit Brussel and by the Local Ethics Committees of 




1.2.3. Outline of this dissertation 
 
In chapter 2 of this first part the results of a secondary analysis of a population-based survey in 
Belgium are presented (addressing research objective 1). 
In part II of this dissertation end-of-life care for older patients in acute geriatric hospital wards 
is described. In chapter 3 end-of-life care in terms of nursing and medical interventions in the 
last 48 hours of life and the quality of dying of patients in acute geriatric hospital wards are 
described (addressing research objective 2). Chapter 4 describes the policy of prescription and 
deprescription of medication in the last 48 hours of life in acute geriatric hospital wards 
(addressing research objective 3). 
Part III of this dissertation deals with the development and testing of the Care Programme for 
the Last Days of Life to improve end-of-life care in acute geriatric hospital wards. The 
development of the Care Programme for the Last Days of Life for the acute geriatric hospital 
setting is described in chapter 5 (addressing research objective 4). Chapter 6 describes the 
testing of the Care Programme for the Last Days of Life (addressing research objective 5). The 
research protocol of a cluster RCT to evaluate the effectiveness of the Care Programme for the 
Last Days of Life in acute geriatric wards, is outlined in chapter 7 (addressing research 
objective 6). 
 
Finally chapter 8 in part IV presents a general discussion of the major findings in this thesis 
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Little is known about the type of care older people of different ages receive at the end of life. 
The goal of treatment is an important parameter of the quality of end-of-life care. This study 
aims to provide an evaluation of the main goal of treatment in the last week of life of people 
aged 85 and older compared with those between 75 and 85 and to examine how treatment 
goals are associated with age. 
METHODS 
Population- based cross sectional survey in Flanders, Belgium. A stratified random sample of 
death certificates was drawn of people who died between 1 June and 30 November 2007. 
The effective study sample included 3,623 deaths (response rate: 58.4%). Non-sudden deaths 
of patients aged 75 years and older were selected (N=1681).  
Main outcome was the main goal of treatment in the last week of life (palliative care or life-
prolonging/curative treatment). 
RESULTS 
In patients older than 75, the main goal of treatment in the last week was in the majority of 
cases palliative care (77.9%). Patients between 75 and 85 more often received life-
prolonging/curative treatment than older patients (26.6% vs. 15.8%). Most patient and health 
care characteristics are similarly related to the main goal of treatment in both age groups. The 
patient’s age was independently related to having comfort care as the main goal of treatment. 
The main goal of treatment was also independently associated with the patient’s sex, cause and 
place of death and the time already in treatment. 
CONCLUSION 
Age is independently related to the main goal of treatment in the last week of life with people 
over 85 being more likely to receive palliative care and less likely to receive curative/life-
prolonging treatment compared with those aged 75-85. This difference could be due to the 
patient’s wishes but could also be the result of the attitudes of care givers towards the 







People aged 85 and older form the fastest growing age group in most European countries and 
their number is predicted to double in the next 20 years [1].
 
To date, little is known about the 
type of care that older people of different ages receive at the end of life. Palliative care has 
been identified as a public health priority worldwide for older people [2,3]. The WHO 
promotes palliative care as the preferred approach to end-of-life care, irrespective of age. The 
absence of a palliative or comfort care goal at the time of death in patients suffering from 
chronic life-limiting diseases is generally associated with poor quality end-of-life care [4].  
Palliative care is aimed at improving the quality of life of patients and their families by 
providing relief from physical, psychological and spiritual problems, while curative treatment 
is focused on cure or management of a chronic disease and on prolonging life [2-4]. Many 
chronically ill older people need a mix of both palliative and life-prolonging or curative 
treatment
 
[5]. However, life-prolonging and curative treatment decreases as the illness 
progresses and at the end of life the main goal of treatment should be palliative-oriented for 
most people [4]. 
Previous studies in Belgium have shown that for approximately 20% of patients a palliative 
treatment goal is lacking in the last week of life [6]. Recognizing that death is imminent is 
particularly challenging in the care of older people suffering from slowly progressive or 
fluctuating long term conditions [5,7]. Studies have shown that the quality of end-of-life care 
for older people is often suboptimal, especially in hospitals where burdensome interventions 
aimed at cure or prolonging life are sometimes continued until death [8-10]. Furthermore, a 
growing body of scientific literature shows that provision of end-of-life care also varies 
between patients of different ages [11-13]. 
The objective of this study is to provide a population-based evaluation of the main goals of 












This is a secondary analysis of a survey with the primary aim of studying end-of-life practices 
in Flanders, Belgium. The survey was conducted with the use of data from death certificates in 
the Flemish speaking part of Belgium. In 2007, we performed a large-scale death certificate 
study in Flanders, Belgium (approximately 55,000 deaths per year). Questionnaires were sent 
to the reporting physicians on a representative sample of death certificates received by the 
Flemish Agency for Care and Health between June 1 and November 30, 2007. We received 
questionnaires for 3,623 of the 6927 initial cases. From non-response analyses, we found that 
for 725 cases response was not possible owing to issues of access to the medical file or to 
patient identification; these cases were removed from the sample. Cases were weighted to be 
representative of all deaths in Flanders in 2007.  
In the questionnaire, the treating physician was asked whether the death was sudden and 
unexpected (yes/no). The questionnaire included the question: ‘What was the main goal of 
treatment in the last week of life?’ with answer categories ‘cure’, ‘life-prolonging’ or 
‘comfort’.  For this paper, ‘life-prolonging’ and ‘cure’ were concatenated. All non-sudden 
deaths of persons aged 75 years and older were selected as being in principle eligible for 
comfort care in the final week of life. 
The study protocol has been published elsewhere [14]. Positive recommendations for the 
anonymity procedure and study protocol were obtained from the Ethical Review Board of the 
University Hospital of the Vrije Universiteit Brussel, the Ethics Committee of the University 
Hospital of Ghent University, the Belgian National Disciplinary Board of Physicians and the 
Belgian Federal Privacy Commission. 
 
ANALYSES 
Bivariate differences between age groups were tested by Chi-square test. P-values that were 
less than or equal to 0.05 were considered to indicate statistical significance.  
A binary multivariable logistic regression analysis was performed for both age groups to 
estimate the factors associated with palliative care as the main goal of treatment in the last 






Characteristics of non-sudden deaths by age groups 
The study sample included 6202 deaths. The response rate was 58.4%. Of all deaths of 
patients over 75 years old, 1681 were deemed non-sudden. Of those 57.3% were between the 
ages of 75 and 85 and 42.7% were older than 85 (Table 1). The older group differed in 
characteristics from the younger group. They were more often female (70.2 vs. 48.9%), 
widowed (72.1 vs. 38.9%) and of lower education (47.4 vs. 39.5%).  Also they more often 
died from cardiovascular diseases (31.3 vs. 21.3%) and in care homes (54.0 vs. 21.1%).  











Sex   <0.001 
Female 471 (48.9) 503 (70.2)  
Male 493 (51.1) 214 (29.8)  
Marital status   <0.001 
Widowed 375 (38.9) 517 (72.1)  
Married 473 (49.0) 133 (18.5)  
Single 90 (9.3) 57 (7.9)  
Divorced 27 (2.8) 10 (1.4)  
Education   <0.001 
Primary school 381 (39.5) 340 (47.4)  
High school (not graduated) 182 (18.9) 89 (12.4)  
High school/college 123 (12.7) 73 (10.2)  
Unknown 279 (28.9) 216 (30.1)  
Cause of death   <0.001 
Cardiovascular disease 205 (21.3) 224 (31.3)  
Malignant disease 314 (32.6) 103 (14.4)  
Respiratory disease 136 (14.1) 100 (14.0)  
CVA/stroke 102 (10.6) 62 (8.7)  
Disease of the nervous system 42 (4.4) 29 (4.1)  
Other disease 165 (17.1) 198 (27.7)  
Place of death   <0.001 
Hospital 537 (55.7) 229 (31.9)  
Care home 204 (21.1) 387 (54.0)  
Home 203 (21.1) 85 (11.9)  
Other/unknown/missing 20 (2.1) 16 (2.2)  
 
*Number of cases (weighted percentages) 
† Chi-square test for differences between age group 
 
















Patient and health care characteristics by age groups and goal of treatment in the last week 
of life 
Patients between 75 and 85 years more often received life-prolonging or curative treatment 
than those over 85 years (26.6% vs. 15.8%, p<0.001).  In both age groups, comfort care was 
more often the main goal of treatment for people in care homes or at home compared with 
those in hospitals.  Other disease characteristics related to receiving comfort care are dying 
from a malignant disease and being in treatment for a longer period of time (table 2).   
In the older group, female patients more often had a comfort care goal in the last week of life 
than did their male counterparts, as had patients without a partner. In the younger group those 
lacking capacity were more likely to receive life-prolonging or curative treatment at the end of 
life than were those of that age group with capacity, a difference not found in the older group. 
 
 
Table 2. Patient and health care characteristics by age groups and goal of treatment in the last week of life* 
 
 75-85 years 
N= 964 (57.3) 
>85 years 
N= 717 (42.7) 
 Comfort care 
 
N= 683 (73.4) 
Life-prolonging or 
curative treatment 
N= 248 (26.6) 
p-value Comfort care 
 
N= 574 (84.2) 
Life-prolonging or 
curative treatment 
N= 108 (15.8) 
p-value 
Sex   0.540   0.005 
Female 337 (72.5) 128 (27.5)  418 (86.7) 64 (13.3)  
Male 346 (74.2) 120 (25.8)  156 (78.0) 44 (22.0)  
Marital status   0.505   0.004 
Widowed 258 (70.9) 106 (29.1)  425 (85.9) 70 (14.1)  
Married 347 (75.6) 112 (24.4)  94 (74.0) 33 (26.0)  
Single 59 (72.8) 22 (27.2)  45 (88.2) 6 (11.8)  
Divorced 19 (73.1) 7 (26.9)  10 (100) 0 (0.0)  
Education   0.131   0.141 
Primary school 262 (69.7) 114 (30.3)  284 (85.3) 49 (14.7)  
High school  
(not graduated) 
126 (75.4) 41 (24.6)  77 (90.6) 8 (9.4)  
High school/college 86 (72.3) 33 (27.7)  50 (79.4) 13 (20.6)  
Unknown 209 (77.7) 60 (22.3)  163 (81.1) 38 (18.9)  
Place of death   <0.001   <0.001 
Hospital 292 (57.1) 219 (42.9)  148 (70.5) 62 (29.5)  
Care home 180 (90.5) 19 (9.5)  338 (89.7) 39 (10.3)  
Home 191 (95.5) 9 (4.5)  74 (91.4) 7 (8.6)  
Cause of death   <0.001   <0.001 
Cardiovascular disease 116 (60.4) 76 (39.6)  174 (84.9) 31 (15.1)  
Malignant disease 276 (89.9) 31 (10.1)  93 (93.9) 6 (6.1)  
Respiratory disease 86 (65.6) 45 (34.4)  61 (65.6) 32 (34.4)  
CVA/stroke 65 (65.7) 34 (34.3)  53 (88.3) 7 (11.7)  
Disease of the nervous system 34 (81.0) 8 (19.0)  25 (86.2) 4 (13.8)  
Other disease 106 (66.2) 54 (33.8)  168 (86.2) 27 (13.8)  
Capacity to make decisions†   <0.001   1.000 
Capable 153 (92.7) 12 (7.3)  62 (89.9) 7 (10.1)  
Incapacitated 264 (71.9) 103 (28.1)  269 (89.1) 33 (10.9)  
Time in treatment for disease 
that caused death 
  <0.001   <0.001 
1-7 days 67 (39.4) 103 (60.6)  90 (65.7) 47 (34.3)  
7 days – 1 month 102 (63.4) 59 (36.6)  103 (80.5) 25 (19.5)  
1 month – 1 year 132 (76.7) 40 (23.3)  98 (90.7) 10 (9.3)  
More than 1 year 69 (94.5) 4 (5.5)  34 (97.1) 1 (2.9)  
 
*Number of cases (weighted percentages) 




Factors associated with goal of treatment in the last week of life 
After controlling for the confounders sex, cause of death, place of death and time in treatment 
for the disease, age was independently related to the main goal of treatment in the last week of 
life. Those in the older group had a 1.61 higher chance (95% confidence interval: 1.20-2.17) of 
having a comfort care goal in the last week of life as compared with the younger group (not in 
tables). Other factors associated with comfort care as the main goal of treatment in the last 
week of life were similar in both age groups (Table 3). The chances of receiving comfort care 
in the last week of life rather than life-prolonging or curative treatment were in both age 
groups lower for those dying from non-malignant diseases, for those having been in treatment 
for the disease for a shorter period of time and for those dying in hospital.   
 
Table 3. Differences in age and other factors associated with having a comfort care goal as main goal of treatment* 
 
Factors related to goal of treatment 75-85 years 
 
>85 years 
 OR (95% CI) 
 
 OR (95% CI) 
 
Sex   
Male 1.00 (1.00-1.00) 1.00 (1.00-1.00) 
Female 1.37 (0.90-2.07) 1.82 (1.03-3.23) 
Cause of death   
Cardiovascular disease 0.25 (0.13-0.48) 0.28 (0.09-0.91) 
Malignant disease 1.00 (1.00-1.00) 1.00 (1.00-1.00) 
Respiratory disease 0.28 (0.14-0.55) 0.14 (0.04-0.43) 
CVA/stroke 0.47 (0.23-0.96) 0.59 (0.16-2.21) 
Disease of the nervous system 0.21 (0.07-0.68) 0.48 (0.08-2.95) 
Other disease 0.28 (0.14-0.56) 0.27 (0.08-0.85) 
Time in treatment for disease that caused 
death 
  
<1week 1.00 (1.00-1.00) 1.00 (1.00-1.00) 
1 week-1 month 2.42 (1.48-3.96) 2.14 (1.17-3.93) 
1 month-1 year 2.97 (1.73-5.08) 4.23 (1.90-9.43) 
>1 year 7.43 (2.27-24.35) 11.12 (1.07-115.57) 
Place of death   
Care home 8.67 (4.07-18.48) 2.91 (1.65-5.15) 
Home 16.17 (3.13-83.62) 7.41 (1.25-44.07) 
Hospital 1.00 (1.00-1.00) 1.00 (1.00-1.00) 
 
*Multivariable logistic regression. Presented figures are odds ratios and 95% confidence intervals. 
Significant results are indicated in bold. Independent variables which have no significant 












This study indicates that for patients aged 75 and above, the main goal of treatment in the last 
week of life was in a large majority of cases comfort care (77.9%). However, those aged 
between 75 and 85 were more likely to receive mainly life-prolonging or curative treatment 
than those older than 85 (26.6% vs. 15.8%) at the expense of comfort care (73.4% vs 84.2%). 
This age difference persists even after controlling for relevant confounders of sex, cause of 
death, place of death and time in treatment for the disease.  In both age groups, the chances of 
receiving comfort care in the last week of life were lower for people dying from non-
malignant diseases, for those having been in treatment for their disease for a shorter period of 
time and for those dying in hospital.   
Our study used a robust design also pursued in previous studies [15,16], including a large 
representative sample of death certificates and applying a mailing procedure guaranteeing total 
anonymity for patients and physicians. Although a non-response bias cannot be completely 
excluded, our non-response survey did not point in that direction. Consequently, we believe 
our results to be representative for all non-sudden deaths of those older than 75 in 2007 in 
Flanders, Belgium. As this is a secondary analysis of a survey primarily intended to study end-
of-life practices, certain aspects that would have provided a more complete insight, such as the 
severity of the patient’s condition and their functional status, the content of care in the last 
week of life, the patient’s wishes for end-of-life care or the existence of an advance care plan 
were not studied. Nevertheless, our study is the first to provide robust epidemiological 
information about the extent to which older people predominantly receive comfort care at the 
end of life and which factors influence these patients receiving such care. 
Although all deaths in this study were deemed non-sudden and expected by the treating 
physician, cure or life-prolonging treatment was the main goal of treatment in a substantial 
number of cases.  Controlling for other factors, those above 85 are more likely to have a 
comfort care goal in the last week of life than are those between 75 and 85. A similar result 
was found in the Netherlands [17].
 
There are several possible explanations for this finding: it 
may suggest a palliative care ethos in the care of those above 85 or, alternatively, it may point 
to a form of ageism in the sense that age may be used as a criterion for rationing health care 
[13]. This would imply that the medical system will use more potentially life-saving options, 
appropriately or not, for those 75-85 than for those older than 85. It may also be that 
physicians believe that above 85, people are less likely to respond to life-prolonging 
treatments than are younger old patients or that they feel obliged to ‘do everything’ for 
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younger patients, even though they may find life-prolonging treatments futile for seriously ill 
patients of any age [12]. The fact that the lack of capacity to participate in decision-making 
leads to more aggressive treatment in the 75-85 age-group but not in those above 85 
corroborates this hypothesis. It suggests that, in the absence of patient directives, there is an 
inclination to pursue life-prolonging treatments as long as the patient is not deemed ‘too old’. 
Irrespective of age group, the chance of receiving comfort care in the last week of life is much 
lower for older patients who die in a hospital than for those who die in a care home or at home. 
It is likely that these are older patients sent to hospital precisely for life-saving or curative 
efforts, for instance in situations where acute care is required. Previous research has indicated 
that a high number of hospital admissions in older people can, however, be avoided and may 
be inappropriate [18,19]. A series of complex reasons, including factors relative to the 
physician, the patient and the family, are usually given for this, the main underlying reason 
often being the failure to recognize approaching death at the appropriate time and thus to shift 
treatment towards maintaining comfort [18,19]. Once a patient is referred to a hospital for 
curative or life-prolonging reasons, the chance to change the focus to palliation may be missed 
as it can be challenging for hospital staff to distinguish people who can still be treated and 
recover from their acute situations from those who have reached a point where a shift in focus 
to palliative or end-of-life care would be more appropriate [20]. Additionally, as reported in 
previous studies [21,22], acute care hospitals often lack a palliative care ethos. It is likely that 
in those cases where comfort is not the main goal of treatment in the last week of life, an 
opportunity for a transition to palliative care has been missed, even though most older people 
may be in need of some kind of palliative care [2,3,5]. 
The likelihood of older people with cancer, compared with those with other chronic diseases, 
receiving care primarily aimed at comfort is striking. This may be related to the fact that 
palliative care has historically been focused on cancer patients [23], who generally have a 
clearer prognosis than those with non-malignant diseases such as organ failure, stroke or 
dementia for whom the timing of death often remains unpredictable until it is very close or 










Although improving the accessibility of palliative care for older people has been identified as 
an international public health priority [2,3], our findings show that even in the last week of life 
comfort care is not the main goal of care for a substantial proportion of older people, even 
among those over 85. These findings warrant more attention to the palliative care needs of 
older patients, perhaps particularly those between 75 and 85 who seem to be at a higher risk of 
receiving burdensome curative or life-prolonging interventions, possibly at the cost of their 
comfort, than those over 85. Further research is needed to better understand the needs of 
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Understanding the current quality of end-of-life care delivered to patients in acute geriatric 
hospital wards and their quality of dying can have a positive impact on improving practice. 
This study addresses the following main research questions: (1) which nursing and medical 
interventions are performed in the last 48 hours of life of patients dying in acute geriatric 
hospital wards, and (2) what is the quality of dying of these patients?  
METHODS 
We conducted a retrospective cross-sectional descriptive study in 23 acute geriatric wards in 
13 hospitals in Flanders. This sample was obtained after we had invited all acute geriatric 
Flemish wards to participate in the study. Patients who died between October 1
st
 2012 and 
September 30
th
 2013 were included in the study. For each included patient, structured after-
death questionnaires were filled out by the nurse, the physician and the family carer most 
involved in end-of-life care. Main outcome measures were the percentages of performed 
nursing and medical interventions in the last 48 hours of life and the quality of dying. 
RESULTS 
We included 338 patients (mean age 85.7 years; 173 female). Almost 58% had dementia 
(mild, moderate or severe) and nearly half were not able to communicate in the last 48 hours 
of their life. The most frequently continued or begun nursing and medical interventions in the 
last 48 hours of life were measuring temperature (91.6%), repositioning (83.3%), washing 
(89.5%), oxygen therapy (49.7%), intravenous fluids and nutrition (30%), antibiotics (22.8%) 
and routine blood tests (19.2%). In the same time span, shortness of breath, lack of serenity, 
lack of peace and lack of calm were reported most frequently by both nurses and family carers. 
CONCLUSION 
Many nursing and medical interventions are continued or even begun in the last hours of a 
patient’s life, which may not always be in their best interests. Furthermore, patients dying in 
acute geriatric wards are often affected by several symptoms which poses challenges to the 








Populations worldwide are ageing, leading to a major increase in the proportion of those aged 
65 years and older
1
. Patterns of disease in the last years of life are also changing with more 
people dying from chronic debilitating conditions, such as cardiovascular disease, chronic 
obstructive pulmonary disease, diabetes, cancer and dementia
1
. Since many of these illnesses 
are more common among older people, this group frequently experiences multiple and 
complex health problems and disabilities until death, and will therefore have special care 
needs at the end of life
1,2
. 
Despite the fact that many people prefer to die at home
3
, a substantial proportion of these older 
people will die in a hospital setting
4
, e.g. in acute geriatric hospital wards, where ensuring 
appropriate end-of-life care is complex and challenging due to a focus on cure and life-
prolonging treatment
5–8
, a lack of palliative care knowledge in hospital staff and difficulties in 
predicting the time of death in older people
5–7,9–11
.  However, delivering optimal end-of-life 
care is a necessity for every patient, regardless of age, setting and diagnosis
1
. It is known for 
instance that appropriate care for the dying consists of the prevention of symptoms such as 
pain and distress, urinary retention, constipation and pressure ulcers, performing mouth care, 
carefully considering the need for rehydration and avoiding over-intervention with 
inappropriately aggressive treatments
12,13
. International research suggests that older people 
have reported that adequate pain and symptom management, spiritual and/or psychological 
well-being, avoiding inappropriate prolongation of dying, and providing best quality of life for 
their families are important aspects of optimal care which may contribute to a ‘good death’
13
. 
If we want to ensure and improve the quality of end-of-life care for people hospitalized in 
acute geriatric wards, we must first understand how end-of-life care is currently delivered and 
how people are presently dying. Knowledge regarding the nature and quality of end-of-life 
care in older people is increasing
7,13–27
, both in nursing homes and in the acute hospital setting. 
However, published research about end-of-life care for older patients in the acute hospital 






, with no research 
published for the Belgian context where hospital care might be differently organized and care 
processes may be delivered differently. Additionally, the research that has been performed in 
the hospital setting is characterized by low sample sizes, an investigation of either the 
perspectives of nurses, physicians or family carers but no combination of these and a 
retrospective case note review methodology. Nevertheless, due to the limitations of incomplete 
documentation, difficulty in interpreting information found in the documents and variance in 
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the quality of information recorded by medical professionals
25,28,29
 adopting this methodology 
is discouraged and other methodologies such as a questionnaire study are preferable. None of 
these studies were performed solely in specialized acute care units for older people, e.g. acute 
geriatric wards, indicating that research regarding end-of-life care for patients hospitalized in 
such wards is lacking. It is therefore beneficial to investigate end-of-life care delivered to 
patients hospitalized in acute geriatric wards, and how such patients die, by using a 
questionnaire methodology. 
Hence, the general aim of this multicentre study was to examine end-of-life care and quality of 
dying by answering the following main research questions: (1) which nursing and medical 
interventions are performed in the last 48 hours of life of patients dying in acute geriatric 




A retrospective cross-sectional descriptive study was conducted in Flanders, Belgium. 
Structured after-death questionnaires were filled out by the nurse, the physician and the family 
carer most involved in the care for the patient who died on the geriatric ward.  
SETTING AND STUDY POPULATION 
After we had invited all hospitals situated in East and West Flanders and five hospitals from 
Antwerp and Limburg to participate in the study, we obtained a sample consisting of 23 acute 
geriatric wards in 13 Flemish hospitals. Deceased patients were included in the study and thus 
eligible for evaluation if they (a) had given their informed consent at the time of admission for 
the use of their personal information from medical or nursing records for the purposes of the 




 2012 to September 30
th
 2013 all participating geriatric wards included 
patients who died on the ward. For each eligible patient, the following characteristics were 
collected by the researcher via the administrative files of the participating hospitals: age, 
gender and length of hospital stay (Figure 1). The nurse and the physician who had been most 
closely involved in the end-of-life care of the patient were asked to fill out a questionnaire 
within one week after death in order to minimize recall bias (Figure 1). Six weeks after death a 
questionnaire was sent to the patient’s family carer who had been most closely involved in the 
end-of-life care and had given informed consent to be contacted by the researcher (Figure 1). 
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In cases where the family carer did not respond to the original questionnaire up to two 
reminders were sent, two weeks after the initial sending of the questionnaire and two weeks 
after that.  
MEASUREMENTS  
After-death questionnaires filled out by the nurse, the physician and the family carer surveyed 
socio-demographic characteristics, clinical characteristics, the performed nursing and medical 
interventions in the last 48 hours of life and the quality of dying (Figure 1).   
Performed nursing and medical interventions in the last 48 hours of life were measured by 
asking about visits from a palliative care nurse, the performance of nursing interventions at 
three points (48 to 24 hours before death, 24 to 12 hours before death and in the last 12 hours 
before death) and the performance of medical interventions in the last 48 hours of life (Figure 
1). To measure the quality of dying, the nurse and family caregiver questionnaire contained 
the validated Comfort Assessment in Dying End-of-Life in Dementia Scale (CAD-EOLD)
30
 
(Figure 1). The original scale aims to measure the perceptions of symptom intensity and 
conditions common during the last week of life and contains 14 items each with a possible 
range from 1 (worst) to 3 (best). The total score is a summation of the 14 items and ranges 
from 14–42, with a higher score indicating a higher level of comfort for the patient
31,32
. In 
order to assess the comfort in the last 48 hours of life instead of the last week of life, wordings 




STATISTICAL ANALYSIS  
Descriptive statistics were used to describe the characteristics of the study population, the 
performed nursing and medical interventions in the last 48 hours of life and the quality of 
dying (CAD-EOLD). Results are reported as means and standard deviations (SD) or 
percentages. The Friedman Test was used to compare performed nursing interventions 
between the three different periods (48 to 24 hours before death, 24 to 12 hours before death 
and in the last 12 hours before death). All analyses were performed with SPSS statistical 
software, version 20 (SPSS Inc., IBM, USA). 
ETHICAL APPROVAL 
Approval was obtained from the Central  Ethics Committee of the Vrije Universiteit Brussel 
(VUB) (Belgium) and by the Local Ethics Committees of the participating hospitals in 
Flanders (B.U.N. 143201213985). 
 
RESULTS 
Included patients who died on the acute geriatric wards 
From October 1
st
 2012 to September 30
th
 2013 a total of 993 patients died on the wards. Of 
these, 655 could not be included in the study because they had not given informed consent at 
admission for their personal data to be used for research purposes (n = 638) or because they 
were hospitalized for less than 48 hours (n = 17); 338 patients could thus be included in the 
study (Figure 2). There were no differences between included patients (n=338) and non-
included patients (n=655) in terms of age (p=0.370) and gender (p=0.531). However, the mean 
length of hospital stay of non-included patients (16.4 days) was significantly shorter than that 
of included patients (23.7 days) (p <0.001). 
Responses of nurses, physicians and family carers 
Response rates for questionnaires of nurses was 91%, for physicians 85% and for family carers 
35% (Figure 2). Since we obtained high response rates for the nurse and physician 
questionnaires, we were able to perform a thorough non-response analysis to assess a possible 
response bias for family carers. Results from a multivariate analysis showed that age and 
dying alone were independently related to the response of the family carer. Older patients were 
more likely to be evaluated by a family carer than younger patients (OR 1.05; p=0.020) and it 





Characteristics of included patients 
Of the 338 included patients, the mean age was 85.7 (SD 6.52) years and 52% were female 
(Table 1). Mean length of stay in the hospital was 24.8 (SD 23.28) days (Table 1). Almost 
20% of the included patients stayed longer than four weeks on the acute geriatric ward 
whereas the other 80% died after a shorter period (Table 1). According to the family carers 
approximately 48% of the patients wished to die at home and nearly 22% in a nursing home, 
service flat or hospital (Table 1). Nurses reported that 37% of the patients died alone on the 
ward (Table 1). Almost 58% of the patients had dementia (mild, moderate or severe) and 
nearly half were not able to communicate in the last 48 hours of life due to dementia, 
decreased consciousness, unconsciousness or an acute confusional state (Table 1). Acute organ 
failure (43.5%) and acute infectious diseases (39.9%) were the most important immediate 




Table 1 Characteristics of included patients died in acute geriatric wards 
Patient characteristics N = 338 n (%)  
Age at death, mean number of years (SD)* [Observed range] 85.7 (6.52) [63-103] 
Gender* 
   Female  




Residency before admission to hospital† 
   Home 
   Nursing home 
   Service flat 
   Other hospital 




 10 (3.5) 
3 (1.0) 
2 (0.7) 
Reason(s) for admission to acute geriatric ward† || 
   A medical intervention was necessary  
   The care burden was too high for family carers  
   The care burden was too high for health care staff of the NH 
   The patient desired a hospital admission  
   There was no place in a nursing home  








Length of hospital stay, mean number of days (SD)* 24.8 (23.28) 
Length of stay on acute geriatric ward† 
   >4 weeks 
   2-4 weeks 
   1-2 weeks 
   72 hours-1 week 







Living situation before hospital admission‡ 
   Home, alone 
   Home with partner/children/other 
   Nursing home, alone 






Desired place of death‡ 
   Home 
   Nursing home 
   Service flat 
   Hospital 







Persons at bed side when dying§ || 
   Died alone 
   Family 
   Nurse 
   General practitioner 
   Hospital physician 








Immediate cause of death† 
   Acute oncologic 
   Acute infectious 
   Acute organ failure 
   Frailty/dementia 
 
32 (11.5) 
 111 (39.9) 
 121 (43.5) 
14 (5.0) 
Underlying diseases† 
   Metastatic cancer 
   Neurodegenerative disorder 
   Frailty 
   Organ failure 
   Frailty and organ failure 
   Neurodegenerative disorder and frailty  
   Neurodegenerative disorder and organ failure  
   Neurodegenerative disorder, frailty and organ failure 
 








Stage of dementia† 
   No dementia  
   Mild  
   Moderate 






Able to communicate during the last 48 hours† 
   Yes  
   No, because of ||  Dementia 
                                Decreased consciousness  
                                Unconsciousness  
                          Acute confusional state 








Missing values: age at death: n=11/338 (3.3%), gender: n=5/338 (1.5%), residency before admission: n=2/290 (0.7%), reason(s) for 
admission: n=2/290 (0.7%), length of hospital stay: n=7/338 (2.1%), length of stay on acute geriatric ward: n=6/290 (2.1%), living situation 
before admission: n=1/119 (0.8%), desired place of death: n= 4/119 (3.4%), persons at bed side when dying: n=5/307 (1.6%),  cause of death: 
n=12/290 (4.1%), underlying diseases: n=10/290 (3.4%), stage of dementia: n=25/290 (8.6%), able to communicate during last 48 hours: 
n=3/290 (1.0%). * Collected by the researcher; † Reported by the physician; ‡ Reported by the family carer; § Reported by the nurse; || More 
than one response was possible; Abbreviations: NH = nursing home 
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End-of-life care in terms of performed nursing and medical interventions 
Nursing interventions 
Forty-six and a half percent of the deceased patients received one or more visits from a 
palliative care nurse. Mouth care in the last 48 hours of life was performed for 98%. For at 
least 75% of the patients who experienced breathing difficulties due to mucus production, 
measures were taken. However, for 21%  the nurse did not know if any measures were taken. 
The three most frequently performed nursing interventions in the last 48 hours of life were 
measuring temperature, repositioning and washing (Table 2). As death approached the 
patient’s vital signs were taken significantly less often and washing and wound care were 
performed significantly less often (Table 2). 
Medical interventions  
During the last 48 hours of life, 49.7% of the patients received oxygen therapy, 30% 
intravenous fluids and nutrition, 22.8% antibiotics and in 19.2% a routine blood test was 
performed (Table 2). Antibiotics, intravenous fluids and nutrition and blood sugar regulation 
were stopped in the last 48 hours of life for 17.2%, 15.7% and 12.5% of the patients 
respectively (Table 2). 
Table 2 Nursing and medical interventions in the last 48 hours of life 
 
 %  p-value* 
 
Nursing interventions 
N = 307 
 




24 to 12 hours 
before death 
 
last 12 hours 
before death 
  
Blood pressure measurement  
Pulse measurement  











































N = 290 
 






Started   
 
 
Routine urine test 
Routine blood test 
Blood sugar regulation 
Antibiotics 
Intravenous fluids and nutrition 
Tube feeding 




































Missing values are for nursing interventions 48 to 24 hours before death n= 20/307 (6.5%), nursing interventions 24 to 12 hours before death 
n=24/307 (7.8%) and nursing interventions last 12 hours before death n=11/307 (3.6%). 
*Differences between the frequency of performed nursing interventions 48 to 24 hours before death, 24 to 12 hours before death and the last 
12 hours before death are tested using Friedman Test, significance level at 0.05.  
Missing values are for routine urine test n=9/290 (3.1%), routine blood test n=4/290 (1.4%), blood sugar regulation n=10/290 (3.4%), 
antibiotics n=5/290 (1.7%), intravenous fluids and nutrition n=4/290 (1.4%), tube feeding n=7/290 (2.4%), body fluid drainage n=4/290 
(1.4%) and oxygen therapy n=8/290 (2.8%). 
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Quality of dying 
Comfort Assessment in Dying - End-of-Life in Dementia (CAD-EOLD)  
In the last 48 hours of life, highest levels of comfort were reported by both nurses and family 
carers for crying (mean for nurse 2.9; mean for family carer 2.6) and moaning (2.5; 2.4). The 
reported level of the pain item was 2.2 according to nurses and 2.1 according to family carers 
(Table 3). More exactly, according to nurses and family carers, 59% and 69% of the patients 
respectively experienced a lot of pain or some pain. 
Both proxies reported lowest levels of comfort around dying for shortness of breath (2.0; 1.8), 
serenity (2.0; 2.0), peace (2.1; 2.0), and calm (2.1; 2.0) (Table 3). More specifically, according 
to nurses and family carers, 69% and 72% of patients respectively were moderately to highly 
affected by shortness of breath and the majority experienced a lack of serenity (76% and 80% 
respectively). 
According to family carers, low levels of comfort were also reported for difficulty with 
swallowing (1.8) and restlessness (1.9) (Table 3).  
Table 3 Quality of dying measured by CAD-EOLD*: mean scores and distribution 
 
 Reported by nurse 
N = 307 
Reported by family carer 
N = 119 
  %  % 
CAD-EOLD item scores 
 
Mean scores (SD)†  
[Observed range] 
A lot Sometimes Not at all Mean scores (SD)†  
[Observed range] 





4. Shortness of breath 
5. Choking  
6. Gurgling 



































































































































CAD-EOLD total score 
 
 
31.9 (5.73) [16-42] 
    
29.1 (5.85) [15-42] 
 
   
*The CAD-EOLD consists of 14 items with each a possible range from 1 (worst) to 3 (best). All items were (re)coded so that higher scores 
means better symptom management. The 14 items can be separated into four subscales. The CAD-EOLD total score is constructed by 
summing the value of 14 items. It ranges from 14 to 42 with higher scores indicating better symptom control; missing CAD-EOLD items 
were imputed with patients’ means in case there were four or fewer missings scores on the scale. 
Missing values for CAD-EOLD item scores varied between 2.3% and 7.8%  for reports by nurses and varied between 14.3% and 21.0% for 
reports by family carers. Total scores (imputed with subject means for a maximum of four items missing) refer to reports by nurses (9.1% 
missing) and reports by family carers (23.5% missing).  






This cross-sectional study examined end-of-life care provided for patients hospitalized in acute 
geriatric hospital wards in Flanders and their quality of dying. The study showed that several 
nursing and medical interventions, ie measuring temperature, repositioning, washing, oxygen 
therapy, intravenous fluids and nutrition, antibiotics and routine blood tests, are continued or 
even begun in the last 48 hours of life. Nurses and family carers reported that the quality of 
dying of these older patients is reasonably good although there is some room for improvement 
regarding shortness of breath and items related to the patient’s well-being, such as serenity, 
peace and calm. 
Our study was large-scale and multicentric with 338 patients recruited from 23 acute geriatric 
wards in 13 Flemish hospitals. As we included hospitals from different regions and of different 
sizes, this may have increased the generalizability of the study findings
26
. Unlike earlier 
conducted studies, we did not use a retrospective case note review methodology to examine 
end-of-life care and quality of dying. Due to incomplete documentation and lack of 
standardized structure, case note review methodology may lead to underreported variables and 
thus the validity of the findings may be questioned
25,29
. In contrast, our study adopted a more 
valid methodology by retrospectively completing questionnaires. Furthermore, three different 
questionnaires were developed to be filled out by a nurse, a physician and a family carer, 
which permitted us to investigate the perspectives of different proxies and to assess different 
constructs within end-of-life
33
. Finally, in this study we obtained a high response rate for both 
nurses (91%) and physicians (85%).  
A number of limitations have to be considered. First, we cannot preclude selection bias as the 
study wards participated in the study on a voluntary basis and may have had a prior interest in 
end-of-life care. Furthermore, selection bias may have been introduced because of our 
inclusion criteria and the low response rate for family carers. This could have biased our 
results with regard to the quality of end-of-life care and the quality of dying. Although no 
differences were found between included and non-included patients within our sample in 
terms of age and gender, the mean length of hospital stay of the included patients was 
significantly longer. Regarding the low response rate for family carers (35%), a non-response 
analysis detected few significant differences between characteristics of patients for whom a 
family carer questionnaire was received and those for whom no family carer questionnaire was 
received.  Only age and dying alone were independently associated with evaluation by a 
family carer and it may thus be that younger patients and those who died without being 
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surrounded by family members or friends had a different quality of dying as reported by the 
family carer. Second, our results may have been affected by assessment bias. Due to the 
vulnerability and poor health conditions of dying patients, we were not able to interview the 
patients themselves. Our data are based on proxy measures and not on what the patients 
themselves experienced. However, the reliability of proxy assessments in older patients with 
and without dementia for various aspects of quality of end-of-life are well described
34
. 
Assessments made by health care staff and family carers are reasonably accurate and nurses 
may be the most suitable source of proxy information, though proxy assessments should 
always be interpreted with caution
35
.  Finally, for practical reasons, we did not compare the 
performance of medical and nursing interventions and quality of dying between the different 
participating geriatric wards, which could have added value to the study by providing insight 
into the extent to which variations in end-of-life care exist between settings. 
For about half of the patients, a palliative care nurse visited at the end-of-life, which is more 
often than what was found in other studies performed in acute hospital in the United Kingdom 
and Singapore, where palliative care advisory support was sought for only two out of the 25 
patients and 31% of patients respectively
22,24
. This may suggest that health care staff more 
willingly adopt a palliative care approach in an acute geriatric ward than in the average acute 
hospital ward and consequently more often contact a member of the palliative care team. 
Alternatively, it could also be that health care staff on the ward have more and easier access to 
palliative care services or that the palliative care team is more integrated into the acute 
geriatric ward than into other wards.  
We also found that nursing interventions, such as mouth care and the management of 
breathing difficulties due to mucus production, were appropriately performed in the last 48 
hours of life, which are important in contributing to a comfortable death
12,13
.  Although some 
nursing interventions were significantly less often performed as death approached, several 
interventions such as measuring temperature, repositioning and washing were continued until 
death in a substantial number of cases. The influence of these interventions on the patient’s 
comfort is questionable. It is for instance known that preventing and treating pressure ulcers 
by repositioning the patient may relieve discomfort and pain and thus contribute to a pain free 
death
36,37
. In contrast, other studies show that regularly repositioning or turning the patient 
may disturb or tire them, or induce pain
38,39
. Also a number of medical interventions, such as 
oxygen therapy, intravenous fluids and nutrition, antibiotics and routine blood test are 
continued until death and their appropriateness is also controversial. The choice to continue or 
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start these interventions should thus be well considered and must be tailored to the individual 
needs of patients and their family
40–45
. 
Comparison of the CAD-EOLD scores with those from other studies is difficult because of 
important differences in setting and population, although the current study results seem to 
support previous research that used the same tool
14,17,27,31
. It was for instance found that both 
nursing home residents with dementia and older patients living with advanced dementia in the 
community died with a lack of serenity, peace and calm
14,17,27,31
 Results of both the present 
study and these earlier studies stress the magnitude of unmet psychosocial and existential 
needs at the end-of-life and the need to address these needs. One possible explanation for these 
findings could be that in the acute hospital less attention is given to psychosocial and 
existential aspects of end-of-life care compared with the medical aspects of care. It might also 
be that addressing these needs in our study population is challenging, knowing that nearly half 
of patients are not able to communicate in the last 48 hours of their life. 
The present study also showed that nurses and family carers reported that a substantial portion 
of patients hospitalized in acute geriatric wards die with shortness of breath. As measured by 
the CAD-EOLD, the mean score on this item is similar to what was found in previous research 
performed in nursing homes
14,17,27,31
According to research in the acute hospital setting, 
shortness of breath is a common symptom associated with end-of-life care in older patients
24
. 
Also pain appears to be an important symptom during the dying process of older people in 
acute hospital
24
. Previous research has shown that older people, particularly those suffering 
from non-malignant diseases, are less likely to receive appropriate pain control at the end of 
life compared with their younger counterparts
46
. However, in this study we cannot 
convincingly consider pain as a concern as we obtained a better mean score on the pain item in 
comparison with earlier performed studies in nursing homes
14,17,27,31
 although the majority of 








This study provides important insights into the challenges of providing quality end-of-life care 
for older people dying in acute geriatric hospital wards. A number of interventions are 
continued or even begun in the last 48 hours of life which are at the least controversial and 
may not be in the patient’s best interest. Further research should focus on the appropriateness 
of these interventions in the last days of life. Using the CAD-EOLD, we found that breathing 
problems and items related to the psychosocial and existential domain of wellbeing were 
common for patients dying in acute geriatric wards. The priorities for considering the 
appropriateness of nursing and medical interventions and for improving comfort around dying 
for this population should include structuring care processes in the last days of life, with 
specific attention to the identified problems. Second, health care staff should be educated 
regarding palliative care principles, including symptom management and comfort in the last 
days of life, so that they are able to address the identified problems and ensure better quality of 
care around dying. Third, health care staff could be encouraged to seek the support of the 
palliative care team for dealing with the psychosocial and existential needs of dying patients. 
In short, structuring care processes in the last days of life by using end-of-life care plans based 
on best practices for care in the last days of life may strongly contribute to the management of 
unfavourable symptoms in the terminally ill older patient, especially in acute geriatric wards, 
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DEPRESCRIPTION OF MEDICATION 
DURING THE LAST 48 HOURS OF LIFE: 


















To describe the anticipatory prescription of medication for symptomatic treatment and the 
deprescription of potentially inappropriate medication (PIM) during the last days of life.  
DESIGN 
Cross-sectional descriptive study between October 1st 2012 and September 30th 2013. 
SETTING 
Twenty-three acute geriatric wards in 13 hospitals in Flanders, Belgium.  
PARTICIPANTS 
Patients hospitalized for more than 48 hours before dying in the participating wards. 
MEASUREMENTS 
Structured after-death questionnaires, filled out by the treating geriatrician. Main outcome 
measures were the anticipatory prescription and deprescription of medication during the last 
48 hours of life. 
RESULTS 
Anticipatory prescription of medication for symptomatic treatment was present in 65.4% of 
cases, 45.5% of these prescriptions being for morphine, 15.5% for benzodiazepine and 13.8% 
for scopolamine hydrobromide. A deprescription of PIM was noted in 67.9% of cases. Where 
death was expected by the physician, anticipatory prescription was present in 83% and de-
prescription of PIM took place 86% of cases. The likelihood of anticipatory prescription was 
significantly higher in cases where death was expected (OR 19; 95%CI [9-40]; p<0.0001) and 
significantly lower where dementia was present (OR 0.35; 95% CI [0.16-0.74]; p<0.006). The 
likelihood of deprescription was higher in cases where death was expected (OR 20; 95% CI 
[10 – 43]; p<0.0001) and in cases of patients dying from an oncological disease compared 
with those dying from frailty or dementia  (OR 7.0; 95% CI [1.1-45.6], p=0.042). 
CONCLUSION 
Anticipatory prescription of medication and deprescription of PIM at the end of life in acute 
geriatric wards could be further improved. A well-developed evidence-based intervention to 
guide health care staff in developing a medication policy for older patients in the last days of 







As a result of increasing life expectancy, nearly 50% of the population of Western Europe die 
aged 80 years and older (1). Depending on the country, from about 30% to over 60% of those 
die in acute hospital wards (2). Studies show that palliative care for the older person is often 
limited, resulting in poor symptom control and poor quality of dying (3,4). The population 
with dementia is particularly prone to poor symptom control during the last week of life (5,6).  
One of the core principles of palliative care is the relief of suffering and improvement of 
quality of life through the impeccable treatment of pain and symptoms (7). Therefore, 
appropriate pharmacological management is increasingly highlighted as a quality indicator of 
palliative care (8). Two important aspects should be considered in appropriate 
pharmacological management at the end of life. First, there should be anticipatory prescribing 
of symptomatic medication to respond to fluctuations in symptom levels (8). Anticipatory 
prescribing of opioids has been studied in randomized control trials in cancer patients (9), but 
there are few data regarding anticipatory prescribing for other illnesses at the end of life 
(10,11). Secondly, because of the high incidence of multiple diseases and the consequential 
high intake of multiple medications, some authors highlight the necessity of a medication 
review and the deprescription of potentially inappropriate medication (PIM) at the end of life 
in frail older patients and in those with dementia (12-16). However, recent meta-analysis 
shows that little rigorous research has been conducted in this area (17). Moreover, the criteria 
for discontinuance of medication are heterogeneous, ranging from well-standardized 
appropriateness criteria like Beers, START/STOPP and the Medication Appropriateness Index 
to more implicit criteria taking into account the overall health condition like the Good 
Palliative-Geriatric Practice algorithm (17).  
Un to now there have been few epidemiologic studies describing pharmacological 
management in nursing homes (18) and among cancer patients at the end of life (19-23), none 
of which address the subject of pharmacological management during the last days of life of 
frail older people on a specialized acute geriatric ward. Therefore, this study aims to describe 
(1) the anticipatory prescription of symptomatic medication and (2) the deprescription of PIM 
during the last 48 hours of life in acute geriatric wards; the relationship between medication 







A cross-sectional descriptive study was conducted in Flanders, Belgium. Structured after-
death questionnaires were filled out by the treating geriatricians.  
SETTING AND STUDY POPULATION 
Twenty-three acute geriatric wards in 13 Flemish hospitals participated in the study. Deceased 
patients were included in the study if they met the following criteria: (a) being hospitalized on 
the geriatric ward for more than 48 hours and (b) having given informed consent at the time of 
admission for the use of their medical or nursing records. Approval for the study was obtained 
from the Central Ethics Committee of the Vrije Universiteit Brussel (VUB) and by the Local 
Ethics Committees of the participating hospitals (B.U.N. 143201213985). 
DATA COLLECTION 
Data collection took place between October 1st 2012 and September 30th 2013. For each 
patient who died on the ward, administrative data such as age, sex and length of hospital stay 
were collected by the researcher. The treating geriatrician was asked to fill out a questionnaire 
within one week of death in order to minimize recall bias. Detailed information on the study 
methodology is described elsewhere (24). 
MEASUREMENTS 
After-death questionnaires surveyed, among other variables, underlying diseases, cause of 
death, the main goal of treatment, ability to communicate, whether the death was expected by 
the geriatrician, anticipatory prescription of medication and deprescription of PIM during the 
last 48 hours of life. The anticipatory prescription was measured by questioning whether, 
during the last 48 hours of life, medication for symptom control had been prescribed and, if so, 
what that medication was. A list of PIM was developed using the Good Palliative-Geriatric 
Practice algorithm (16) and reviewed through pilot testing by two geriatricians with 
experience in palliative medicine. Out of this list of PIM, the geriatrician indicated which 
medications were started, stopped or continued during the last 48 hours of life. 
STATISTICAL ANALYSIS 
Values are reported as absolute numbers and percentages. Chi-square tests were used for 
analyzing differences in characteristics between patients dying with or without dementia, and 
between patients in the different stages of dementia (beginning, mild, severe).  Associations 
between patient characteristics, anticipatory prescribing and deprescribing were analyzed 
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using chi-square-tests (univariate analysis). Multivariable logistic regression models were built 
to detect key factors associated with having an anticipatory prescription or deprescription 
during the last 48 hours of life. All analyses were performed with SPSS statistical software, 
version 20 (SPSS Inc., IBM, USA). 
RESULTS 
A total of 993 patients died on the participating wards during the study period; 338 met the 
inclusion criteria and a questionnaire was filled out by a geriatrician for 290 of those (response 
rate 85%). 
The mean age of the patients was 85.7 years (not in tables); 53% were women and 73.4% were 
admitted from home (Table 1). In 70.6% the geriatrician had expected the patient’s death.  
Fifty three percent were diagnosed with dementia. Those with and without dementia differed 
for the immediate cause of death (p=0.001), the patient’s ability to communicate (p<0.001) 
and whether or not death had been expected by the geriatrician (p=0.046).  
Table 1 Demographic and clinical characteristics of patients in the study 
 Total population 
n=290 
People with dementia  
n=154 (53.1%) 































Frailty and organ failure 
Neurodegenerative disorder  
and frailty 
and organ failure 


































































Residency before admission 
Long term care facility 
Home 

















Reason for admission 









Length of stay 
> 4 weeks 
2-4 weeks 






















Ability to communicate 53.0% 35.1% 73.3% <0.001 





A total of 185 patients (65.4%) had an anticipatory prescription of medication during the last 
48 hours of life (Table 2), 45.5% for morphine, 15.5% for a benzodiazepine and 13.8% for 
scopolamine hydrobromide (not in tables). No significant association between the class of 
drug medication prescribed and the immediate cause of death was found (not in tables). 
Table 2 Relation between the anticipatory prescription of medication and patient characteristics in 23 acute geriatric wards (n=290) 
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Frailty and organ failure 
Neurodegenerative disorder  
and frailty 
and organ failure 






























Death expected by physician (n=282) 
















*Missing value: 7 out of 290 included patients; % calculated on included patients 
Numbers in rows are different due to missing values 
 
The geriatrician expecting the patient to die (p<0.001) was significantly related to a higher 
prescription rate of anticipatory medication (Table 2). In 83% of those patients expected to die 
an anticipatory prescription was present (not in tables). Further, the anticipatory prescription 
of morphine was significantly lower in patients with dementia (Table 2; p=0.013) and 
especially in those with early stage dementia (p=0.034) (not in tables). For the anticipatory 
prescription of other medication no significant correlation with the stage of dementia was 
found. After multivariable adjustment for age, sex, cause of death and ability to communicate 
during the last 48 hours of life, the likelihood of having anticipatory medication was 
significantly higher in patients where death was expected by the physician OR 19; 95% CI [9-
40]; p<0.0001) and significantly lower in patients with dementia (OR 0.35; 95% CI [0.16-
0.74]; p<0.006) (Supplementary table online).
Supplementary tables online 
Anticipatory prescription: Logistic Regression  
 
 B S.E. Wald Df Sig. Exp(B) 
95% C.I.for EXP(B) 
Lower Upper 
Step 1a Dementia (yes versus no) -1,060 ,389 7,445 1 ,006 ,346 ,162 ,742 
Age patient (versus ≥ 95)   ,187 3 ,980    
     (<75) -,067 1,107 ,004 1 ,951 ,935 ,107 8,189 
     (75-84) -,124 ,938 ,017 1 ,895 ,883 ,141 5,550 
     (85-94) ,036 ,911 ,002 1 ,969 1,036 ,174 6,179 
Cause of death (versus frailty)   5,749 3 ,124    
     (oncological) -,791 ,897 ,776 1 ,378 ,454 ,078 2,633 
     (infectious) ,200 ,783 ,065 1 ,799 1,221 ,263 5,671 
     (organ failure) -,655 ,788 ,690 1 ,406 ,520 ,111 2,435 
Expected death (yes versus no) 2,960 ,369 64,252 1 ,000 19,294 9,357 39,786 
Ability to communicate (no vs. yes) ,520 ,383 1,844 1 ,175 1,682 ,794 3,563 
Gender patient (male vs. female) -,587 ,356 2,719 1 ,099 ,556 ,277 1,117 
Constant -,328 1,199 ,075 1 ,784 ,720   
a. Variable(s) entered on step 1: dementiayesorno, leeftijdscategorie_patiënt, doodsoorzaak_nieuw, verwacht_overlijden, arts_A7gesprek, Geslacht_patiënt. 
 
Deprescription: Logistic Regression  
 
 B S.E. Wald Df Sig. Exp(B) 
95% C.I.for EXP(B) 
Lower Upper 
Step 1a Dementia (yes versus no) ,073 ,394 ,035 1 ,852 1,076 ,497 2,328 
Age patient (versus ≥ 95)   ,580 3 ,901    
     (<75) ,259 1,239 ,044 1 ,834 1,296 ,114 14,688 
     (75-84) -,118 1,016 ,014 1 ,907 ,888 ,121 6,503 
     (85-94) -,273 ,983 ,077 1 ,781 ,761 ,111 5,232 
Cause of death (versus frailty)   11,479 3 ,009    
     (oncological) 1,946 ,956 4,146 1 ,042 7,002 1,076 45,586 
     (infectious) ,813 ,758 1,151 1 ,283 2,255 ,511 9,958 
     (organ failure) -,076 ,755 ,010 1 ,920 ,927 ,211 4,070 
Expected death (yes versus no) 3,032 ,371 66,803 1 ,000 20,739 10,023 42,908 
Ability to communicate (no vs. yes) -,148 ,389 ,144 1 ,704 ,863 ,402 1,849 
Gender patient (male vs. female) -,199 ,354 ,316 1 ,574 ,820 ,410 1,639 
Constant -1,251 1,253 ,997 1 ,318 ,286   
a. Variable(s) entered on step 1: dementiayesorno, Age_categorical, cause_of_death, expected_death, ability_to_communicate, Gender_patient. 
72 
 
The potentially inappropriate medications at the end of life with which patients were most 
often being treated on admission to the geriatric ward were antihypertensives (71.5 %), 
antibiotics (63.6%), diuretics (61.3%), anti-ulcer drugs (59.2%) and inhalation betamimetics 
and/or steroids (58.4%) (Table 3). In 67.9% of patients, and in 86% of those whose death was 
expected by the physician, one of the medications prescribed at admission was deprescribed 
during the last 48 hours of life (not in tables). Those most often withdrawn during the last 48 
hours of life were antihypertensives (in 44.8% of all patients) and antibiotics (in 42.4% of all 
patients) (Table 3).  
Table 3 Deprescription of potentially inappropriate medication during the last 48 hours of life in 23 acute geriatric wards (N=290) 
 % patients treated at admission % patients treated until death 
Inhalation betamimetics and/or steroids (n=262) 58.4 32.1 
Antihypertensive (n=270) 71.5 26.7 
Anti-ulcer drugs (n=260) 59.2 26.5 
Diuretics (n=266) 61.3 23.3 
Antibiotics (n=264) 63.6 21.2 
Laxatives (n=256) 44.5 15.2 
Anticoagulants (n=250) 33.6 14.8 
Aspirin (n=264) 45.5 13.3 
Corticosteroids (n=247) 30.8 13.0 
Bisphosphonates (n=256) 23.4 8.6 
Lipid Lowering Drugs (Statins) (n=251) 21.5 8.8 










Numbers in row are different due to missing values 
 
A multivariable logistic regression analysis simultaneously controlling for various possible 
confounders showed that the likelihood of medication being deprescribed was higher in 
patients where the death was expected by the geriatrician compared with those where the death 
was not expected (OR 21; 95% CI [10–43]; p<0.0001) and higher in patients dying from an 
oncological disease than in those dying from frailty or dementia (OR 7.0; 95% CI [1.1-45.6], 










This multicentre cross-sectional study investigated the policy of anticipatory prescription of 
symptomatic medication and the deprescription of potentially inappropriate medication during 
the last 48 hours of life in Flemish acute geriatric wards. Firstly, we found a clear positive 
correlation between anticipatory prescription and the recognition of the dying phase by the 
geriatrician, while lower anticipatory prescription rates for morphine were found in patients 
with dementia, especially in those in the early stages. Secondly, only half of the medications 
prescribed at admission were withdrawn indicating that there is still significant use of 
potentially inappropriate medication during the last 48 hours of life.  
The percentages found in our acute geriatric ward population for the use of antihypertensives, 
anti-infectives, anticoagulants and bisphosphonates are similar to the percentages found in 
previous studies looking at medication practice during the last three days of life in a 
hospitalized cancer population (19,20). In those studies anti-ulcer drugs and corticosteroids 
were more often used than in our study population. Possible explanations for these differences 
are the characteristics of the studied population (cancer versus frail elderly people) and a 
difference between countries in prescription patterns.  
According to the classification of appropriateness of medication developed by Holmes et al 
(15) lipid lowering drugs and acetylcholinesterase inhibitors would never be appropriate in our 
population, yet we found them present in, respectively, 8.8% and 5.7% of cases. In the class of 
rarely appropriate medication, bisphosphonates were still given to 8.6% of patients and 
anticoagulants to 14.8%. A possible explanation for the high rate of inappropriate medication 
in the last days of life may be the lack of evidence about the benefits or harms of medication 
withdrawal. To our knowledge, only one recent RCT has studied the withdrawal of potentially 
inappropriate medication. For statins it has recently been shown that they can be safely 
withdrawn in cancer patients with a survival prognosis of less than one year (25). Although 
recent studies and opinion papers show that the idea of deprescribing PIM in the older frail 
population is high on the agenda (12-17), we found in our study that patients dying with frailty 
or dementia, compared with those with cancer, had a higher risk of continuing PIM until 
death. This together with our finding that the likelihood of the deprescription of PIM is higher 
in patients whose death is expected, points to the importance of an accurate recognition of the 
dying phase. However, an accurate prognostication of survival in those with non-malignant 
diseases seems to be difficult and may lead to postponement of medical decisions (26). This 
prognostic paralysis can be overcome to some extent by the early instigation of discussion of 
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the patient’s preferences and wishes about their end of life (advance care planning) including 
the deprescribing of PIM. This approach may enhance trust between the physician and the 
patient leading to acceptance of the withdrawal of lifelong medication (27). A systematic 
approach, such as the five key steps to identifying and withdrawing medication in the older 
patient, can be useful (12). Scott et al have developed a deprescribing protocol starting with 
the indications for the current drugs, the overall risk of drug-induced harm, the assessment of 
each drug for its eligibility to be discontinued, a prioritization of drugs for discontinuation and 
the implementation and monitoring after drug discontinuation (12).  
Optimal care during the last days of life also suggests the prescription of appropriate 
medication to optimize symptom control such as opioids, benzodiazepines, haloperidol and 
medication suppressing the death rattle (7,9-10). As it has been shown that very old patients 
have lower requirements in the dose of medications we focused mainly on the presence of an 
anticipatory prescription during the last 48 hours of life as an indicator of optimal 
symptomatic care (28). If compared with results from other studies investigating the 
anticipatory prescription of medication for patients with cancer in acute hospital care (19, 20) 
and of older patients in a nursing home setting (6,18) the anticipatory prescription of morphine 
(45.5%), benzodiazepine (15.5%) and scopolamine (13.8%) in our study population was lower 
than that reported post-implementation in a study of a care pathway in a Dutch cancer 
population (respectively 53%, 23% and 25%) (20) and than that reported in a nursing home 
population in Norway (respectively 82.6 %, 70.4% and no reported data for antisecretory 
drugs) (18). Although slightly more than half of the dying population in our study had an 
anticipatory prescription, our findings suggest a need for improving end of life care. 
Introduction of a palliative care consultation and a standardized care pathway such as the 
Liverpool Care Pathway has been shown to increase the rate of anticipatory prescriptions of 
medication (20,21). 
Surprisingly we found that patients with dementia, especially those with early stage dementia, 
had a significantly lower anticipatory prescription rate for morphine (only 28%). A possible 
explanation may be that physicians fear the side effects of morphine on cognitive functioning. 
This finding is comparable to other studies showing undertreatment of pain with opioids in the 
very old (29). However, the percentage is in sharp contrast with that found in nursing home 
residents in the Netherlands and Norway where 77% of those with dementia received opioids 
(7,18). The observed differences may reflect differences in health care organization or cultural 
practices as a result of different expectations of family and caregivers towards end of life care. 
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This study has several strengths and limitations. It is large-scale multicentric study including 
hospitals from different regions and of different sizes, which increases the generalizability of 
the findings. A high response rate by treating physicians was obtained (85%). The data were 
gathered in a systematic way through a validated questionnaire filled in by the treating 
geriatrician within one week of death. One of the limitations of this study is that only the 
anticipatory prescription of medication and not the exact dose of medication given during the 
last 48 hours was registered. Another is that the list of potentially inappropriate medication 
was developed based on rather implicit criteria and only through a small Delphi procedure and 
pilot testing. However, according to the existing literature, the list seems to contain all widely 
accepted potentially inappropriate medications.  
In conclusion, this study shows that anticipatory prescription of medication and deprescription 
of potentially inappropriate medication at the end of life in older patients dying in hospital can 
be further improved. Future research should focus on the development of well-designed trials 
to demonstrate the effect of anticipatory prescription of medication on the quality of dying and 
the safety and benefits of deprescribing PIM. A well-developed intervention to guide health 
care staff in caring for older patients in the last days of life (24,30) can be a first step towards 








































This study was supported by a grant from the Agency for Innovation by Science and 





1. Cohen J, Bilsen J, Addington-Hall J et al. Population-based study of dying in hospital in 
six European countries. Palliat Med 2008;22:702-710.  
2. Davies E, HigginsonIJ. WHO better palliative care for older people. 




3. Walling AM, Asch SM, Lorenz KA et al. The quality of care provided to hospitalized 
patients at the end of life. Arch Intern Med 2010;170:1057-1063. 
4. Brandt HE, Deliens L, Ooms ME et al. ,. Symptoms, Signs, Problems and Diseases of 
Terminally ill Nursing Home Patients. A Nation-Wide Observational Study in the 
Netherlands. Arch Intern Med 2005;165:314-20. 
5. Vandervoort A,. Van den Block L, Vander Stichele R et al. Nursing home residents dying 
with dementia in Flanders, Belgium: a nationwide post-mortem study on clinical 
characteristics and quality of dying. JAMDA 2013;14:485-92. 
6. Hendriks SA, Smalbrugge M, Hertogh CM et al. Dying with dementia: symptoms, 
treatment, and quality of life in the last week of life. J Pain Symptom Manage 
2014;47:710-720. 
7. World Health Organisation. WHO definition of palliative care. 
http://www.who.int/cancer/palliative/definition/en/. Assessed May 25
th
 2015. 
8. Ellershaw JE, Wilkinson S. Care of the dying: A pathway to excellence. 2nd ED. Oxford: 
Oxford University press 2010. 
9. Caraceni A, Hanks G, Kaasa S et al. Use of opioid analgesics in the treatment of cancer 
pain: Evidence based recommendations from the EAPC. Lancet Oncol 2012;13;e58-e68. 
10. Lindqvist O, Lundquist G, Dickman A et al. Four essential drugs needed for quality care of 
the dying: a Delphi-based international expert consensus opinion. J Palliat Med 
2013;16:38-43. 
11. Russell BJ, Rowett D, Currow D. Pro re nata prescribing in a population receiving 
palliative care: A prospective Consecutive Case Note review. J Am Geriatr Soc 
2014;62:1736-40. 
12. Scott IA, Hilmer SN, Reeve E et al. Reducing Inappropriate Polypharmacy: The Process of 
Deprescribing. JAMA Intern Med. 2015 Mar 23. doi:10.1001/jamainternmed.2015.0324. 
[Epub ahead of print]  
78 
 
13. van Nordennen RT, Lavrijsen JC, Vissers KC et al. Decision making about change of 
medication for comorbid disease at the end of life: an integrative review. Drugs Aging 
2014;31:501-512. 
14. Cruz-Jentoft AJ, Boland B, Rexach L. Drug therapy optimization at the end of life. Drugs 
Aging 2012;29:511-521. 
15. Holmes HM, Sachs GA, Shega JW et al. Integrating palliative medicine into the care of 
persons with advanced dementia: identifying appropriate medication use. J Am Geriatr Soc 
2008;56:1306-1311. 
16. Garfinkel D, Zur-Gil S, Ben-Israel J. The war against polypharmacie: a new cost-effective 
geriatric-palliative approach for improving drug therapy in disabled elderly people. Int 
Med Assoc J 2007;9:430-4. 
17. Tjia J, Velten SJ, Parsons C et al. Studies to reduce unnecessary medication use in frail 
older adults: a systematic review. Drugs Aging. 2013;30:285-307.  
18. Jansen K, Schaufel MA, Ruths S. Drug treatment at the end of life: an epidemiologic study 
in nursing homes. Scand J Prim Health Care. 2014;32:187-92.  
19. Lee HR, Yi SY, Kim do Y. Evaluation of Prescribing Medications for Terminal Cancer 
Patients near Death: Essential or Futile. Cancer Res Treat. 2013;45:220-5. 
20. Raijmakers NJ, van Zuylen L, Furst CJ et al. Variation in medication use in cancer patients 
at the end of life: a cross-sectional analysis. Support Care Cancer 2013;21:1003-1011. 
21. Hui D, Li Z, Chisholm G. Changes in medication profile among patients with advanced 
cancer admitted to an acute palliative care unit. Support Cancer Care 2015;23:427-432. 
22. Lindsay J, Dooley M, Martin J et al. Reducing potentially inappropriate medications in 
palliative cancer patients: evidence to support deprescribing approaches. Support Care 
Cancer 2014;22:1113-1119. 
23. Currow DC, Stevenson JP, Abernethy AP et al. Prescribing in palliative care as death 
approaches. J Am Geriatr Soc 2007;55:590-595. 
24. Verhofstede R, Smets T, Cohen J et al. Improving end-of-life care in acute geriatric 
hospital wards using the care programme for the last days of life: study protocol for a 
phase 3 cluster randomized controlled trial. BMC Geriatrics 2015;15:13. 
25. Holmes HM, Todd A. Evidence-Based deprescribing of statins in patients with advanced 
illness. JAMA Intern Med 2015 Mar 23. doi: 10.1001/jamainternmed.2015.0328. [Epub 
ahead of print] PubMed PMID: 25799203. 
26. Pontin D, Jordan N. Issues in prognostication for hospital specialist palliative care doctors 
and nurses: a qualitative inquiry. Palliat Med 2013;27:165-171. 
79 
 
27. Reeve E, Wiese MD, Hendrix I et al. People's attitudes, beliefs, and experiences regarding 
polypharmacy and willingness to deprescribe. J Am Geriatr Soc. 2013;61:1508-1514. 
28. Bailey FA, Williams BR, Goode PS et al. Opioid pain medication orders and 
administration in the last days of life. J Pain Symptom Manage 2012;44:681-691. 
29. Bernabei R, Gambassi G, Lapane K et al. Management of pain in elderly patients with 
cancer. SAGE StudyGroup. Systematic Assessment of Geriatric Drug Use via 
Epidemiology. JAMA. 1998;279:1877-1882. 
30. Bailey FA, Williams BR, Woodby LL et al. Intervention to improve care at life's end in 










































































DEVELOPMENT OF THE CARE 
PROGRAMME FOR THE LAST DAYS 
OF LIFE IN ACUTE GERIATRIC 
HOSPITAL WARDS: A PHASE 0-I 
STUDY ACCORDING TO THE 





Rebecca Verhofstede, Tinne Smets, Joachim Cohen, Massimo Costantini,
 
Nele Van Den 
Noortgate, Agnes van der Heide, Luc Deliens 
 





The effects of the Liverpool Care Pathway (LCP) have never been investigated in older 
patients dying in acute geriatric hospital wards and its content and implementation have never 
been adapted to this specific setting. Moreover, the LCP has recently been phased out in the 
UK hospitals. For that reason, this study aims to develop a new care programme to improve 
care in the last days of life for older patients dying in acute geriatric wards.  
METHODS 
We conducted a phase 0-1 study according to the Medical Research Council Framework. 
Phase 0 consisted of a review of existing LCP programmes from the UK, Italy and the 
Netherlands, a literature review to identify key factors for a successful LCP implementation 
and an analysis of the concerns raised in the UK. In phase 1, we developed a care programme 
for the last days of life for older patients dying in acute geriatric wards based on the results of 
phase 0. The care programme was reviewed and refined by two nurses and two physicians 
working in an acute geriatric ward and by two experts from Italy and the Netherlands. 
RESULTS 
Phase 0 resulted in the identification of nine important components within the LCP 
programmes, five key factors for a successful LCP implementation and a summary of the LCP 
concerns raised in the UK. Based on these findings we developed a new care programme 
consisting of (1) an adapted LCP document or Care Guide for the older patients dying in an 
acute geriatric ward, (2) supportive documentation and (3) an implementation guide to assist 
health care staff in implementing the care programme on the acute geriatric ward. 
CONCLUSIONS 
Based on the existing LCP programmes and taking into account the key factors for successful 
LCP implementation as well as the concerns raised in the UK, we developed a care 
programme for the last days of life and modelled it to the acute geriatric hospital wards after 











 and the increasing prevalence of chronic and degenerative conditions
5
 imply that 
a growing number of older people in developed countries will need palliative care. The World 




Despite the fact that the majority of older people prefers to die at home
7
 and the increasing 
importance of the nursing home as a place of end-of-life care and dying
8
, a large proportion of 
the aged population (>70 years) die in a hospital
9
 where palliative care goals and principles are 
often achieved with difficulty
10,11,12
. Previous studies have shown the poor quality of care 
delivered to the older population at the end of life, especially in the hospital setting
13,14
. 
Several end-of-life care pathways have been developed to improve the quality of end-of-life 
care 
15,16,17
.  The Liverpool Care Pathway (LCP) for the Dying Patient is one such pathway. It 
was developed in 1997 in the United Kingdom (UK) as a multi-professional document that 
provides a template of care for the final days and hours of life and aims to transfer the hospice 
model of care to mainstream hospital services
15,18
. The LCP is based on the principles of 
palliative care: regular assessment and management of symptoms, comfort measures, effective 
communication with patients and their families, and provision of psychological, social and 
spiritual/existential support. It focuses on the individual physical, psychological and spiritual 
needs of the dying patient and their family during the last hours and days of life and provides 
health care professionals with guidance on the different aspects of care required, including 
comfort measures, anticipatory prescribing of medications, discontinuation of inappropriate 




Although studies suggest that the LCP can improve the quality of end-of-life care in a cancer 
population
19,20 ,21,22
, its effectiveness in people dying of causes other than cancer, especially 
older people, has not yet been investigated. Furthermore, although the LCP as developed in the 
UK is meant to be implemented in every health care setting, the provision and organization of 
end-of-life care can vary between health care settings and specific patient populations should 
be taken into account
6
. It is for instance known that the recognition of the dying phase is more 
challenging in older non-cancer patients
15
 and that around half of older patients in hospital are 
cognitively impaired
23
. Older people dying in hospital are thus a specifically vulnerable patient 
group for which end-of-life care can be significantly improved
13,14
. Hence, if we want to 
introduce and use a care programme for the last days of life in acute geriatric hospital wards, 
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the context should also be taken into account, especially during the process of implemention. 
As the LCP has been widely criticized since June 2012 for failing to help physicians and 
nurses provide appropriate care, the development of an adapted care programme for the last 
days of life should also take into account the concerns that have been raised in the UK. Raised 
concerns regarding the LCP arise mainly from inappropriate implementation and use and not 
the principles of the LCP itself. This was also recently highlighted in an independent review 
which recommended phasing out the LCP in the UK by July 2014
24
. 
This study aims to develop a new care programme to improve care in the last days of life of 
older people dying in acute geriatric wards.  
METHODS 
STUDY DESIGN 
To develop a care programme for the older hospital population to improve care in the last days 
of life the Medical Research Council (MRC) Framework was used. The MRC Framework is 
an approach aimed at providing a robust methodological basis to the development and 
evaluation of complex interventions
25
. According to the MRC Framework, interventions 
should be developed and tested systematically using a phased approach
26,27
. In this study we 
aimed to complete the first two phases: phase 0 and phase 1.  
The study is approved by the Ethics Committee of the University Hospital of Ghent 
University, the Central Ethics Committee of the University Hospital of the Vrije Universiteit 
Brussel and by the Local Ethics Committees of the participating hospitals in Flanders. 
Phase 0: Preclinical phase 
The preclinical phase consisted of a review of existing LCP programmes, a literature review to 
identify key factors for a successful LCP implementation and an analysis of the concerns 
regarding the use of the LCP in the UK. 
Review of existing LCP programmes  
We first reviewed the LCP programme developed in the UK, which is a Continuous Quality 
Improvement Programme to be implemented, disseminated and sustained according to the 
Service Improvement Model, moving on 4 phases and incorporating 10 different steps
18
. The 
development of our care programme is also based on this theoretical approach. Also the LCP 
programmes developed in the Netherlands and Italy, which are based on the original LCP 
programme from the UK, were selected to be reviewed. The aim of the review was to identify 
the different components of the LCP programmes, to compare them and to identify useful 
87 
 
components for the development of our care programme for older patients dying in acute 
geriatric wards. Specific reasons have guided the selection of these programmes: the LCP 
programme from the UK was the one originally developed
18,28
, the Dutch LCP programme 
uses similar language to that of Flanders
29
 and  the Italian LCP programme
30
 is, to our 




Review of literature to identify key factors affecting a successful LCP implementation  
A PubMed literature search on LCP implementation in the hospital setting was conducted. The 
search used the terms ‘Liverpool Care Pathway’, ‘hospital’ and ‘implementation’. Studies 
were included if they were published in English, performed in a hospital setting and if they 
provided an explanation of the process of implementation, such as facilitating factors or 
barriers. As the LCP was developed only in the late 1990s we limited our search to relevant 
literature dated from 1998 to December 2012. The literature retrieved was examined in depth 
and key factors for a successful implementation of the LCP were identified. 
Analysis of the concerns regarding the LCP in the UK 
Our methodology consisted of a close follow up of the media concerns by all involved 
researchers. We collected and read related reports about the criticisms of the LCP in the UK 
disseminated in press coverage or published on PubMed between the onset of the public 
discussion (October 2012) and the development of our care programme (March 
2013)
34,35,36,37,38,39,40,41
. During several meetings we discussed the reports with each other and 
aimed to deduce the main concerns about the use of the LCP. The raised concerns were 
subsequently discussed with clinicians from the UK, Italy and the Netherlands. 
Phase 1: Modelling phase 
We developed and modelled a care programme for the last days of life for the older hospital 
population using the different identified components of the LCP programmes reviewed and the 
key factors for successful LCP implementation and taking into account the concerns raised 
regarding the LCP in the UK. In order to take into account the specificities of the older 
hospital population and the setting in which they are cared for, the preliminary programme 
was reviewed by two nurses caring for older hospitalized patients, two geriatricians and one 
internal medicine physician. Also experts from the UK, Italy and the Netherlands were 
involved in this phase: clinicians and a psychologist responsible for the coordination of project 
implementations. Five researchers, consisting of one geriatrician, three sociologists and one 
nurse, discussed all the input gathered and the feedback of the reviewers and used the results 
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of this discussion for the refinement of the programme.  As it is not embedded in our culture to 




Phase 0: Preclinical phase  
Review of existing LCP programmes 
The review of the original LCP programme developed in the UK
18,28
 and the LCP programmes 
used in Italy
30
 and the Netherlands
29
 identified three common documents: 1) an LCP 
document, 2) supportive documentation and 3) an implementation guide. 
1) The LCP document 
The original LCP document was developed in 1997 in the UK and has regularly been updated 
in accordance with the latest evidence. The latest LCP generic version 12 was launched in 
December 2009 and can be used in all health care settings where end-of-life care needs to be 
provided. An algorithm in the LCP document is included to support the clinical decision 
making process regarding the recognition and diagnosis of dying and the appropriate use of 
the LCP to support care in what are thought to be the last hours or days of life. The LCP can 
be used when the multidisciplinary team – physicians, nurses and allied health professionals 
treating a patient - has agreed that the patient is dying and all reversible causes for the current 
situation have been considered. Recognizing and diagnosing the last days and hours of life is 
complex and a second opinion or the support of a palliative care team may be required. When 
the LCP is initiated, the focus of care changes to care of the dying, including discussion with 
the family carer and when possible the patient. The current plans of care need to be reviewed 
and inappropriate interventions stopped when the burden is greater than the benefits. The LCP 
includes a regular assessment process. If the patient improves and is deemed not to be dying 
by the multidisciplinary team, the LCP can be stopped
18
. 
The LCP document lists a number of care goals that guide health professionals to focus on the 
major issues that are likely to be relevant for patients and their families in the last hours or 
days of life. Each care goal is accompanied by prompts in order to help health care staff to 




Section 1: initial assessment. This section is to be completed when the multidisciplinary team 
estimates that the patient has entered the dying phase. This section deals with anticipatory 
89 
 
prescription of important medications, discontinuation of inappropriate interventions, 
spiritual/religious assessment and appropriate information-giving and communication with 
patients, family and others. 
Section 2: ongoing assessment. This section focuses on regular assessment of important 
indices of comfort for the dying patient and their family including symptom control and 
maintaining the ongoing physical, psychological and spiritual/religious/existential comfort of 
the patient and family.  
Section 3: care after death. This section focuses on the assessment of important practical issues 
and appropriate support for family carers after the death of the patient 
Care goals are to be documented as either ‘achieved’, ‘not achieved’, or, where appropriate 
‘not applicable’. Where ‘not achieved’ is documented, the care professional must make notes 
concerning the cause or reason and detail the course of action taken. “Not achieved” care goals 
are not seen as negative but highlight the importance of clinical skills in deciding to deviate 
from the suggested plan of care in response to individual patient needs
18,42
. An accurate 




In Italy, an earlier LCP hospital version 11 was translated in compliance with the original UK 
format and approved by the LCP Central Team of the Marie Curie Palliative Care Institute 
Liverpool (MCPCIL)
20
. The content and structure of the Italian document is very similar to the 
UK LCP document. 
In the Netherlands, the LCP generic version 12 was translated into Dutch and substantive 
changes were made. In the Dutch LCP document some care goals were considerably modified 
or deleted
44
. The care goals concerning clinically assisted nutrition and hydration are less 
prominently presented, the care goal concerning the maintenance of the patient’s skin integrity 
was deleted and the form of documentation of the care goals was changed to ‘yes’ or ‘no’ 
instead of ‘achieved’ or ‘not achieved’. 
2) Supportive documentation 
In all three countries supportive documentation has been developed. These documents consist 
of a goal data dictionary and information leaflets for health care professionals and family 
carers in support of the LCP document. The goal data dictionary, originally developed in the 
UK, is designed for health care staff to fully understand the care goals stated in the LCP 
document and to guide them in correctly recording “not achieved” care goals. In all three 
countries information leaflets were developed. A leaflet for health care professionals about the 
LCP was developed in the UK and the Netherlands. The following leaflets for family carers 
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were developed: a leaflet about communication, medication, comfort and reduced need for 
food and drink to be given following a discussion regarding the plan of care (UK only), a 
leaflet about the entering of the dying phase (UK and the Netherlands), a leaflet about the 
facilities in the health care setting (UK, Italy, and the Netherlands), a leaflet about grief and 
bereavement after the patient’s death (UK, Italy, and the Netherlands) and a leaflet about 
practical arrangements after the patient’s death (Italy only). 
3) Implementation guide  
An implementation guide to assist health care staff in correctly implementing the LCP 
document and its supportive documentation within a health care setting was developed in all 
three countries. We identified nine components in the implementation guides used in the UK, 
Italy and the Netherlands: 1) establishing the LCP implementation project and preparing the 
environment for organizational changes, 2) preparing the documentation, 3) baseline review, 
4) training health care staff, 5) LCP use and ongoing support, 6) reflective practice, 7) 
evaluation, 8) continuing development of competencies and 9) ongoing education, training and 
support. Consistencies and differences in the components of the different implementation 
guides are listed in table 1. 
 
Table 1 Consistencies and differences in the components of three LCP implementation guides 
 
 
United Kingdom Italy The Netherlands 
Component 1-Establishing the LCP implementation project and preparing the environment for organizational change 
1. Informing all relevant clinical staff 1 1. Informing all relevant clinical staff 1. Informing all relevant clinical staff 
2. Executive endorsement 2. Executive endorsement 2. Executive endorsement 
3. Involvement of specialist palliative 
care services is recommended 
3. Involvement of specialist palliative care services is 
obvious: Palliative Care Unit (PCU) is responsible for 
implementation 
3. Involvement of specialist palliative 
care services is recommended 
4. LCP facilitators 2: members of the 
ward 
4. No LCP facilitators: PCU is responsible for 
implementation 
4. LCP facilitators: members of the ward 
5. Steering group 3 : members of the 
ward 
5. Steering group: PCU with two reference persons as a 
link between ward and PCU 
5. Steering group: members of the ward 
6. Intensive training 4: of LCP 
facilitators 
6. Intensive training of PCU 6. Intensive training of LCP facilitators 
7. Project registration with LCP Central Team (UK), LCP National Centre (Italy), or Comprehensive Cancer Centre of the Netherlands 
Component 2-Preparing the documentation 
Adapting the LCP document and/or supportive LCP documentation to the ward5 
Component 3-Baseline review 
Analyzing end-of-life care data and feedback the results to the staff6 
Component 4-Training health care staff 
1. LCP facilitators and specialist 
palliative care colleagues train health 
care staff 
1. Health care staff follow a mandatory 12 hours training 
organized by PCU 
1. LCP facilitators and specialist 
palliative care colleagues train health 
care staff 
2. Aim training 2. Aim training 2. Aim training 
o To understand and work with LCP 
document 
o To understand and work with LCP document o To understand and work with LCP 
document 






United Kingdom Italy The Netherlands 
Component 5-LCP use and ongoing support 
1. LCP use after sufficient training and 
education 
1. LCP use after sufficient training and education 1. LCP use after sufficient training and 
education 
2. Ongoing support and supervision of 
LCP facilitators each time the LCP 
document is used 7 
2. Intensive support and supervision of PCU through 
repeated coaching, telephone, and direct guidance, discussion 
of clinical cases, and clinical audits 
2. Ongoing support and supervision of 
LCP facilitators each time the LCP 
document is used 
Component 6-Reflective practice 
1. To engage staff in ongoing and 
reflective practice 9 
1. Semi-intensive support and supervision of PCU through 
repeated coaching, telephone, and direct guidance, discussion 
of clinical cases, and clinical audits 
1. To engage staff in ongoing and 
reflective practice 
2. To develop and deliver ongoing and 
sustainable education strategies 
2. To develop and deliver ongoing and 
sustainable education strategies 
Component 7-Evaluation 
1. To organize a formal and quantitative 
reflection (= audit) 10 
1. To organize a qualitative evaluation of implementation 11 1. To organize a formal and 
quantitative reflection (= audit) 
2. The audit acknowledges areas where 
further education or training is needed 
2. The qualitative evaluation acknowledges areas where 
further support, education, or training is needed 
2. The audit acknowledges areas where 
further education or training is needed 
Component 8-Continuing development of competencies 
1. To develop knowledge and skills of 
staff constantly to embed LCP model 
within the ward 12 
1. PCU supports ward staff through repeated coaching, 
telephone, and direct guidance, discussion of clinical cases, 
and clinical audits 
1. To develop knowledge and skills of 
staff constantly to embed LCP model 
within the ward 
Component 9-Ongoing education, training, and support 
To create structures and processes to underpin the continuing education, training, and support required 
Examples: 
❖To link with local audit departments to encourage ongoing reflection on the quality of care delivery 
❖To keep up to date with developments in end of life care 
❖To encourage ongoing liaison with local specialist palliative care teams 
❖To participate in regional and national audit 
 
1All clinical staff are to be informed about the project and made aware of the importance to change the care in the last days of life. 
2LCP facilitators are assigned to preside the steering group. 
3A steering group needs to be established to coordinate the project and consists of members of the ward who are motivated for this project or 
the PCU with two reference persons (Italy). 
4LCP facilitators or PCU (Italy) are intensively trained in order to provide leadership for the project. 
5The ward implementing the LCP can adapt the LCP document and/or supportive LCP documentation to the local health care setting if these 
adaptations are approved by the LCP Central Team, LCP National Centre, or Comprehensive Cancer Centre of the Netherlands (i.e. adapting 
prompts of care goals, adding care goals, adapting information leaflets, local design of information leaflets). 
6To highlight and reinforce the need for change within the ward, it is important to retrospectively evaluate the care during the last days of life 
by reviewing the medical and nursing files and giving feedback about these results to the staff. 
7Training and education is also related to competencies important for good care during the last days of life (i.e. communication, symptom 
control). 
8Ongoing support and supervision each time the LCP document is used for a dying patient, is necessary to increase staff’s knowledge and 
confidence in using the LCP and empower them in caring for the dying. 
9Reflections on the LCP document use and the specific elements of care delivery provide an opportunity to acknowledge which competencies 
need to be maintained and which need to be improved. 
10The first LCP documents are quantitatively evaluated in order to provide feedback, highlight improvements since the implementation and 
identify areas where further education or training is needed. 
11The PCU qualitatively evaluates and discusses the performance and progress of each of the previous components in order to identify staff’s 
training needs and barriers for the LCP use and provision of optimum end-of-life care. 













Identification of key factors for a successful implementation of the LCP  
The PubMed search on key factors affecting a successful LCP implementation in the hospital 
setting resulted in 15 records. The title and abstract of all these records were screened for 
inclusion criteria and five full-text articles were retrieved for detailed evaluation from which 
five key factors for a successful LCP implementation could be identified. These factors are: 
1) having a dedicated facilitator to provide training and ongoing support on the hospital ward 
about the benefits and goals of the LCP
45,46,47
, 2) training and ongoing education on why and 
how to use the pathway, for nurses and especially physicians
45,47,48,46
, 3) the organization of an 
audit and of feedback opportunities
45,47
, 4) having a central coordinating LCP office to support 
local LCP facilitators
49




Analysis of the concerns regarding the LCP in the UK 
Since the second half of 2012 family carers of dying patients in the UK had begun to express 
their concerns regarding the LCP. Reports in some newspapers suggested that thousands of 
patients were being put on the pathway and were having treatment, including hydration and 
nutrition, withheld because they were difficult to manage and in order to free up beds
34
.  
Family carers also expressed their concerns because the LCP was often used without their 
consultation or knowledge
35,36
. Supporters of the LCP reiterated that the LCP is not about 
ending life but about delivering excellent end-of-life care and published a statement refuting 
the misconceptions about the pathway
34,37
. Nevertheless, it was acknowledged that there were 
some problems with it. Consequently, an independent review of the concerns regarding the 
LCP was performed to better understand them and to investigate ways in which the LCP has 
worked well
36
. As that review was only published in July 2013, five months after the initiation 
of our study, we could not use its findings for the development and modelling of our care 
programme. Nevertheless, we were able to deduce the main concerns over the use of the LCP 
from reports, letters, reviews and views disseminated in the media and published on PubMed. 
The concerns centered mainly around (1) improper or poor implementation of the LCP leading 
to cases of inadequate end-of-life care
35,34,38
, (2) unacceptable and inadequate communication 
with the patient and/or family carers
39,35,40
, (3)  the LCP being used as a tick box exercise
41
, 
and (4) the use of the term ‘pathway’ which created the perception that a patient has to die 







Phase 1: Modelling phase 
Results of the phase 0 were used to develop the care programme for the last days of life for  
the older hospital population. It consists of the following parts: (1) a Care Guide for the Last 
Days of Life, (2) supportive documentation and (3) an implementation guide.  
1) Care Guide for the Last Days of Life  
We first developed a care guide for the older hospital population. The original LCP generic 
version 12 from the UK was translated into Flemish in compliance with the original format. 
Afterwards the translation was grammatically compared with the Dutch LCP version and 
improved in terms of wordings. The translated document was then reviewed for legibility, 
usability and applicability by two nurses caring for older hospital patients, two geriatricians 
and one internal medicine physician, which led to a number of adaptations in order to refine 
and improve the document. A first adaptation concerned the change of the name ‘Liverpool 
Care Pathway’ into ‘Care Guide for the Last Days of Life’. According to the reviewers this 
change was crucial to avoid misconceptions about the true nature of the LCP, as the term ‘care 
pathway’ was perceived as a protocol rather than an approach to care. This change directly 
addressed one of the identified concerns regarding the LCP in the UK. A second refinement 
was the adaptation of the care goals to the older hospital population and the setting in which 
they are cared for. Table 2 lists these adaptations for section 1 and 2 of the Care Guide. 
Thirdly, the reviewers suggested the Care Guide should be shortened as the document was 
perceived as bulky. Therefore the introductory part of the document (i.e. the information for 
family carers concerning communication, medication, comfort and reduced need for food and 
drink and information for health care professionals about the LCP) and the prompts illustrating 
the care goals were left out of the care guide. The information for family carers is instead 
presented in a separate information leaflet for family carers and the prompts illustrating the 
care goals are placed in a separate goal data dictionary. To improve the readability of the Care 
Guide, a fourth refinement was made, namely highlighting in different colours the care goals 










Table 2 The adaptation of the care goals of the UK LCP version 12 to the older hospital population 
 








▪ Reworded questioning under this care goal: 
‘Does the patient have an expressed wish for organ/tissue’ replaced by ‘Does 
the patient have an expressed wish to donate his/her body to medical science’ 
 Spirituality 3.1 and 3.2 ▪ Changes related to these care goals: 
‘Spirituality’ replaced by ‘Religious, spiritual, and cultural needs’ 
More space for the nurse to report on these needs 
Anointing of the sick is added 
 Medication 4.1 ▪ Added care goal: 
‘Current medications are assessed and non-essential medications are 
discontinued’ 
  4.2 ▪ Addition to care goal: 
The anticipatory prescribing of medication for the symptom ‘anxiety’ is added 
  4.3 ▪ Reworded care goal: 
‘Equipment is available for the patient to support a continuous subcutaneous 
infusion (CSCI) of medication where required’ replaced by ‘If no intravenous 
or subcutaneous infusion already in place, the need for a subcutaneous infusion 
is reviewed’ 
 Explanation of the plan 
of care 
9.5 ▪ Added care goal: 
‘The patient’s care providers involved in the hospital and in home care are 
notified that the patient is dying’ 
 
2  c ▪ Reworded care goal: 
‘The patient does not have respiratory tract secretions’ replaced by ‘The patient 
does not experience discomfort of the respiratory tract secretions’ 
  k ▪ Reworded care goal: 
‘The patient receives fluids to support their individual needs’ replaced by ‘The 
need for hydration is reviewed by the multidisciplinary team’ 
  p  ▪ Care goals p and q from the UK are combined: 
‘The psychological well-being of the family carer and the patient are 
maintained’ 
  q ▪ Added care goal: 
‘Care givers are able to provide the necessary care’ 
  r  ▪ Added care goal: 
‘The patient/family carer is informed about the patient’s condition’ 
  s ▪ Added care goal: 
‘The patient/family carer in informed about any change in the plan of care’ 
 
 
2) Supportive documentation 
A goal data dictionary and information leaflets for health care staff and for family carers were 
developed. The goal data dictionary was based on the Dutch version and slightly adapted in 
compliance with the content of the new Care Guide.  
Four information leaflets were developed based on the Dutch versions: a leaflet for health care 
professionals about the Care Guide and three leaflets for family carers about the entering of 










3) Implementation guide 
To help health care staff implementing the care programme for the last days of life in acute 
geriatric hospital wards, an implementation guide was developed. Table 3 shows the different 
components of our implementation guide and what they are based on. The implementation 
guide takes into account most of the components identified in the reviewed LCP programmes 
and the key factors for a successful LCP implementation. 
 
Table 3 Overview of the components within the implementation guide for the acute geriatric ward 
Components Source* 
Component 1-Establishing the implementation project and preparing the environment 
 
❖Informing the health care staff caring for older hospitalized patients about the implementation project and the importance of    
change in care during the last days of life 
1 
❖Executive endorsement: acquiring management approval for the trainings and audits 
 
❖Involvement of specialist palliative care services is recommended: at least one member of the Palliative Support Team of the 
hospital is member of the steering group 
1 
1 
❖Facilitators: a nurse and a physician of the geriatric ward 1, 2 
❖Formation of steering group: at least four people of the geriatric ward (facilitators included) 1 
❖Intensive 2-day training of facilitators 1, 2 
Component 2-Preparing the documentation 
 
1. Development of an information leaflet for family carers about the facilities in the geriatric ward 1 
Component 3-Baseline review 
 
1. Analyzing end-of-life care data of deceased older hospitalized patients using the patients’ medical files 
1, 2 
2. Feedback of the results to the staff and focusing on improvement within the geriatric ward 
Component 4-Training health care staff caring for older hospitalized patients 
 
1. Facilitators and specialist palliative care colleagues train health care staff with the aid of a training package (i.e. hand-outs with 
information about the Care Guide, a copy of the Care Guide, a casus to discuss in group etc.) 
1, 2 
2. Aim training 
1, 2 
o To understand and work with the Care Guide 
Component 5-Care Guide use and intensive support 
 
1. Care Guide use after sufficient training and education 1, 2 
2. Intensive support and supervision by the steering group through repeated coaching, telephone, and direct guidance, discussion of 
clinical cases, and clinical audits 
1, 2 
Component 6-Semi-intensive support 
 
1. Semi-intensive support and supervision by the steering group through repeated coaching, telephone, and direct guidance, 




1. To organize a qualitative evaluation of the implementation: evaluating and discussing the performance and progress of each of the 
previous components 
1, 2 
2. The qualitative evaluation acknowledges areas where further support, education, or training is need 1 
Component 8-Consolidation 
 
1. To adopt a strategy to maintain/improve the implementation and sustainability of the Care Guide 1 
2. Support and supervision by the steering group through repeated coaching, telephone, and direct guidance, discussion of clinical 
cases, and clinical audits 
1, 2 
Component 9-Ongoing education, training, and support 
 




1: based on the results of the review of the LCP programmes from the UK, Italy, and the Netherlands. 










This article describes the development of a care programme for the last days of life for the 
older hospital population consisting of a Care Guide for the Last Days of Life, supportive 
documentation and an implementation guide to help health care staff in implementing the Care 
Guide on the acute geriatric ward and to standardize the implementation process across 
different wards. 
An important strength of our study is that it uses the MRC Framework for the development of 
a complex intervention as a conceptual and methodological basis. This framework, following a 
five phase iterative approach from pre-clinical phase to large-scale implementation, has 
proved to be valuable in guiding the development, modelling and evaluation of complex 
interventions
26
. To our knowledge, the developed care programme is the first programme that 
aims to improve care in the last days of life for the older hospital population.  
Some limitations have to be acknowledged. Firstly, only three existing LCP programmes were 
reviewed. As the LCP has been implemented in more than 20 countries, reviewing LCP 
programmes from other countries could possibly have provided us with more information for 
the development of our care programme. However, the components of the three reviewed LCP 
programmes were similar which suggests that a more extensive review would not necessarily 
have had any added value. Secondly, we did not perform a systematic review concerning the 
key factors for a successful LCP implementation. However, the key factors identified in our 
study largely correspond with key factors identified in a more recently published systematic 
review
50
. Only one additional contextual factor was mentioned in the review. It was found that 
a major cultural shift is needed to change the perception from dying as a failure of medical 
care into dying as a time of life when care takes priority over cure
50
. Also findings from a 
recent Dutch qualitative study evaluating barriers and facilitators to LCP implementation 
confirm the key factors identified in our study
51
. 
Older patients, especially those dying in hospital are a specifically vulnerable patient group for 
which end-of-life care can be significantly improved
13,14
. Despite advances in palliative care, 
hospitalized older patients do not have access to palliative care services in the proportions that 
might be expected
52
 and do not often die a peaceful death, due to prolonged aggressive life-
sustaining treatments
53,54,55
. There is considerable evidence of underassessment and 
undertreatment of symptoms such as pain in hospitals
52
. Moreover,  studies have shown that 
hospitalized elderly people are less likely to receive appropriate pain control and more often 





However, to our knowledge, no initiative has yet been developed or implemented in order to 
improve end-of-life care in acute geriatric wards in Flanders. 
The care programme for the last days of life, developed for the older hospital population, can 
be considered as being different from the original LCP programme in several ways. It is 
specifically adapted to the older hospital population and setting although only small changes 
were deemed necessary by the reviewers. In the care guide, more attention is paid to specific 
care goals such as those related to communication, medication and 
existentialism/spirituality/religiosity, and the content of the implementation guide was adapted 
in such a way that an acute geriatric ward would be better able to implement the Care Guide 
within its own setting. 
The care programme for the last days of life also took into account most of the concerns 
regarding the use of the LCP raised in the UK. An independent review recently highlighted 
and confirmed these concerns and subsequently recommended phasing out the LCP in the UK 
by July 2014
24
. First, the terminology was changed from ‘Pathway’ to ‘Care Guide’. This 
might prevent misconceptions about the LCP, such as those among health care staff and family 
carers and patients in the UK who have perceived  ‘pathway’ as a ‘route to death’
34,35,38
. The 
term ‘Care Guide’ suggests that the document is supposed to guide the health care staff in 
making individualized choices in caring for dying patients, without being a protocol that has to 
be followed. This change in terminology was later also recommended in the Neuberger 
review
24
. Secondly, the importance of a thorough and correct implementation of the Care 
Guide, underpinned by education and training, is stressed in our implementation guide. 
Therefore it incorporates nine components to be performed and includes a detailed and 
elaborate training package to help health care staff in educating and supporting their 
colleagues in using the Care Guide in a correct and compassionate way. This counters the 
identified problem of poor or improper implementation of the LCP in the UK leading to cases 
of inadequate end-of-life care in the hospital setting
34,35,38
. The Neuberger review indeed also 
confirmed that when the LCP is correctly applied it helps patients to have a dignified and pain-
free death. Sufficient training and education should prevent staff from using the Care Guide as 
a ‘tick box’ exercise instead of as a guidance tool to assist them in decision-making in 
accordance with a patient’s individual needs
24
.  
However, not all identified components and key factors could be incorporated into our 
implemention guide. First, since there is no central coordinating LCP office in Belgium, the 
project registration with and the support by a central LCP office, which is part of all LCP 
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programmes and an important key factor for a successful LCP implementation, could not be 
included in the implementation guide. Secondly, training of health care staff, is included in the 
implementation guide but is limited to understanding and working with the Care Guide. 
Education related to providing good end-of-life care such as symptom control and 
communication is not part of the training. Nevertheless, the steering group – responsible for 
the coordination of implementation and consisting of at least one physician, two nurses and a 
member of the Palliative Support Team (PST) - is recommended to identify and tackle 
problems or difficulties in the provision of good end-of-life care during the whole 
implementation process and can organize additional training if deemed necessary.  
Finally, funding for efforts such as facilitation of the implementation process was not available 
and was thus not included in the implementation guide. 
Although the LCP is an evidence-based framework founded on high quality medical practice 
in palliative care, the Neuberger review underlined the lack of research on the effectiveness of 
the LCP and on how factors can result in better or worse implementation
24
. We will therefore 
perform a phase 2 study to evaluate the feasibility of the implementation process and to 
identify potential problems and difficulties in implementation and use of the care programme 
in the acute geriatric hospital wards. Based on the results of this phase 2 study we will be able 
to refine our preliminary care programme. Having developed and modelled this specific care 
programme it will be important to evaluate its effectiveness thoroughly.  
 
CONCLUSIONS 
Performing a phase 0-1 study according to the MRC Framework helped us to develop a care 
programme for the last days of life for older patients dying in the acute geriatric hospital 
wards. With the relevant background information we were able to develop a new care 
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To improve the quality of end-of-life care in geriatric hospital wards we developed the Care 
Programme for the Last Days of Life. It consists of 1) the Care Guide for the Last Days of 
Life, 2) supportive documentation and 3) an implementation guide. The aim of this study is (1) 
to determine the feasibility of implementing the Care Programme for the Last Days of Life in 
the acute geriatric hospital setting and (2) to explore its preliminary effects on end-of-life care. 
METHODS 
A phase 2 mixed methods study according with the MRC framework was performed in the 
acute geriatric ward of Ghent University Hospital between 1 April and 30 September 2013. 
During the implementation process a mixed methods approach was used including participant 
observation and the use of a quantitative evaluation tool. This tool measured the success of 
implementation using several indicators, such as whether a steering group was formed, 
whether and how much of the health care staff was informed and trained and how many 
patients were cared for according to the Care Guide for the Last Days of Life. 
RESULTS 
The evaluation tool showed that implementing the Care Programme for the Last Days of Life 
in the geriatric ward was successful and thus feasible; a steering group was formed consisting 
of two facilitators, health care staff of the geriatric ward were trained in using the Care Guide 
for the Last Days of Life which was subsequently introduced onto the ward and approximately 
57% of all dying patients were cared for according to the Care Guide for the Last Days of Life.  
With regard to preliminary effects, nurses and physicians experienced the Care Guide for the 
Last Days of Life as improving the overall documentation of care, improving communication 
among health care staff and between health care staff and patient/family and improving the 
quality of end-of-life care. Barriers to implementing the Care Programme for the Last Days of 
Life successfully are, among others, difficulties with the content of the documents used within 
the Care Programme for the Last Days of Life and the low participation rate of physicians in 
the training sessions and audits. 
CONCLUSIONS 
Results of this mixed methods study suggest that implementing the Care Programme for the 
Last Days of Life is feasible and that it has favorable preliminary effects on end-of-life care as 
reported by health care professionals. Based on the identified barriers during the 
implementation process, we were able to make recommendations for future implementation 
and further refine the Care Programme for the Last Days of Life before implementing it in a 
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Ageing, coupled with a rising prevalence of chronic and degenerative conditions, means that 
many more older people will need end-of-life care, and this number will continue to increase 
in future
1
. Although most people wish to die at home
2,3
,  a substantial number of older people 
die within the acute hospital setting, for example in an acute geriatric ward. It is estimated that 
deaths in institutions such as hospitals are likely to increase in the next decades
4,5,6
.  
Traditionally, high quality care at the end of life has been provided mainly for cancer patients, 
but optimal end-of-life care should be provided for all patients regardless of diagnosis
1
. 
Optimal end-of-life care for older hospitalized patients should include good symptom control, 
respect for patient preferences, appropriate use of diagnostic and therapeutic interventions at 
the end of life and support for the family
7
. However, many older people dying in hospital 
experience poor care
8,9,10,11
. Research shows that they often receive undesired and burdensome 
interventions that negatively affect their quality of life
11
 and there is also considerable 
evidence of underassessment and undertreatment of symptoms such as pain
1,12
.  
A number of barriers to optimal end-of-life care have been identified including difficulty in 
recognizing the dying phase, difficulties in withdrawing futile diagnostic procedures and 
treatments, failure to implement an appropriate end-of-life plan of care, inadequate pain and 
symptom management and ineffective communication with patients and between patients, 
relatives and professionals
13,14,15
. In addition, during medical education, the need for the 




To improve the quality of end-of-life care for older patients dying in hospital, we developed 
the Care Programme for the Last Days of Life (hereinafter - Care Programme) for acute 
geriatric hospital wards (Verhofstede R, Smets T, Cohen J, Costantini M, Van Den Noortgate 
N, van der Heide A, Deliens L: Development of the care programme for the last days of life 
for older patients dying in acute geriatric hospital wards: a phase 0-1 study according to the 
Medical Research Council Framework, in revision).  
This programme is based on the Liverpool Care Pathway (LCP) programme, taking into 
account the raised concerns in the UK regarding the LCP and adapted to the older hospital 
population and setting. The Care Programme consists of: (1) the Care Guide for the Last Days 
of Life, (2) supportive documentation and (3) an implementation guide (figure 1). The Care 
Programme aims to introduce and embed the Care Guide for the Last Days of Life (hereinafter 
- Care Guide), a multi-professional document that provides a template of care for the last days 
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and hours of life in order to ensure that optimal end-of-life care is delivered to every patient 
dying in an acute geriatric ward. 
This study aims (1) to assess the feasibility of implementing the Care Programme in the acute 
geriatric hospital setting and (2) to explore the preliminary effects of the Care Programme on 
end-of-life care. 
 















 A multi-professional document that provides a template of care for the last days and hours of life with recommendations on different  
  aspects of care and guidance for the psychological and spiritual support of patients and their families 
2
 This guide assists health care staff in implementing the Care Programme for the Last Days of Life on the geriatric ward during a six-month  
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Guide for the Last Days of Life 
A manual for health care staff 
on how to use Care Guide for 
the Last Days of Life 
Three leaflets for family carers 
about the entering of the dying 
phase, grief and bereavement 
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We performed a phase 2 mixed methods study according to the MRC Framework for the 
development and assessment of complex interventions
16
. The Care Programme was 
implemented during a six-month period (April-September 2013). In order to assess the 
feasibility of the implementation process and explore the preliminary effects of the Care 
Programme on end-of-life care, a mixed methods approach was used during the 
implementation process. This approach included a quantitative evaluation tool measuring the 
success of implementation and participant observation to estimate the feasibility of 
implementation and the preliminary effects of the Care Programme. For this study we obtained 
approval of the Medical Ethics Commission of the Brussels University Hospital and Ghent 
University Hospital.  
SETTING 
The Care Programme was implemented in the acute geriatric hospital ward of Ghent 
University Hospital. At the time of the study, the geriatric ward had 30 beds organized in 17 
rooms, an overall staff of four geriatricians (including two in training) and 39 nurses and the 
available support of a hospital-based palliative support team (PST). The PST consists of a 
palliative care nurse, a social nurse (a combined nurse and social worker), a physician and a 
clinical psychologist and provides consultation on request and works closely together with 
existential/spiritual counsellors. 
DATA COLLECTION 
Evaluation tool  
We developed an evaluation tool to measure the success of implementation, i.e. the degree to 
which each of the nine components of the implementation guide is implemented. In order to 
know how well each component was implemented, a number of indicators were developed. 
The indicators, for which an ideal outcome or standard was formulated, were measured by the 
researcher (RV) during the implementation process (Table 1). In this way, the completed 
evaluation tool could inform us about the success rate of the implementation process. 
Participant observation 
A member of the research team (RV) attended and observed five steering group meetings (i.e. 
meetings of a work group of persons coordinating the implementation of the Care 
Programme), two training sessions and one audit related to the implementation and use of the 
Care Guide. Careful notes were made during each of these meetings and one audit was 
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recorded and transcribed verbatim. A signed informed consent was obtained from each 
participant attending the audit. The researcher also made notes of face-to-face and telephone 
contacts with the members of the steering group and of face-to-face contacts with other health 
care staff of the acute geriatric ward. Finally, the researcher made notes of a meeting of the 
Advance Care Planning work group, which she attended and during which the Care 
Programme was discussed. This work group is organized within the Medical Ethics 
Commission of Ghent University Hospital in order to discuss end-of-life care issues on a 
regular basis. In total, qualitative data were gathered from twelve nurses, four physicians and 
two members of the Palliative Support Team i.e. a nurse and a religious counsellor.   
OUTCOME MEASURES 
The first outcome measure, the feasibility of implementing the Care Programme, was assessed 
using two different methods: the quantitative evaluation tool and participant observation. The 
quantitative evaluation tool measured the degree to which the Care Programme was 
implemented according to the components of the implementation guide, using several 
indicators. Most important indicators are: the proportion of health care staff informed about 
the implementation project, the composition of a steering group, number of facilitators, 
attendance at a two-day intensive training programme by facilitators, retrospective evaluation 
of end-of-life care and discussion of the results with health care staff, training health care staff 
in using the Care Guide, introduction of the Care Guide on the geriatric ward, organization of 
clinical audits and the proportion of patients cared for according to the Care Guide (Table 1). 
Participant observation provided additional qualitative data regarding the barriers to the 
implementation process perceived by the health care staff, which allowed us to gain a deeper 
understanding of the feasibility of implementing the Care Programme.  
The second outcome measure, the preliminary effects of the Care Programme on end-of-life 
care, was explored using participant observation, including notes taken during meetings, 
verbatim transcription of a clinical audit and notes based on face-to-face and telephone 
contacts with the members of the steering group and other health care staff. 
DATA ANALYSIS 
Quantitative data analysis  
The outcomes of the indicators within the evaluation tool were measured or observed by the 





Qualitative data analysis 
In order to assess the feasibility of implementing the Care Programme, the textual data, i.e. 
notes and a transcript, were thematically analyzed. The analysis process consisted of five 
interconnected stages: (1) involved familiarization, (2) identifying a thematic framework, (3) 
coding, (4) charting and (5) interpretation
17
. One researcher (RV) performed thematic coding 
using the nine components within the implementation guide as a framework. A second 
researcher (TS) checked the coding process and discussed it with RV.  
Insights from each set of transcripts served to deepen understanding of the implementation 
process and to assess the feasibility of the implementation of the Care Programme.  
In order to assess the preliminary effects of the Care Programme on end-of-life care, thematic 
analysis was used to capture themes. This analysis was inductive, not restricted by any a priori 
theoretical framework. After reading the textual data, a preliminary coding framework was 
developed by one researcher (RV) and discussed with a second researcher (TS). Next, all 
textual data were read line by line and labels were assigned by one researcher (RV). The 
coding framework was adjusted where needed, in consensus with a second researcher (TS). 
The results were discussed within the research team to ensure consistency. A final framework, 
including results and quotes, was agreed within the research team.  
 
RESULTS 
Feasibility of implementing the Care Programme 
Findings with regard to the feasibility of implementing the Care Programme are presented in 
table 1. The results of the evaluation tool showed that for 15 of the 17 indicators the standard 
was essentially met; a steering group was formed consisting of two facilitators both of whom 
attended a two-day intensive training workshop, a leaflet concerning the facilities on the ward 
was developed, end-of-life care was retrospectively evaluated and discussed with the staff, the 
health care staff of the ward were trained in using the Care Guide, two audits were organized 
and the steering group organized a meeting to evaluate and discuss the performance and 
progress of the implementation in order to identify training needs and barriers for using the 
Care Guide and providing optimum end-of-life care. Lastly, more than half of the deceased 
patients had been cared for according to the Care Guide, i.e. of the 19 people who died on the 
ward during the implementation period, 11 were cared for according to the Care Guide. Six 
months after the implementation of the Care Programme, the Care Guide was still in use. In 




However, despite the fact that two training sessions were organized, only one out of four 
geriatricians was trained. Furthermore, for two indicators the standard was not met: 37% 
instead of 100% of the health care staff were informed about the implementation project and 
one out of the three audits that should have been organized was not. 
Health care staff identified four types of potential barriers to implementing the Care 
Programme. Firstly, there were barriers related to practical issues, e.g. many health carers 
perceived the double registration (i.e. the electronic patient file in combination with the Care 
Guide in printed version) as a barrier to use the Care Guide. A second type of barrier was 
related to the content of the documents used within the Care Programme, e.g. some staff had 
difficulties with the term ‘care goal’ within the Care Guide and perceived the term as being 
too coercive. A third type of barrier was related to the low motivation of some health care 
staff. Nurses mentioned that low motivation of health care staff resulted in a low participation 
rate of staff in collective and essential meetings to implement the Care Programme on the 
geriatric ward. For example, few physicians attended the training sessions and nurses 
perceived this as an important barrier to introducing and using the Care Guide. A fourth and 
important barrier was related to difficulties inherent in the organization and provision of care 
in the last days of life rather than to using the Care Programme. It was for instance found that 
health care staff had difficulties with recognizing when the dying process had started and, 
related to this, medical staff often felt resistant to initiating the Care Guide. Furthermore, in 
relation to the organization of end-of-life care, nurses often felt uneasy about communicating 
with the physician that a patient had entered the dying phase. They also indicated that they 











Table 1 Quantitative and qualitative evaluation of the feasibility of implementing and sustaining the Care Progamme for the Last Days of Life in the 
geriatric ward of Ghent University Hospital 
                                                          
1
 Perceived difficulties that emerged from the qualitative evaluation 
2
 In the further course of this table we used ‘Care Programme’ for the complete term ‘Care Programme for the Last Days of Life’  
3
 Health care staff refers to all health carers involved in care on the acute geriatric hospital ward, i.e. nurse, nursing aide, psychologist, physiotherapist, physician, etc. 
4
 During the information moment, the steering group aims to inform health care staff about the implementation project  
5









 among staff in implementing 
 the Care Programme
2 
Indicator Standard  Outcome 
 
1. Establishing the implementation 
project and preparing the 
environment 
 
(1) Proportion of health care staff 







37% (23/62)  
 
 Limited time to establish the implementation project, e.g. 
composition of steering group with facilitators  
 
 Information moment4 was organized too early 
 
 Information moment did not reach all geriatric health 
care staff (1) 
 
 Content of the 2 day intensive training is not yet fully 
adjusted to geriatric hospital setting 
 (2) Executive endorsement: 
management approval for 
organization training and audits  
Yes Yes 
 (3) Composition of steering group 2 nurses 





1 physician  
1 PST member 
 (4) Facilitators: 
   Number  
   Function  
 
≥2 
nurse & physician  
 
2 
nurse & physician  
 (5) Attendance at the 2 day intensive 
training by 2 facilitators 
Yes Yes 
 
2. Preparing the documentation  
 
(6) Development of information 
leaflet concerning the facilities on 







3. Baseline review 
 
(7) Retrospective evaluation of 







 Feedback of results to health care staff more feasible if 
incorporated in training sessions 




                                                          
6




Quantitative evaluation using the evaluation tool 
 
 
Perceived difficulties among staff to implement  
the Care Programme
 
Indicator Standard Outcome 
 
4. Training health care staff on the 
geriatric ward 
 
(9) Training health care staff 
   Duration (minutes per edition) 
   Editions (No.) 
   Nurses involved (%) 












67% (26/39)  
25% (1/4)  
 
 Only feasible if training content is well prepared by 
steering group 
 
 Documents for training health care staff need adaptations 
(i.e. hand-outs, geriatric casus, manual for using the Care 




 Care Guide needs adaptations 
 
5. Use of the Care Guide for the 
Last Days of Life with intensive 
support 
 







 Training sessions dit not reach enough physicians (9) 
 
 No audit was organized (11) 
 
 Physicians are hesitant to initiate or use the Care Guide 
 
 The term ‘care goal’ lead to misinterpretations and is 
perceived as being too coercive 
 (11) Clinical audit 
   Organized 
   Nurses involved (%) 







No audit organized 
No audit organized 
 
6. Use of the Care Guide with semi-
intensive support 
 
(12) Clinical audit 
   Organized 
   Nurses involved (%) 










20% (9/39)  
25% (1/4)  
 
 
 Low attendance of health care staff during audit (12) 
 
 Diagnosing dying is difficult 
 
 Physicians are hesitant to initiate or use the Care Guide 
 
 Nurses are too scared of taking responsibility 
 
 The term ‘care goal’ is perceived as being too coercive 
 





                                                                                                                                                                                                                                                                                              
 
7
 The steering group needs to qualitatively evaluate and discuss the performance and progress of each of the previous components in order to identify staff’s training needs and 
barriers for the use of the Care Guide for the Last Days of Life and provision of optimum end-of-life care 
8




Quantitative evaluation using the evaluation tool 
 
 
Perceived difficulties among staff to implement the  
Care Programme
 














(14) Clinical audit 
   Organized 
   Nurses involved (%) 










26% (10/39)  
0% (0/4) 
 
 Low attendance of health care staff during second audit 
(14) 
 
 Diagnosing dying is difficult 
 
 Physicians are hesitant to initiate or use the Care Guide 
 
 Continuing support by all steering group members is 
important (one nurse of the ward is not sufficient) 
  
(15) Proportion of dying patients cared 
for according to Care Guide during 
the implementation period  






57.9% (11/19)  
 
9. Use of the Care Guide with 
ongoing education, training and 
support 
 










The researcher only followed up during the implementation 
period   (17) Proportion of dying patients cared 
for according to Care Guide during 
the 6 months after completion of 
implemention period 
 




Preliminary effects of the Care Programme  
Four key themes relating to the effects of the Care Programme on end-of-life care emerged 
from the data analysis. These key themes were: 1) documentation of end-of-life care, 2) 
content and quality of end-of-life care, 3) communication between health care staff and family 
carers, and 4) communication among health care staff.  
Documentation of end-of-life care 
Nurses and physicians agreed that there had been an improved documentation of care since the 
introduction and use of the Care Guide. 
“Previously they said, yes, he is uncomfortable, but, what does that mean? What is uncomfortable? And now you 
will document it more in detail, it was because of that kind of pain, or it was his breathing, or it was something 
else” [Nurse A ] 
According to the nurses, the improved documentation of care in the Care Guide also led to a 
better understanding and delivering of care for the dying patient.    
“For example, if we document the aspiration frequency as four, other caregivers know that we did it four times, I 
mean that they know, if they are aspirating for the third time, that this is normal” [Nurse B ] 
Content and quality of end-of-life care 
Since the introduction of the Care Guide nurses felt empowered to approach the patient 
holistically. Where nurses tended to pay more attention to physical aspects in the care of the 
dying patient before the introduction of the Care Guide, they claimed they were now more 
focused on psychosocial and existential/spiritual aspects of care. 
“The Care Guide helps nurses, who were previously focused on the physical aspects, to also think about other 
care dimensions”. [Nurse C ] 
There was a consensus of opinion between the nurses that the Care Guide stimulates them to 
study each perceived symptom or problem of the dying patient as well as to reflect on an 
adequate approach to alleviate the symptom.  
“I often hear, people are not comfortable, and then you are wondering what needs to happen, but now the Care 
Guide has the advantage that this problem is elaborated in depth, that we can find out what the underlying 





Nevertheless, one nurse was not convinced of the idea that the Care Guide delivers better care 
for the dying patient. According to her, delivering good symptom control is much more than 
symptom assessment and reflecting on an ideal approach; a nurse must also be capable of 
ensuring good symptom control, which is not always the case. 
Nurses and physicians also agreed that using the Care Guide ensures better continuity of care 
at the end of life. Because of the four-hour registration of symptoms and reported interventions 
or actions in the Care Guide, each staff member involved in the care of the dying patient has 
knowledge of the clinical status of the patient and of the medical and nursing interventions 
previously taken, which allows them to ensure continuity of care.   
“I think it is very interesting as a communication tool, in the continuity of care, if one nurse takes it over from 
another nurse, that she clearly sees what already happened and how far we are in the provision of end-of-life 
care, and what she can further improve during her late shift” [Nurse E] 
According to some nurses the Care Guide provides a structure in delivering optimal end-of-life 
care to patients and family carers. One nurse stated:  
“When I start to support a dying patient with the Care Guide, I will do it in a structured way, I will tell him, it is 
not going well and you will die, and I will consider his spiritual/existential needs and wishes, then I will think 
about all these issues” [Nurse A] 
Nurses and physicians agreed that the Care Guide serves as a memory aid as it reminds them 
to consider all relevant aspects of end-of-life care. Two physicians perceived this as one of the 
most important advantages of the Care Guide. However, these physicians felt that for them the 
Care Guide was only an aide-memoire as they believed end-of-life care was already optimal in 
their ward though in hospitals struggling to deliver good end-of-life care it could be of more 
benefit.  
Reference was also made by several nurses and one physician to medication policy, i.e. 
anticipatory prescribing and effective medication use. Nurses confirmed that the Care Guide 
implied a clearer policy regarding anticipatory prescribing of medicines to ensure that there is 
no delay in responding to symptom if they occur.   
“Previously, before the introduction of the Care Guide, it happened that I had to call the on-call physician 




One respondent mentioned that, since the Care Guide had been introduced, she gives 
medicines for symptom control only when needed, at the right time and just enough and no 
more than is needed to relieve the symptom.  
However, another respondent expressed concerns about the management of pain medication.  
“Once a patient is supported by the Care Guide, some nurses think they must give and increase all the 
medication, whereas this is not necessary for every patient, and it must be more tailored to the individual needs 
and wishes of the patient” [Nurse C] 
Communication between health care staff and family carers  
Some nurses agreed that the Care Guide helped them to reflect on practical issues that are 
important to relatives, for example: 
“It is a control check for us, do I have a phone number of the patient’s family carer, or do I know when I can call 
this person, or that you are at least reflecting on it”. [Nurse F] 
Nurses agreed that since the introduction of the Care Guide communicating with the relatives 
had been given a higher priority. According to them the impending death and care of the dying 
person could be discussed in a more open way.  
However, the Care Guide did not change the extent of involvement of the patient’s family 
carer in discussions regarding the plan of care. Some nurses believed that decisions and 
reasons for them were already communicated and explained well enough to family carers 
before the introduction of the Care Guide. 
“Actually, what we are doing, we say, yes, it’s a bit…” [Nurse A] 
“I don’t think it’s different than before the introduction of the Care Guide” [Nurse E] 
“No no” [Nurse C] 
“No, I think it’s indeed a bit the same as we did before” [Nurse A] 
"Actually it doesn’t change; from the moment you see that someone’s condition is worse, you communicate that 
and you say, look, we stop antibiotics" [Nurse C] 
Communication among health care staff 
There was an overall agreement among nurses and physicians that communication between 
health care staff was improved after implementation of the Care Guide. They were convinced 
that introduction of the Care Guide 1) facilitates discussion between medical and nursing staff 
about recognizing the dying phase in patients, 2) stimulates hospital staff to inform the 
patient’s general practitioner about their impending death and 3) creates the opportunity to 
evaluate and discuss the delivered care between each other.  
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“You have to report a lot…” [Nurse B] 
“Yes, to describe details, so that you can check with your colleague…” [Nurse G] 
“It will be a little more objective” [Physician] 
“…why he doesn’t think that…or that you think someone should have more comfort. You’ve 
got a medium now, in order to evaluate the care commonly” [Nurse G] 
“Your arguments are more clear for each other” [Nurse E] 



















The results of this mixed methods study suggest that implementing the Care Programme in the 
acute geriatric hospital setting is feasible and also has valuable preliminary effects on end-of-
life care: nurses and physicians experienced it as improving the overall documentation of care, 
improving communication among health care staff and between health care staff and 
patient/family and improving the quality of end-of-life care. However, difficulties with the 
content of the documents used within the Care Programme and the low participation rate of 
physicians in the training sessions and audits were perceived as important barriers to 
successful implemention of the Care Programme in the geriatric ward.  
The proportion of dying patients cared for according to the Care Guide is an important 
indicator of the success of implementation in terms of consolidation and ongoing use of the 
Care Guide. During the implementation period and six months after, approximately 60% of all 
patients who died in the geriatric ward were cared for according to the Care Guide.  Other 
studies performed in the UK and the Netherlands found that the LCP, an end-of-life care 
pathway for the last days of life similar to our Care Guide, had been used for around 85% of 
all cancer patients who died during the research period in a hospice, and for 50% of all cancer 
patients who died in a Palliative Care Unit
18
. Nevertheless, we deem 60% as a sufficient result 
for our study
19,20
, recognizing that the dying phase is considered to be more difficult in older 
patients who often suffer from multiple chronic conditions than in those dying from cancer as 
the actual death is often more unexpected
19
. In addition, our mixed methods study was 
conducted in a hospital setting, where the focus may be more on cure or life-prolonging than 
in hospices or palliative care units
20
. Furthermore, results from an Italian cluster randomized 
controlled trial performed in hospitalized cancer patients showed that during LCP 
implementation only 34% of dying patients were cared for in accordance with the programme 
and that this percentage decreased during the six months after implemention
21
.  
Other factors that indicate that implementing the Care Programme is feasible are that the acute 
geriatric ward was able to create a steering group, involve palliative care services (e.g. 
members of a Palliative Support Team), appoint two facilitators responsible for the  
coordination of the implementation process, organize training sessions on why and how to use 
the Care Guide and organize audits.  
The health care staff of the geriatric ward perceived the Care Programme as having 
predominantly positive effects on end-of-life care, which confirms the findings of earlier 
qualitative studies
22,23,24
. More specifically, according to nurses and physicians, use of the 
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Care Programme improves the overall documentation of care and positively influences 
communication among health care staff and between health care staff and patients/families. 
They also experienced a positive effect of the Care Programme on the quality and content of 
end-of-life care. For instance, according to nurses and physicians, using the Care Guide 
stimulates a multidisciplinary approach in care at the end of life. It also stimulates greater 
reflection among health care staff on end-of-life care, stimulates continuity of care, helps 
structure care delivery and promotes a clearer policy regarding anticipatory prescribing of 
medicines. Moreover, as no additional resources or persons were needed to implement the 
Care Programme, positive effects could be achieved without any additional cost.  
Since one nurse remarked that good end-of-life care requires more than just the use of the Care 
Guide, training of health care staff in symptom management and in delivering optimal end-of-
life care is required if we want the Care Guide to add value to end-of-life care. This confirms 
what was recently recommended by a review performed in the UK in response to the concerns 
about the LCP
25
. According to that review, the importance of a well thought-out 
implementation strategy, underpinned by training and education of all staff involved, cannot 




Barriers to implementing and using the Care Programme in the acute geriatric hospital ward 
identified in our study include practical issues such as insufficient time, the administrative 
burden of using the Care Guide and the lack of integration with electronic patient files. The 
same barriers were identified in a recently published qualitative study about barriers and 
facilitators to implementation of the LCP in a hospital, a hospice, a home care setting and a 
nursing home in the Netherlands
26
.   
Lack of motivation of some health care staff, for instance reflected in the low involvement of 
physicians during the training sessions, was another important barrier to successful 
implemention. This lack of motivation may have been related to the insufficient authority and 




Finally, the difficulties with recognizing the dying phase and the resistance of health care staff 
to initiating the Care Guide also seem to be important barriers to adequately use of the Care 
Guide. This barrier was also identified in a study investigating barriers to implementation of 
an integrated care pathway for the last days of life in nursing homes
27
. Diagnosing when a 
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patient is dying, understanding the dying process and communicating about dying are indeed 
very difficult issues in practice, but they are a prerequisite for delivering good end-of-life care. 
The barriers identified enabled us to further refine the Care Programme. For instance, the Care 
Guide and other supportive documents were adapted to overcome the barriers related to the 
content of the documents. For example, the term ‘care goal’ which was used in the Care Guide 
was changed into ‘point of attention’; another example is that practical barriers such as a lack 
of time can be overcome by recommending and predicting more time for preparation within 
the implementation guide. Furthermore, based on the barriers identified, we were also able to 
make recommendations for future implementation. Firstly, wards that are willing to implement 
the Care Programme are encouraged to seek management approval to create more time to 
compose a steering group and inform all involved health care staff. Secondly, in order to 
overcome the low motivation of some health care staff and thus the low participation in 
training and audits, the importance of a very motivated steering group and good facilitators 
who can enthuse other staff cannot be overestimated as they are key to successful 
implementation
26
. Thirdly, difficulties inherent to the organization and provision of end-of-life 
care need to be incorporated into and discussed during the training sessions and audits. It is 
therefore essential that all health care staff who will use the Care Guide attend these meetings.  
Further research in order to gain a better understanding of these barriers and how they could 
best be approached or addressed would also be very helpful. 
Over many years various pathways have been developed and implemented in order to improve 
end-of-life care
28,29,30
. Since 2012 the LCP has been widely criticized for failing to provide 
appropriate care and an independent review has recommended that it should be phased out in 
the UK
25
. However, this should not be a reason to abandon any efforts to structure and further 
improve end-of-life care in health care settings. Rather, it pinpoints the need to develop, 
evaluate and implement ameliorated end-of-life care improvement programmes (Verhofstede 
R, Smets T, Cohen J, Costantini M, Van Den Noortgate N, van der Heide A, Deliens L: 
Development of the care programme for the last days of life for older patients dying in acute 
geriatric hospital wards: a phase 0-1 study according to the Medical Research Council 
Framework, in revision). We believe that the Care Programme makes an important 
contribution to the acute geriatric hospital ward in that respect. One of the lessons learned 
from the UK is that an end-of-life care programme should never be implemented in practice 
without proper evaluation of its beneficial effects and potential harms. Our mixed methods 
study is only a first, but important, step in evaluating the feasibility and effectiveness of the 
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Care Programme; however it allows us to further improve our programme before evaluating it 
in a larger cluster randomized controlled trial and before further wide-scale implementation. 
An important strength of our study is that it uses a phase 2 approach according to the MRC 
Framework for the development of a complex intervention
16
. This framework, following a five 
phase iterative approach from pre-clinical phase to large-scale implementation, provides a 
valuable structure to guide the development and modelling of a complex intervention to 
improve end-of-life care in acute geriatric hospital wards
16
. Secondly, our study uses 
methodological triangulation
31
; multiple qualitative methods (i.e. notes and a transcripts) and a 
quantitative method to evaluate the feasibility and effects of the Care Programme.  
There are also limitations in the study that need to be considered. Firstly, because it took place 
only in one geriatric hospital ward, located in a university hospital, our results cannot be 
automatically generalized to other wards in other hospitals. Secondly, we only explored the 
perceptions of health care staff whereas family carers and patients could have provided 
additional information on the effects of the Care Programme.  
CONCLUSIONS 
Results of this mixed methods study suggest that implementing the Care Programme in an 
acute geriatric hospital setting is feasible as most of our indicators for a successful 
implementation were met. Nurses and physicians also found that the Care Programme has 
favorable preliminary effects on the documentation of care and the content and quality of end-
of-life care and communication among health care staff and between health care staff and 
patient/family. However, several barriers to the implementation process were perceived 
relating to practical issues, the content of the supportive documents within the Care 
Programme, the low involvement of health care staff during meetings and training and 
difficulties inherent to the organization and provision of end-of-life care in the last days of life. 
To resolve most of these barriers, adaptations were made to the Care Guide and 
implementation guide that have resulted in a refined Care Programme. However, barriers 
related to the low motivation of staff and the organization and provision of end-of-life care are 
more challenging to resolve. Health care staff desiring to implement and use the Care 
Programme on their ward should take these challenges into consideration. Further research 
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The Care Programme for the Last Days of Life has been developed to improve the quality of 
end-of-life care in acute geriatric hospital wards. The programme is based on existing end-of-
life care programmes but modeled to the acute geriatric care setting. There is a lack of 
evidence of the effectiveness of end-of-life care programmes and the effects that may be 
achieved in patients dying in an acute geriatric hospital setting are unknown. The aim of this 
paper is to describe the research protocol of a cluster randomized controlled trial to evaluate 
the effects of the Care Programme for the Last Days of Life. 
METHODS AND DESIGN 
A cluster randomized controlled trial will be conducted. Ten hospitals with one or more acute 
geriatric wards will conduct a one-year baseline assessment during which care will be 
provided as usual. For each patient dying in the ward, a questionnaire will be filled in by a 
nurse, a physician and a family carer. At the end of the baseline assessment hospitals will be 
randomized to receive intervention (implementation of the Care Programme) or no 
intervention. Subsequently, the Care Programme will be implemented in the intervention 
hospitals over a six-month period. A one-year post-intervention assessment will be performed 
immediately after the baseline assessment in the control hospitals and after the implementation 
period in the intervention hospitals. Primary outcomes are symptom frequency and symptom 
burden of patients in the last 48 hours of life. 
DISCUSSION 
This will be the first cluster randomized controlled trial to evaluate the effect of the Care 
Programme for the Last Days of Life for the acute geriatric hospital setting. The results will 
enable us to evaluate whether implementation of the Care Programme has positive effects on 
end-of-life care during the last days of life in this patient population and which components of 
the Care Programme contribute to improving the quality of end-of-life care. 
TRIAL REGISTRATION 







Pain and symptom management, appropriate treatments and medication and communication 
about end-of-life issues are identified as key elements of quality care for terminally ill patients 
[1]. However, clinicians are often inadequately prepared to diagnose dying effectively [2] or to 
discuss the likelihood of imminent death with patients and families [3-7]. Studies have also 
shown that older hospitalized people are less likely to receive appropriate pain control and 
more likely to receive burdensome interventions at the end of life than their younger 
counterparts [8-11]. Although end-of-life care has been identified as a priority for older people 
[8,12] and a large proportion die in hospital [13-15], the quality of end-of-life care for older 
hospitalized patients is suboptimal, leaving room for improvement [16]. As a significant 
number of older patients may die within the acute geriatric ward of a hospital, it is an 
important setting in which end-of-life care could be improved.  
To improve the quality of care at the end of life in the geriatric hospital population we 
developed and successfully piloted the Care Programme for the Last Days of Life 
(Verhofstede R, Smets T, Cohen J, Costantini M, Van Den Noortgate N, van der Heide A, 
Deliens L: Development of the care programme for the last days of life for older patients in 
acute geriatric hospital wards: a phase 0–1 study according to the Medical Research Council 
Framework, submitted; Verhofstede R, Smets T, Cohen J, Costantini M, Van Den Noortgate 
N, Deliens L : Feasibility and preliminary effects of the Care Programme for the Last Days of 
Life in an older acute hospital population: mixed-methods study of the success of 
implementation and staff perceptions, in preparation). This programme is based on the 
Liverpool Care Pathway (LCP) programme, taking into account the concerns regarding the 
LCP raised in the UK and adapted to the geriatric hospital population and setting (Verhofstede 
R, Smets T, Cohen J, Costantini M, Van Den Noortgate N, van der Heide A, Deliens L: 
Development of the care programme for the last days of life for older patients in acute 
geriatric hospital wards: a phase 0–1 study according to the Medical Research Council 
Framework, submitted). The Care Programme essentially aims to raise awareness among 
geriatric health care staff of the importance for improving end-of-life care and to prepare them 
for a change in end-of-life care, to train staff in delivering good end-of-life care with the 
support of a multi-professional document called the Care Guide for the Last Days of Life, to 
support dying geriatric patients with the Care Guide for the Last days of Life, to regularly 
evaluate the delivered end-of-life care and support and to further educate the staff in delivering 
optimal end-of-life care.  
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The Care Programme consists of the following documents: (1) the Care Guide for the Last 
Days of Life, (2) supportive documentation and (3) an implementation guide (Figure 1). 















 A multi-professional document that provides a template of care for the last days and hours of life with recommendations on different  
  aspects of care and guidance for the psychological and spiritual support of patients and their families 
2
 This guide assists health care staff in implementing the Care Programme for the Last Days of Life on the geriatric ward during a six-month  
   period 
 
Although end-of-life care programmes have been developed since the 1990s and have already 
been implemented in more than 20 countries [17], the available evidence regarding their 
effectiveness is weak and studies are limited to the cancer population. Two systematic reviews 
conclude that randomized controlled trials or other well designed controlled studies are needed 
to obtain additional evidence about the effectiveness of end-of-life care pathways [18]. To 
date, only one cluster randomized controlled trial has been performed to study the effects of 
the LCP in oncology patients dying in Italian hospitals [19,20]. Results of that study show that 
a well-implemented LCP programme has the potential to reduce the gap in quality of care 
between hospices and hospitals. However, the results also show that the effects of the LCP 
programme are smaller than those shown in qualitative and before-and-after non-controlled 
studies, and no significant effects on the overall quality of care were found [20]. Nonetheless, 
the effectiveness of the LCP programme was evaluated in a cancer population whereas end-of-
life care pathways or programmes are often used for patients who are dying from diseases 
Care Programme for the Last Days of Life 
Care Guide for the Last 
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other than cancer. Furthermore, the study was underpowered and therefore may have led to 
underestimated results. 
Although it is now widely accepted that clinical practice should be, wherever possible, 
evidence-based, clinical pathways to improve the quality of end-of-life care are often 
implemented without a thorough evaluation of their effectiveness [21]. Additional and robust 
evidence is required [18,22] before realizing a large scale implementation of an end-of-life 
care pathway. Hence, a thorough evaluation of the effectiveness of the Care Programme for 
the Last Days of Life is needed before implementing it in practice. We will therefore evaluate 
the Care Programme in a phase 3 trial according to the MRC framework [23]. 
The aim of this article is to describe the research protocol of the cluster randomized controlled 
trial that will be performed to evaluate the effectiveness of a complex intervention, the Care 



















While a classic randomized clinical trial is known as the most appropriate method to study the 
effect of an intervention, it is impossible to randomize a complex intervention within a 
hospital without contamination of the control arm [24]. For this reason, a multicentre two arm 
cluster randomized controlled trial will be performed. To prevent possible bias at the level of 
the hospital, a clustering will take place on the hospital level. Consequently, randomization 
will be carried out at the level of the hospital. The flow diagram of the study protocol is 
outlined in Figure 2. The CONSORT guidelines have been followed to design this study [25]. 
The trial is registered in ClinicalTrials.gov, identifier NCT01890239. 
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The inclusion criteria of the hospitals in the trial are: 
o the cluster or hospital has one or more acute geriatric wards 
o the medical and nursing head of one or more acute geriatric wards per hospital give 
consent for participation in the study 
The inclusion criteria of patients are: 
o those dying in the acute geriatric ward between October 2012 and March 2015 
o those that having been hospitalized for more than 48 hours 
o those having given informed consent at admission for the use of their personal 
information from medical or nursing records for the purposes of the study 
GENERAL PROCEDURES OF THE CLUSTER RCT 
First, a one-year baseline assessment will be conducted in all participating acute geriatric 
wards of participating hospitals. During that period care will be provided as usual. At the end 
of the baseline assessment all participating hospitals with one or more participating wards will 
be randomized into intervention or control groups. In the intervention group the Care 
Programme for the Last Days of Life will be implemented over a six-month period with the 
support of an implementation guide (Figure 2). After the implementation period, the 
intervention group will conduct a one-year post-intervention assessment during which the Care 
Guide for the Last Days of Life will continue to be used. The control group will continue to 
provide care as usual and will conduct a one-year post-intervention assessment directly 
following the one-year baseline assessment (Figure 2). 
INTERVENTION 
The Care Programme aims to introduce and embed the Care Guide for the Last Days of Life, 
which will be initiated when a patient is diagnosed as dying and which provides a 
comprehensive template of evidence-based, multidisciplinary care for the last days and hours 
of life. The Care Programme will be implemented and subsequently established according to 
an implemention guide incorporating nine components: (1) establishing the implementation 
project and preparing the environment for organizational changes, (2) preparing the 
documentation, (3) baseline review, (4) training geriatric health care staff, (5) use of the Care 
Guide for the Last Days of Life with intensive support, (6) semi-intensive support, (7) 
evaluation, (8) consolidation and (9) ongoing education, training and support (Table 1). 
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Table 1 Overview of the nine components within the implementation guide 
 
N° Content 
Component 1 Establishing the implementation project and preparing the environment 
 ▪ Informing the geriatric health care staff about the implementation project and the importance of change in care 
during the last days of life 
 ▪ Executive endorsement: acquiring management approval for the trainings and audits 
▪ Involvement of specialist palliative care services is recommended: at least one member of the Palliative Support 
Team of the hospital is member of the steering group 
 ▪ Facilitators: a nurse and a physician of the geriatric ward 
 ▪ Formation of steering group: at least four people from the geriatric ward (facilitators included) 
 ▪ Intensive 2-day training of facilitators 
Component 2 Preparing the documentation 
 ▪ Development of an information leaflet for family carers about the facilities in the geriatric hospital ward 
Component 3 Baseline review 
 ▪ Analyzing end-of-life care data of deceased geriatric hospital patients using the patients’ medical files 
Component 4 Training geriatric health care staff 
 ▪ Feedback of the results to the staff and focusing on improvement within the geriatric ward 
 ▪ Facilitators and specialist palliative care colleagues train geriatric health care staff with the aid of a training 
package (i.e. hand-outs with information about the Care Guide for the Last Days of Life, a copy of the Care Guide 
for the Last Days of Life, a casus to discuss in group etc.) 
Component 5 Care Guide use and intensive support 
 ▪ Care Guide use after sufficient training and education 
 ▪ Intensive support and supervision by the steering group through repeated coaching, telephone and direct guidance, 
discussion of clinical cases and clinical audits 
Component 6 Semi-intensive support 
 ▪ Semi-intensive support and supervision by the steering group through repeated coaching, telephone and direct 
guidance, discussion of clinical cases and clinical audits 
Component 7 Evaluation 
 ▪ To organize a qualitative evaluation of the implementation: evaluating and discussing the performance and 
progress of each of the previous components 
 ▪ The qualitative evaluation acknowledges areas where further support, education or training is needed 
Component 8 Consolidation 
 ▪ To adopt a strategy to maintain/improve the implementation and sustainability of the Care Guide 
 ▪ Support and supervision by the steering group through repeated coaching, telephone and direct guidance, 
discussion of clinical cases and clinical audits 
Component 9 Ongoing education, training and support 
 ▪ Keeping up to date with developments in end-of-life care and a continuing education and evaluation within the 
hospital ward 
The development and content of the Care Programme for the Last Days of Life are extensively 
described elsewhere (Verhofstede R, Smets T, Cohen J, Costantini M, Van Den Noortgate N, 
van der Heide A, Deliens L: Development of the care programme for the last days of life for 
older patients in acute geriatric hospital wards: a phase 0–1 study according to the Medical 
Research Council Framework, submitted). 
OUTCOME MEASURES 
Primary outcome 
Quality of dying during the last 48 hours of life: the patient’s symptom frequency and 
symptom burden measured using the EOLD-SM and EOLD-CAD [26] 
Secondary outcomes 
1. the quality of care during the last three days of life as perceived by nurses, i.e. physical 
symptoms, emotional, psychological and spiritual/existential needs and provision of 
information and support measured using the POS [27] 
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2. the quality of care during the last 48 hours of life as perceived by family carers, i.e. 
satisfaction with the care provided to the patient during the last 48 hours of life measured 
using the EOLD-SWC [26] 
3. the content of care during the last 48 hours of life, i.e. the goal of treatment, medical and 
nursing interventions, medication policy 
4. the communication among clinical staff, i.e. informing the family physician about the 
impending death 
5. the communication between clinical staff and patients and/or family carers, i.e. the 
perception of communication with the physician during the dying phase by family carers 
measured using the FPPFC [28] 
6. the level of bereavement of family carers after the death of the patient measured using the 
PGD scale [29] 
Process evaluation 
We will also evaluate the quality of the process of implementation in the intervention group. 
An evaluation tool was developed to measure the degree to which the Care Programme for the 
Last days of Life was implemented in each ward in compliance with the implementation 
guide. For each component of the Care Programme indicators were developed so that the 
implementation of each individual component as well as the entire implementation process 
could be documented and quantitatively evaluated. This evaluation tool has been developed 
and piloted in a phase 2 study (Verhofstede R, Smets T, Cohen J, Costantini M, Van Den 
Noortgate N, Deliens L : Feasibility and preliminary effects of the Care Programme for the 
Last Days of Life in an older acute hospital population: mixed-methods study of the success of 
implementation and staff perceptions, in preparation). 
MEASUREMENT INSTRUMENTS 
Primary and secondary outcomes will be measured retrospectively after each death on the 
ward using questionnaires to be filled out by three different respondent types: the nurse who 
was most closely involved in the care for the deceased patient, the physician who was most 
closely involved in the care for the deceased patient, and a family carer of the deceased 
patient. The nurse and family carer questionnaires contain validated measurement instruments, 
in addition to self-developed questions. The physician questionnaire only contains self-
developed questions (Table 2). Regarding the validated measurement instruments, the nurse 
questionnaire contains: the End-of-Life in Dementia Scales Symptom Management (EOLD-
SM) [26], the End-of-Life in Dementia Scales Comfort Assessment in Dying Management 
(EOLD-CAD) [26] and the Palliative care Outcome Scale (POS) [27]. 
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Table 2 Content of the three different questionnaires for nurses, physicians and family carers 
 
Questionnaire Questions Scale Primary and secondary outcomes 
Nurse Used from a scale EOLD-SM Symptom frequency* 
  EOLD-CAD Symptom burden* 
  POS Quality of care 
 Self-developed questions  Content of care, i.e. nursing interventions, 
   Communication between clinical staff and patients and/or family carers of 
dying patients 
   Communication among clinical staff 
Physician Self-developed questions  Content of care, i.e. goal of treatment, medical interventions, medication 
policy 
Communication among clinical staff 
Family carer Used from a scale EOLD-SM Symptom frequency* 
  EOLD-CAD Symptom burden* 
  FPPFC Communication between clinical staff and patients and/or family carers of 
dying patients 
  EOLD-SWC Quality of care 
  PGD Level of bereavement 
 Self-developed questions  Communication between clinical staff and patients and/or family carers of 
dying patients 
 
* primary outcome  
 
In the questionnaire for the family carer the following validated instruments are included: the 
EOLD-SM [26], the EOLD-CAD [26], the End-of-Life in Dementia Scales Satisfaction With 
Care (EOLD-SWC) [26], the Family Perception of Physician-Family Caregiver 
Communication (FPPFC) [28] and the Prolonged Grief Disorder (PGD) Scale [29]. All three 
questionnaires have been cognitively tested in face-to-face interviews with four nurses, four 
physicians and three family carers respectively, and were subsequently refined where needed. 
DATA COLLECTION 
During the baseline and post-intervention assessment, questionnaires will be filled in for all 
patients who died in the participating geriatric hospital wards and who met the inclusion 
criteria. The nurse and physician most closely involved in the care of the deceased patient will 
be asked to fill in a questionnaire within one week of the death. Six weeks after the death the 
researcher will send a questionnaire to a family carer, if they have given informed consent to 
being contacted by the researcher. In cases where the family carer does not respond to the 
questionnaire up to two reminders will be sent, two weeks after the initial sending of the 
questionnaire and two weeks later. 
SAMPLE SIZE CALCULATION 
The hypothesis of this cluster randomized trial is that there will be significant differences in 
symptom frequency and symptom burden between patients dying in the intervention group and 
those dying in the control group. Symptom frequency and symptom burden will be measured 
using the EOLD-SM and the EOLD-CAD. Because our primary outcome is a reduction in 
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symptom frequency and symptom burden during the last 48 hours of life, we consider a total 
EOLD-CAD score of 3.2 (7.6%) as the minimum clinically important difference for 
implementing the Care Programme for the Last Days of Life [30]. A minimum increase of 3.2 
in the intervention group compared to the control group corresponds with an effect size (EC) 
of about 0.55. A minimum change of 5% to 10% has been found to be clinically significant for 
symptom and quality-of-life analyses [31]. In order to calculate the sample size of this cluster 
trial two other elements are essential: the intra-cluster correlation coefficient and the average 
size of the cluster (number of cluster deaths). We estimate an intra-cluster correlation 
coefficient of between 0.02 and 0.05 [32] and a conservative average of 30 deaths per hospital 
per year based on observed mortality statistics, taking into consideration the non-included 
deceased patients. In Table 3 four ICC scenarios (from 0.02 to 0.05) intersect with three 
scenarios of average size of the cluster (from 20 to 40). This table reports different sample size 
scenarios necessary to detect an ES of 0.55 with alpha = 0.05 and a power of 80% conditional 
on the hypothesized levels of ICC (from 0.02 to 0.05) and average size of cluster (from 20 to 
40). 
Table 3 Total number of clusters required according to different average sizes of the clusters and 
ICC (ES = 0.55, alpha = 0.05, power = 0.80) 
                    Average size of the clusters 
  20 30 40 
 
ICC 
0.02 10 8 8 
0.03 12 10 10 
0.04 12 10 10 
0.05 14 12 10 
 
A sample size of six clusters per group with 30 individuals per cluster achieves 80% power to 
detect a difference of 3.2 between the group means when the intracluster correlation is 0.05 
using a Two-Sided T-test with a significance level of 0.05. 
 
RECRUITMENT OF HOSPITALS 
Based on the cluster size calculation, 10 to 12 hospitals with one or more acute geriatric wards 
must be recruited. In order to recruit these hospitals, the study has been presented at three 
geriatric meetings. Shortly after these meetings information letters were sent to geriatricians. 
Geriatricians who were interested in participating were contacted by the researcher to make an 
appointment to explain and discuss the study and to sign an agreement of participation form. If 
geriatricians did not spontaneously contact the researcher, the researcher took the initiative 




At the end of the baseline assessment the included hospitals with one or more participating 
acute geriatric wards will be randomly assigned to the intervention group (implementing the 
Care Programme for the Last Days of Life) or to the control group (usual care). 
As the number of clusters to be randomized is considerably smaller than in trials where the 
unit of randomization is the patient, there is a chance of baseline imbalance between the 
randomized groups. The risk of baseline differences can be reduced using pair-matched 
randomization [33]. Hospitals will be matched in comparable pairs in terms of 1) the number 
of deaths per year for the participating geriatric wards, and 2) the motivation of the 
participating wards in terms of the number of patients from whom they will acquire informed 
consent for participation in the baseline measurement period. Information related to the 
number of deaths and motivation per hospital will be sent to a statistician outside the research 
group, who will then match the pairs and randomize the hospitals into the experimental and 
control group using a random number generator. 
STATISTICAL ANALYSIS 
All data collected through the three different questionnaires will be stored and collected in 
Ghent University Hospital using IBM SPSS Statistics. Data cleaning will be performed via 
SPSS syntax operations. All statistical tests will be done two-tailed with 95% confidence 
intervals. A p-value <0.05 will be considered statistically significant. 
Descriptive statistics 
Cluster and patient characteristics will be reported as mean and standard deviation (SD) or 
frequency and percentage respectively for continuous and categorical variables. The 
distribution of characteristics of clusters allocated as experimental or control hospitals will be 
compared with the Student t-test (for continuous variables), with non-parametric tests (for 
ordinal variables) and with the Pearson Chi-square (for binary or nominal variables). 
Multivariable analysis 
Our primary aim is to detect any differences in the EOLD-SM [26] and EOLD-CAD [26] 
between those dying in the intervention wards and those dying in the control wards. The 
primary statistical analysis will be by intention-to-treat, using multi-level models, taking into 
account clustering by hospitals. Because these primary outcomes are continuous, hierarchical 
linear models will be used which will be adjusted for the average level of quality of life and 
quality of care provided to the baseline assessment. This method of analysis will also be used 
for our secondary outcome measures. For the assessment of categorical secondary outcomes, 
the hierarchical logistical model will be used. 
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INFORMED CONSENT PROCEDURE 
In order to guarantee privacy for patients whose data is collected in the study, certain 
procedures are necessary. As the Central Ethics Committee requires that data can only be 
collected from deceased patients who have given informed consent prior to the study, written 
informed consent to use personal data for the study will be requested by a nurse from each 
patient at the time of admission of the patient to the ward. If the patient is lacking in capacity, 
written informed consent will be requested from a family carer. Questionnaires will be filled in 
only for patients with informed consent at admission. 
The physician and the nurse who were closely involved in the care of a deceased patient will 
be asked to fill in a questionnaire about the patient. If one of them refuses to complete the 
questionnaire the nurse who is responsible for the study on the ward will pass the 
questionnaire to another nurse or physician. A closely involved family carer will also be asked 
to fill in a questionnaire about their deceased relative and about their own experiences of care 
in the dying phase. In order for the researcher to be allowed to send a questionnaire to the 
family carer, a nurse will ask informed consent of the family carer shortly after the death of 
the patient. Family carers who give informed consent will be asked to sign a written informed 
consent form including their contact details. If the nurse in the hospital is unable to ask 
informed consent from the family carer shortly after the death of the patient, the hospital will 
send an informed consent form by post to the family carer two weeks after the death of the 
patient asking permission for the researcher to contact them. Family carers who give informed 
consent to being contacted by the researcher will be sent a questionnaire six weeks after the 
patient’s death. Family carers are also asked for their informed consent to fill in the 
questionnaire. 
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This will be the first cluster randomized controlled trial to evaluate the effectiveness of the 
Care Programme for the Last Days of Life for the acute geriatric hospital setting. Following a 
baseline assessment, geriatric hospital wards will be randomized to the intervention or control 
group where the Care Programme will be implemented or care will be provided as usual. A 
post-intervention assessment should allow us to detect differences in the symptom frequency 
and symptom burden between patients in the intervention wards and those in the control 
wards. 
A cluster RCT design has several important strengths. The first advantage of this robust design 
is that a control group will be used. Working with control hospitals can avoid the situation 
where differences between the baseline and post- intervention assessments within the 
intervention group are caused by changes other than the intervention that is being studied. 
Secondly, in all participating hospital wards the quality of care and the quality of life during 
the last 48 hours of life will be assessed before and after implementation of the care 
programme. That means that we will be able to compare end-of-life care in geriatric hospital 
wards before and after the implementation of our intervention, and that each hospital operates 
as its own control. A third strength of this design is that cluster randomized trials, unlike 
individually randomized controlled trials, can reduce the effect of treatment contamination as 
one or more geriatric wards from one hospital will handle the same care principles [34]. 
Fourth, this design may also increase compliance due to group participation. 
This study also has several limitations. Firstly, the study questionnaires address symptoms and 
care during the last 48 hours of life, which is more or less the target period of the Care Guide. 
However, it is unknown how long the geriatric patients will be supported by the Care Guide 
for the Last Days of Life. Earlier studies have shown that the median duration and average 
time of use of the LCP in the hospital setting was 16 and 29 hours respectively [35,36]. 
However, another study found that 44% of hospice patients were supported by the LCP during 
two days [37]. We therefore cannot preclude that we may be measuring the quality of care 
during a period when the Care Guide had not yet been put into effect, which could dilute the 
apparent effect of the Care Programme. A second limitation, inherent to the focus on the last 
48 hours of life, is that evaluations of a patient’s quality of life, content of care and 
communication will depend on after-death evaluations by proxies (nurses, physicians and 
family carers). However, in selecting the items for the questionnaires, we have taken into 
account the reliability and validity of proxy-reporting. Proxy measurements have, for 
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instances, been shown to be relatively valid for relatively objective information such as the 
processes of care [38]. In former retrospective studies, bereaved family carers and professional 
caregivers, like nurses and physicians, have acted as proxy respondents and the reliability of 
proxy assessments for various aspects of end-of-life care and quality of life are well described 
[39]. The aspects we choose to measure are those that have shown sufficient agreement 
between patients and proxy respondents: observable physical symptoms, evaluation of care, 
service use and awareness of diagnosis [40]. We will also investigate some aspects that are 
more subjective such as psychological symptoms. It is known that in comparison with patients, 
nurses and family carers tend to overestimate the severity of such symptoms whereas 
physicians tend to underestimate them [39]. We therefore take into account the different 
perspectives of nurses, physicians and family carers. 
Most end-of-life care pathways or programmes such as the LCP have been studied in different 
healthcare settings and have focused mainly on oncology patients. However, due to the ageing 
population and a simultaneous increase in the incidence of chronic diseases, future research 
evaluating the effects of end-of-life care pathways or programmes should also focus on elderly 
people dying of causes other than cancer [12,8]. Evaluating the Care Programme for the Last 
Days of Life for the acute geriatric hospital patient would therefore add evidence of the 
effectiveness of initiatives aimed at improving the quality of life and care for older patients 
dying in acute geriatric hospital wards. 
By using a cluster randomized controlled trial design, the proposed study will contribute 
substantially to the increase in evidence for end-of-life care interventions. To our knowledge 
only one other cluster RCT in this area has studied the effects of the LCP programme on 
cancer patients dying in Italian hospitals [19,20]. A cluster RCT is a challenging, high-risk 
research design. However, results from a before-after cluster phase 2 trial support the need for 
multi-centre cluster randomized controlled trials [41], as this is the only feasible method of 








This will be the first cluster randomized controlled trial aimed at evaluating the effectiveness 
of the Care Programme for the Last Days of Life to improve the quality of care and quality of 
life during the last 48 hours of life of patients dying in acute geriatric hospital wards. Using 
this robust study design will allow us to describe in detail the quality of care and quality of life 
of elderly people dying in hospitals and will add to the evidence about the effectiveness of the 
Care Programme in the acute geriatric hospital setting. The poor quality of end-of-life care in 
hospitals remains a concern and dealing with that problem is a public health priority. We hope 
that this study will not only show whether the Care Programme for the Last Days of Life is 
effective in geriatric hospital wards but will also provide an understanding of the contribution 
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8. Main results and general discussion 
This doctoral thesis consists of four main parts. The first part is a general introduction 
followed by chapter 2 in which we aim to further expand the existing knowledge about end-of-
life care in older patients by providing a population-based evaluation of the main goal of 
treatment that older people of different ages receive at the end of life.  
 
In the second part we explore end-of-life care in 23 acute geriatric hospital wards by (1) 
describing the performed nursing and medical interventions in the last 48 hours of life and the 
quality of dying and (2) describing the policy of anticipatory prescribing and deprescribing of 
potentially inappropriate medication during the last 48 hours of life.  
 
In the third part we present (1) the development of the Care Programme for the Last Days of 
Life for patients in acute geriatric hospital wards, (2) the feasibility of implementing the Care 
Programme and (3) the protocol for a cluster Randomized Controlled Trial (RCT) to evaluate 
the effectiveness of the Care Programme on symptom frequency and symptom burden of 
patients in the last 48 hours of life as the primary outcome. 
 
In this fourth part, we provide an overview of the main findings followed by a discussion and 














8.1. Summary of main findings 
In the following paragraphs, the results of the previous chapters are summarized according to 
the three research aims, i.e. (1) to evaluate the main goal of treatment at the end-of-life in 
older patients, (2) to describe end-of-life care in acute geriatric hospital wards and (3) to 
develop and evaluate the Care Programme for the Last Days of Life to improve end-of-life 
care in acute geriatric hospital wards.   
 
8.1.1. Main goal of treatment at the end-of-life in older people 
 
In chapter 2 (part I), the death-certificate study allowed us to investigate which factors are 
associated with an indicator of quality of end-of-life care such as having comfort care as main 
goal of treatment in the last week of life . 
After controlling for confounder variables, age was independently related to the main goal of 
treatment in the last week of life. Those in the older group (86 years and older) were more 
likely of having a comfort care goal in the last week of life as compared with the younger 
group (75-85 years) (OR 1.61; CI 1.20 – 2.17). In both age groups, also cause and place of 
death were independently related to the goal of treatment, with those dying from non-
malignant diseases and those dying in the hospital being less likely to receive comfort care in 
the last week of life. Patients between 75 and 85 years and those lacking capacity to make 
decisions were less likely to receive comfort care at the end-of-life than were those of the 
same age group with capacity to make decisions (71.9% vs. 92.7%; p<0.001). 
 
8.1.2. End-of-life care in acute geriatric hospital wards 
 
Chapter 3 (part II) presents the results regarding the nursing and medical interventions and the 
quality of dying of patients in 23 acute geriatric hospital wards during the last 48 hours. 
According to family carers approximately 14% of the deceased patients definitely desired to 
die in hospital and the majority preferred home as place of death.  
With respect to nursing interventions at the end-of-life, we found that approximately half of 
the patients received one or more visits of a palliative care nurse, for 98% mouth care was 
performed, and for at least 75% of the patients experiencing breathing difficulties due to 
mucus production necessary measures were taken. Of the nursing interventions wound care, 
aspiration, blood pressure measurement, pulse measurement, temperature measurement, 
repositioning and washing, the latter three were most frequently performed until the patient’s 
death, ie . 70.3%, 80.7% and 69.3% respectively.  
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As death approached the patient’s vital signs - blood pressure, pulse and temperature - were 
significantly less often taken and washing and wound care were significantly less often 
performed. 
 
Regarding medical interventions, 49.7% of the patients received oxygen therapy, 30% 
intravenous fluids and nutrition, 22.8% antibiotics and in 19.2% of the patients a routine blood 
test was performed during the last 48 hours until death. On the other hand, in 17.2% of all 
dying patients antibiotics were stopped, in 15.7% intravenous fluids and nutrition and in 
12.5% blood sugar regulation. 
 
Chapter 3 also describes the quality of dying in acute geriatric wards by using the Comfort 
Assessment in Dying End-of-Life in Dementia (CAD-EOLD). We notified that in the last 48 
hours of life lowest levels of comfort were reported for shortness of breath, serenity, peace and 
calm. The reported level of pain was moderate, according to nurses and family carers. 
 
In chapter 4 (part II), an overview of the anticipatory prescribed and deprescribed medication 
during the last 48 hours of patients in acute geriatric hospital wards is provided. 
During the last 48 hours of life, 65.4% of the patients had an anticipatory prescription of 
medication. In 45.5% of the dying patients, morphine was anticipatory prescribed. For 15.5% 
and 13.8% of  the dying patients, benzodiazepines and scopolamine were prescribed 
respectively. After performing a multivariate analysis controlling for confounders, expected 
death by the physician and dementia were independently related to the anticipatory 
prescription of medication. The likelihood of having anticipatory medication prescribed was 
significantly higher in patients where death was expected by the physician (OR 19; CI 9 – 40; 
p<0.001) and significantly lower in patients with a diagnosis of dementia (OR 0.35; CI 0.16 – 
0.74; p=0.006). 
 
Somewhat more than half of the potentially inappropriate medication with which the patients 
were treated at admission was withdrawn during the last 48 hours of life. The extent to which 
the potentially inappropriate medication, i.e. statins, antidiabetics, antihypertensiva, diuretics, 
antibiotics, aerosols, corticosteroids, aspirins, anticoagulants, osteoporosis medications, 
antiulcer drugs, laxatives and acetylcholinesterase inhibitors, were continued until death, 
fluctuated between 29.2% and 54.9%. After performing a multivariable logistic regression 
analysis controlling for confounders, we found that patients for whom death was expected by 
the physician were more likely to have a deprescription of potentially inappropriate 
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medication than patients for whom death was not expected by the physician (OR 21; CI 10 – 
43; p<0.001). Moreover, patients dying from an oncological disease diagnosis were also more 
likely to have potentially inappropriate medication deprescribed compared with patients dying 
from frailty or dementia (OR 7.0; CI 1.1 – 45.6; p=0.042). 
 
8.1.3. Developing and evaluating the Care Programme for the Last Days of Life to 
improve end-of-life care in acute geriatric hospital wards 
 
Results regarding the third research aim are reported according to the first four phases of the 




(a) Phase 0-I: Development of the Care Programme for the Last Days of Life  
 
Chapter 5 describes the development of the Care Programme for the Last Days of Life for the 
acute geriatric hospital setting, i.e. phase 0 (preclinical phase) and phase I (modeling phase). 
 
In phase 0 we aimed to identify and compare different components of the Liverpool Care 
Pathway (LCP) programmes from the UK, Italy and the Netherlands. Simultaneously, this 
phase consisted of an identification of the key factors for a successful implementation of the 
LCP. The LCP was chosen as a basis for the development of our Care Programme since it is 
the most well-known end-of-life care pathway
2,3,4,5
. Though, during this preclinical phase we 
observed the increasing criticisms regarding the LCP in the UK. These concerns arose mainly 
from inappropriate implementation and use and not the principles of the LCP itself
6
 and we 
therefore took them as much as possible into account when developing our Care Programme.  
We found that all three LCP programmes contain common documents, i.e. an LCP document, 
supportive documentation and an implementation guide. We identified nine components in the 
implementation guides used in the UK, Italy and The Netherlands: (1) establishing the LCP 
implementation project and preparing the environment, (2) preparing the documentation, (3) 
baseline review of the care delivered in the last days of life, (4) training of health care staff, (5) 
LCP use and ongoing support, (6) reflective practice, (7) evaluation of the use of the LCP, (8) 
continuing development of staff competencies and (9) ongoing education, training and support 
of staff. 
The identified key factors for a successful implementation were: having a dedicated facilitator, 
training and ongoing education of the staff, the organization of an audit and of feedback 
opportunities, having a central regional or nationwide coordinating LCP office to support local 
LCP facilitators and, funding and time for implementation efforts. 
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As it was our initial intent to develop an end-of-life care improvement initiative especially for 
patients in acute geriatric hospital wards, the specificities of the older hospital population and 
the setting in which they are cared for were taken into account, i.e. phase I or the modelling of 
the Care Programme. Therefore, our Care Programme - which was initially developed based 
on the results of phase 0 - was reviewed by health care staff and experts from the UK, Italy 
and the Netherlands. Subsequently, researchers discussed all the input gathered and the 
feedback of the reviewers and used the results of this discussion for the refinement of the Care 
Programme. Finally, a preliminary Care Programme for the Last Days of Life was developed 
and modeled consisting of (1) the Care Guide for the Last Days of Life, (2) supportive 
documentation and (3) an implementation guide to help health care staff in implementing the 
Care Guide on the acute geriatric ward. 
 
(b) Phase II: an evaluation of the feasibility of implementing the Care Programme 
for the Last days of Life and exploring its preliminary effects  
 
In chapter 6 the results of the phase 2 mixed methods study are reported which suggest that 
implementing the Care Programme for the Last Days of Life in the acute geriatric hospital 
ward of Ghent University Hospital is feasible and that the Care Programme has positive 
preliminary effects on end-of-life care.  
 
Most of the components of the Care Programme were successfully performed. It was for 
instance found that more than half of the deceased patients (11 out of 19)  had been cared for 
according to the Care Guide during the implementation period. Six months after the 
implementation of the Care Programme, the Care Guide was still in use. In those six months, 
of the 30 patients who died on the ward, 17 were cared for according to the Care Guide. 
However, despite the fact that two training sessions were organized, only one out of four 
geriatricians was trained. Furthermore, not all health care staff were informed about the 
implementation project and one out of the three audits that should have been organized was 
not. 
Additionally, health care staff identified four types of potential barriers to implementing the 
Care Programme: (1) barriers related to practical issues, e.g. many health carers perceived the 
double registration as a barrier to use the Care Guide, (2) barriers related to the content of the 
documents used within the Care Programme, e.g. some staff had difficulties with the term 
‘care goal’ within the Care Guide and perceived the term as being too coercive, (3) barriers 
related to the low motivation of some health care staff and (4) barriers related to difficulties 
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inherent to the provision and organization of care in the last days of life, such as difficulties 
with the recognition of the dying phase or difficulties with an open and clear communication 
between nurses and physicians regarding the entrance of the dying phase. 
 
With respect to the effects of the Care Programme on end-of-life care, our study showed that 
according to nurses and physicians the Care Guide for the Last Days of Life is experienced as 
improving the overall documentation of care, improving the communication among health 
care staff and between health care staff and patient/family, and improving the quality of end-
of-life care.  
 
(c) Phase III: The research protocol of a cluster RCT to evaluate the effectiveness of 
the Care Programme for the Last Days of Life 
 
In chapter 7, we outlined the protocol of a cluster RCT to evaluate the effectiveness of the 
Care Programme for the Last Days of Life to improve the quality of care and quality of dying 
during the last 48 hours of life of patients dying in acute geriatric hospital wards.  
 
The data collection of the cluster RCT has already been initiated in October 2012 and was 
recently finished in March 2015. After a one-year baseline assessment hospitals were 
randomized to the intervention (implementation of the Care Programme) or control group 
(usual care). Subsequently the Care Programme was implemented in the intervention group 
over a six-month period followed by a one-year post-intervention assessment. In the control 
group, the post-intervention assessment was performed immediately after the baseline 
assessment. 
During the baseline and post-intervention assessment primary outcomes, ie symptom 
frequency and symptom burden in the last 48 hours of life, and secondary outcomes were 
retrospectively measured after each death on the ward using questionnaires to be filled out by 
a nurse, physician and family carer. The questionnaires contain validated measurement 
instruments and self-developed questions. The validated measurement instruments are: the 
End-of-Life in Dementia Scales Symptom Management (EOLD-SM)
7
, the End-of- Life in 
Dementia Scales Comfort Assessment in Dying Management (EOLD-CAD)
7
, the End-of-Life 
in Dementia Scales Satisfaction With Care (EOLD-SWC)
7
, the Palliative care Outcome Scale 
(POS)
8
, the Family Perception of Physician-Family Caregiver Communication (FPPFC)
9
 and 
the Prolonged Grief Disorder (PGD) Scale
10
. All three questionnaires have been cognitively 
tested in face-to-face interviews with four nurses, four physicians and three family carers 
respectively, and were subsequently refined where needed. 
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Although the performance of the cluster RCT has recently been finalized, the results have yet 
to be analysed in order to evaluate the effectiveness of the Care Programme for the Last Days 
of Life. We hope that this study will also provide an understanding of the contribution of the 























8.2. Methodological strengths and limitations 
This doctoral thesis has made use of several methods to address three specific research aims, 
each having their own strengths and limitations.  
 
To evaluate the main goal of treatment at the end-of-life in older people of different ages, 
we used a robust design including a large representative sample of death certificates. Although 
a non-response bias cannot be completely excluded, our non-response survey did not point in 
that direction. Consequently, we believe our results to be representative for all non-sudden 
deaths of those older than 75 in 2007 in Flanders, Belgium.  
However, this data collection has been completed almost seven years ago, and we therefore 
have to bear in mind that end-of-life care practices may have changed in the meantime. 
Furthermore, because we performed a secondary analysis of a survey primarily intended to 
study end-of-life practices, certain aspects that would have provided a more complete insight, 
such as the severity of the patient’s condition and their functional status, the content of care in 
the last week of life, the patient’s wishes for end-of-life care or the existence of an advance 
care plan were not studied. Moreover, as this doctoral thesis mainly focuses on end-of-life care 
in acute geriatric hospital wards, it would have been useful if the death-certificate study had 
provided us with more information regarding the place of death, i.e. whether or not a patient 
died in an acute geriatric ward. Additionally, while chronological age is an independent risk 
factor for adverse outcomes in many conditions, it would have also been interesting to 
compare outcomes between patients with and without frailty in this patient population
11
. 
Finally, the delay between the patient’s death and the study of that death has reached as much 
as four months in our study as death certificates have to be processed by the proper authorities 
before they can be made available for research. We therefore cannot exclude the influence of 
recall bias. However, to address this issue, physicians were encouraged to fill out their 
questionnaire using the patient files.  
 
The cross-sectional descriptive study that we have set up to describe end-of-life care in acute 
geriatric hospital wards in Flanders, ie the baseline assessment as part of the cluster RCT to 
evaluate the effectiveness of the Care Programme for the Last Days of Life, was large-scale 
and multicentric with 338 patients recruited from 23 acute geriatric wards in 13 Flemish 
hospitals. As we included hospitals from different regions and of different sizes, this may have 
increased the generalizability of the study findings
12
. Unlike earlier conducted studies, we did 
not use a retrospective case note review methodology to examine end-of-life care and quality 
of dying. Due to incomplete documentation and lack of standardized structure, case note 
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review methodology may lead to underreported variables and thus the validity of the findings 
may be questioned
13,14
. In contrast, our study adopted a more valid methodology by 
retrospectively completing questionnaires. Furthermore, three different questionnaires were 
developed to be filled out by a nurse, a physician and a family carer, which permitted us to 




However, our results may have been affected by assessment bias. Due to the vulnerability and 
poor health conditions of dying patients, our data are based on proxy measures and not on the 
experiences of the patients themselves. However, in selecting the items for the proxy 
questionnaires, we have taken into account the reliability and validity of proxy-reporting. 
Proxy measurements have, for instances, been shown to be relatively valid for relatively 
objective information such as the processes of care
16
. In former retrospective studies, bereaved 
family carers and professional caregivers, like nurses and physicians, have acted as proxy 
respondents and the reliability of proxy assessments in older patients with and without 
dementia for various aspects of end-of-life care and quality of life are well described
17
. 
Assessments made by health care staff and family carers are reasonably accurate and nurses 
may be the most suitable source of proxy information, though proxy assessments should 
always be interpreted with caution
18
.   
Additionally, our results may also have been affected by selection bias. A possible reason for 
this bias is that participants in the study are acute geriatrics wards which may obviously have a 
prior interest in end-of-life care have. Furthermore, only 34% of patients in these wards could 
be included in the study due to the informed consent procedure.  The included patients had a 
significant longer mean length of hospital stay than those not included; however, no 
differences were found between included and non-included patients in terms of age and 
gender. Also the low response rate for family carers (35%) could have biased our results with 
regard to the quality of end-of-life care and the quality of dying. A non-response analysis 
detected that only age and dying circumstances were independently associated with evaluation 
by a family carer; older patients and those surrounded by family members or friends when 
dying had a higher response rate. It may thus be that younger patients and/or those dying alone 
had a different quality of dying as reported by the family carer. Unlike for family carers, there 






Finally, we adopted the Medical Research Council (MRC) Framework
19
 to develop and 
evaluate a complex intervention to improve end-of-life care in acute geriatric hospital wards. 
This approach has proved to be valuable in guiding the development, modelling and 
evaluation of complex interventions
19–21
 and we may affirm that this Framework definitely has 
potential as a broad guide to help researchers move from facing a considerable health problem 
to finding an appropriate solution and evaluating its effectiveness, ie from the preclinical 
phase to phase III.   
The MRC Framework guidance suggests the use of appropriate quantitative and/or qualitative 
methodologies depending on the specific objectives of the phases as well as a specific study 
design taking into account the theoretical basis, any evidence on the issue and the context’s 
specificity
19
. Nonetheless, we experienced some shortcomings within the Framework’s 
guidance. For example, we did not find any details or references in the guidance on how a 
complex intervention could be developed and/or modeled starting from an existing 
intervention, or on how to identify the core components as part of the intervention. More 
comprehensive guidelines on how complex interventions should be developed, tested and 
evaluated with respect to palliative and end-of-life care may thus be helpful for future practical 
and research purposes.  
 
Nevertheless, we have succeeded in performing the first four phases of the MRC Framework 
thoroughly and correctly, with all of them having their specific strengths and limitations.  
 
Importantly, our preclinical phase (phase 0) consisted of  a review of the existing LCP 
programmes, a literature review to identify key factors for a successful LCP implementation 
and an analysis of the concerns regarding the use of the LCP in the UK, which provided us 
with considerable information so that important components of the intervention could be 
deduced. Subsequently, the specificities of the older hospital population and the setting in 
which they are cared for were taken into account by thoroughly reviewing, discussing with 
among others international experts and modeling the preliminary intervention (phase I).  
Although we did not perform a systematic review concerning the key factors for a successful 
LCP implementation, the key factors identified in our study largely correspond with key 
factors identified in a more recently published systematic review
22
. Only one additional 
contextual factor was mentioned in the review. It was found that a major cultural shift is 
needed to change the perception from dying as a failure of medical care into dying as a time of 
life when care takes priority over cure
22
. Also findings from a recent Dutch qualitative study 
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An important strength of our phase II mixed-methods study is that a methodological 
triangulation was used
24
; multiple qualitative methods (i.e. analysis of observation notes and 
audit transcript) and a quantitative method (i.e. evaluation tool) to evaluate the feasibility and 
effects of the Care Programme.  
However, this study took place in only one geriatric hospital ward, located in a university 
hospital. Hence, our results cannot be automatically generalized to other wards in other 
hospitals. Besides, we only explored the perceptions of health care staff whereas family carers 
and patients could have provided additional information on the effects of the Care Programme. 
 
A robust cluster RCT design was chosen for the phase III trial according to the MRC 
Framework. Unlike individually randomized controlled trials, this design can reduce the effect 
of treatment contamination as one or more geriatric wards from one hospital will implement 
the same care principles
25
. Other strenghths of this design are that a control group was used 
and that the quality of care and dying during the last 48 hours was assessed before and after 
implementation of the Care Programme. Moreover, results from a before-after cluster phase 2 
trial support the need for multi-centre cluster RCTs
26
, as this is the only feasible method of 
assessing the effectiveness of end-of-life care interventions
27
.  
However, qualitative methods supplementing our quantitative evaluation approach would have 
been valuable. Thoroughly assessing the effectiveness of the Care Programme is a challenge 
due to the presence of different types of components, activities, interventions and outcomes to 
be achieved
28
. Qualitative methods such as participant observation or interviews would have 
enabled us to better understand to what extent components were performed and to which 
outcomes they may be related.  
Nevertheless, the evaluation tool that has been developed and piloted in our phase II study 
may be helpful in measuring the degree to which each individual component, as well as the 
entire Care Programme for the Last days of Life, was implemented in each ward in 
compliance with the implementation guide. 
For strengths and limitations regarding the assesment procedure of this cluster RCT, we refer 
to the methodological considerations of the abovementioned cross-sectional descriptive study 





8.3. Discussion of the findings 
The following paragraphs provide some reflections on the main results of this study. We first 
attempt to (1) reflect on end-of-life care for older people in acute geriatric wards and (2) 
discuss how potential inadequacies in end-of-life care in acute geriatric wards could optimally 
be addressed. Subsequently, (3) we argue the relevance of developing a new initiative to 
improve end-of-life care for older people dying in acute geriatric wards and reflect upon the 
results of the development and evaluation of the Care Programme for the Last Days of Life to 
improve end-of-life care for patients dying in acute geriatric wards.  
 
(1) Which aspects of end-of-life care can be improved for older people dying in acute 
geriatric wards? 
 
Main goal of treatment in the last week of life as an indicator of the quality of end-of-life care 
It is well known that end-of-life care should always be delivered in accordance with individual 
patient needs. We know for example that many dying older patients do not wish to prolong 
their dying, implying that life-prolongation is no longer a priority when death approaches
29,30
. 
When palliation or comfort care is prioritized in the last week of life, a patient will receive 
better end-of-life care than when the goal of treatment is cure or life-prolongation
31,32
. The 
continuation of unnecessary and often aggressive treatments does not only affect the patient, 
but also the patient’s family and health care professionals
33,34
 
However, according to the results of the death-certificate study the chance of palliation being 
the main goal of treatment in the last week of life was much lower for older patients dying in 
hospital and dying from non-malignant diseases. We may thus infer from these results that 
there is room for improvement regarding the main goal of treatment in the last week of life of 
patients dying in acute geriatric wards.  
 
The greater likelihood of cure or life-prolonging being the main goal of treatment in the last 
week of life in acute geriatric wards may be due to the hospital setting. It is well known that 
changing the focus of the care trajectory from a strictly disease-modifying, curative path to a 
more symptom-focused palliative care path is challenging in the hospital setting
35
. Moreover, 
patients are often admitted to hospital for a curative or life-prolonging treatment which makes 
it more challenging for health care professionals to distinguish people who can still be treated 
from those for whom end-of-life care would be more appropriate
36
. Also the disease may 
affect whether or not health care staff adopt a palliative care approach in the last week of life. 
Older people more often suffer from slowly progressive or fluctuating long term conditions in 
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which the timing of death often remains unpredictable until they are close to it
37
. This is 
different from patients dying from cancer for whom recognizing and diagnosing the dying 




We need thus to ensure that health care staff on geriatric wards are attentive to individual end-
of-life care needs and focus on comfort care as it may help in preparing for the end of life, and 




Involvement of specialized palliative care services 
A palliative care nurse visited about half of the patients dying in the acute geriatric wards at 
the end of life. A growing body of evidence suggests that input from specialists in palliative 
medicine can improve the quality of and satisfaction with patient care, identify and deal with 
patient and family needs and reduce costs
39,40,41
.  
Although the other half of the patients did not receive a visit from a palliative care nurse, the 
number that we found is higher than that found in other studies performed in the acute hospital 
setting
42,43
. One possible explanation for this finding is that health care staff in acute geriatric 
hospital wards may be more willing to adopt a palliative care approach than health care staff in 
other acute hospital wards. Consequently, they may more often contact a member of the 
palliative care team if they themselves are not able to address the patient’s needs. 
Alternatively, it could be that in our study health care staff had better or easier access to 
palliative care services or that the palliative care team is more integrated in acute geriatric 
wards than in other wards.  
However, specialized palliative care services may not always be required. For patients who did 
not receive a visit of a palliative care nurse at the end of life, it could be that the physicians 
and nurses on the ward were perfectly able to deal with the patient’s end-of-life care needs 
themselves. However, it is also possible that a palliative care nurse was not involved in those 
patients for whom death came suddenly and was unexpected.  
 
Discontinuation of potentially inappropriate nursing and medical interventions 
Several nursing and medical interventions that are deemed to be potentially inappropriate were 
continued until death in a substantial number of patients dying in the acute geriatric hospital 
setting, e.g. repositioning, antibiotics. Nonetheless, health care staff should review the need to 
continue nursing and medical interventions at the end of life and should discontinue those 
interventions that are no longer appropriate or beneficial for the patient
5
. However, as the 
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appropriateness of some interventions at the end of life are controversial, reviewing and 
discontinuing inappropriate interventions may be challenging for health care staff
44–51
, 
although some of the potentially inappropriate nursing interventions were significantly less 
often performed as death approached. It may thus be that when health care staff are aware of a 
patient’s impending death, those interventions that seem to harm the patient’s comfort are 
discontinued. 
 
Deprescribing potentially inappropriate medication 
Our study also investigated the degree to which potentially inappropriate medications are 
continued at the end of life in acute geriatric wards. Although more than half of the medication 
with which the patients were being treated at admission was withdrawn during the last 48 
hours of life, the importance of reviewing the continued need for medication and discontinuing 
all those medications that seem to be potentially inappropriate is important when striving for 
optimal end-of-life care in acute geriatric hospital wards
5,52
. It may be that health care staff are 
not always aware of the importance of reflecting upon the need to continue or discontinue 
potentially inappropriate medication at the end of life. However, there is still no consensus 
about the appropriateness of some medication at the end of life, which may hamper health care 
staff reflecting on and stopping potentially unnecessary medication.  
As patients for whom death was not expected by the physician and those dying from frailty 
were especially disadvantaged regarding the deprescription of potentially inappropriate 
medication, we may conclude that the recognition and diagnosis of the dying phase and the 
patient’s disease trajectory may determine whether or not potentially inappropriate 
medications are continued until death. 
 
Anticipatory prescription of medication 
In our study we found that 65.4% of the patients dying in acute geriatric hospital wards had an 
anticipatory prescription of medication. This means there is still room for improvement 
regarding end-of-life care in acute geriatric hospital wards. One study performed in the 
hospice setting has for instance shown higher anticipatory prescription rates for end-of-life 
care symptoms
53
. Although hospice care is by definition aimed at comfort and palliation and 
thus different from the care provided in hospitals, we believe that the current anticipatory 
prescription rates in acute geriatric wards can be improved. However, this requires a shift from 
a disease-modifying curative attitude in the hospital to a more symptom-focused palliative 




Anticipatory prescription of medication for end-of-life care symptoms seemed to be especially 
challenging in patients for whom death was not expected by the physician. Hence we may 
conclude that when the dying phase is not recognized and diagnosed, a physician is less likely 
to provide comfort care and to prescribe medication for end-of-life care symptoms. In 
addition, patients with dementia - especially those with early stage dementia – were 
disadvantaged regarding the anticipatory prescription of morphine. A possible explanation for 
this finding may be that physicians fear the side effects of morphine on the cognitive 
functioning of the patient.  
 
Symptom management 
Our study showed that according to nurses and family carers the quality of dying of patients in 
acute geriatric wards was reasonably good. We may therefore assume that comfort measures 
were appropriately adopted in accordance with the patient’s needs. However, results from 
nurses and family carers showed that there is some room for improvement in the care 
regarding the physical symptom ‘shortness of breath’ and symptoms related to the patient’s 
well-being, such as ‘serenity’, ‘peace’ and ‘calm’. This was also found in other studies 
performed in hospitals and nursing homes, which also revealed the magnitude of unmet 
psychological and existential needs at the end of life
43,54–57
. One possible explanation for this 
finding, among others, may be that in the acute hospital setting less attention is given to 
psychosocial and existential aspects of end-of-life care than to medical aspects of care. A 
second possible explanation is that health care staff in hospitals may not be well trained in 
treating psychological and existential problems. A third explanation is that identifying and 
addressing these needs in the older patient population is challenging because of the specific 
patient characteristics. Nearly half of the patients who die in an acute geriatric hospital ward 
are not able to communicate in the last 48 hours of their life, which may hamper health care 
staff in identifying and dealing with complex psychosocial and existential issues. Finally, it 
may be that the patient and his/her family are actually aware that the patient will die soon 
whereas health care staff may fail to appreciate the impending death. This situation could 









(2) How can inadequacies in end-of-life care in acute geriatric wards be addressed? 
 
When interpreting and discussing the main findings regarding end-of-life care for older people 
in acute geriatric wards, we also aimed to reflect upon how identified inadequacies in that care 
can be addressed. 
 
Striving for a care-oriented approach within the hospital setting 
The realization that a shift from a diseases-modifying attitude to a more symptom-focused 
palliative care approach within the hospital setting may help to address inadequacies related 
to, for example, the main goal of treatment in the last week of life and the anticipatory 
prescription of medication, although we believe that health care staff from acute geriatric 
wards may possibly be more willing to adopt a palliative care approach than health care staff 
in other acute hospital wards. A study performed earlier in Belgium has shown that 
geriatricians treat their older patients at the end of life less aggressively than physicians on 
non-geriatric wards
58
. It may thus be that individual end-of-life care needs are already taken 
into account more in this specific hospital setting. In fact, geriatric medicine already has much 
in common with palliative care, such as its focus on improving quality of life as well as its 
holistic patient view and its multidisciplinary approach
59
. However, that does not mean that 
geriatricians and nurses appropriately recognize the dying phase, which is an important 
prerequisite for adopting a palliative care approach in patients dying in hospital. In other 
words, as geriatric medicine is more often centred on the improvement and the rehabilitation 
of a patient’s functional status, geriatric medicine could learn from palliative care to better 
recognize the dying phase
59
.  
Timely recognition and diagnosis of the dying phase 
Addressing the challenge of timely recognition and diagnosis of the dying phase especially in 
older patients dying from non-malignant diseases
37
 may help to address several of the 
abovementioned inadequacies in end-of-life care for older people. For example, the lower 
percentage of palliation as the main goal of treatment in the last week of life in hospitalized 
older patients, the discontinuation of potentially inappropriate medication and the anticipatory 
prescription of medication. The impact of timely recognition and diagnosis of the dying phase 
on optimal end-of-life care has been shown in a Dutch intervention study in cancer patients. 
Results indicated that the anticipatory prescription rates increased after implementation of the 
Liverpool Care Pathway
60
. This could be due to the fact that this pathway aims to guide health 
care staff in timely recognition and diagnosis of the dying phase and simultaneously stresses 
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the importance of adequate symptom management by, among other things, anticipatory 
prescription of medication. 
Raising awareness and increasing knowledge among health care staff 
Firstly, to address the identified inadequacies related to the discontinuation of potentially 
inappropriate medication and symptom management, health care staff should be made aware 
of the importance and relevance of identifying end-of-life care needs, such as psychosocial 
and existential needs, and adopting the right comfort measures in order to address them 
appropriately. They should also be encouraged to properly determine whether interventions 
and medication should be continued in accordance with the individual patient’s needs. In order 
to establish an adequate end-of-life care plan, health care staff on geriatric wards have to 
identify and discuss a patient’s individual end-of-life care needs and preferences.  
Secondly, health care staff could be taught which interventions and medications are 
appropriate at the end of life. In order that health care staff have better guidance in this respect 
further research should be conducted to determine the appropriateness or inappropriateness of 
nursing and medical interventions and medication at the end of life. In addition, health care 
staff should know and learn how for instance psychological and existential problems need to 
be treated or dealt with. Enhancing knowledge and increasing communication skills with for 
example family caregivers are thus of utmost importance, especially in an older population, 
where approximately half of the patients are no longer able to communicate their wishes and 
preferences. In addition, advance care planning in this population is extremely relevant. 
Paying attention to patients with non-malignant diseases 
Because recognizing the dying phase is easier in cancer patients and palliative care has 
historically been focused on patients dying with cancer
37
, patients dying from non-malignant 
diseases are still disadvantaged with respect to end-of-life care. 
In order to address inadequacies related to the continuation of potentially inappropriate 
medication and anticipatory prescription of medication, particular attention should be paid to 
patients dying from frailty or dementia. To address for instance the potential fear by 
physicians of side effects of morphine in patients with dementia, guidelines could be 
developed to ensure optimal symptom control in this specific patient population.  
Paying attention to patients lacking capacity at the end of life 
It is revealed in the death-certificate study that patients lacking capacity in the younger group, 
namely those between 75-85 years, are more likely to receive life-prolonging or curative 
treatment at the end of life than those of the same age group having capacity. This may 
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suggest that difficulty in discussing a patient’s end-of-life preferences could impede a shift in 
focus to end-of-life care. However, our results indicate that this phenomenon did not occur in 
patients above 85 years, which might suggest the different attitudes of care givers towards the 
treatment of older people, irrespective of their capacity to make decisions. 
 
(3) The Care Programme for the Last Days of Life 
 
Guidelines and care trajectories may help us to address the identified inadequacies in end-of-
life care on acute geriatric wards by implementing one or more of the abovementioned 
improvement strategies. Hence, we aimed to develop the Care Programme for the Last Days of 
Life – an extensive initiative including or meeting most of the abovementioned improvement 
strategies and criteria. 
 
Over the years, several pathways have been developed and implemented in order to improve 
end-of-life care
2,3,4
. The Liverpool Care Pathway (LCP), on which the Care Programme for the 
Last Days of Life has been partly based, has been widely criticized since 2012 for failing to 
provide appropriate care and subsequently an independent review has recommended phasing 
out the LCP in the UK
6
. However, this should not be a reason to abandon any efforts to 
structure and further improve end-of-life care in health care settings. Rather, it pinpoints the 
need to develop, evaluate and implement ameliorated end-of-life care improvement 
programmes, taking into account the lessons learned from the UK. Although the LCP was an 
evidence-based framework founded on high quality medical practice in palliative care, the 
Neuberger review underlined the lack of research on the effectiveness of the LCP itself and on 
how various factors can result in better or worse implementation
6
. Our study is one of the first 
studies that aims to thoroughly evaluate the effects of an end-of-life care programme using a 
robust research design before implemention and dissemination in practice. 
In this study, we developed the Care Programme for the Last Days of Life and evaluated its 
effects using the Medical Research Council (MRC) Framework approach
19,21
. 
Our Care Programme is different from the original LCP programme in several ways. Firstly, it 
is specifically adapted to the older hospital population and setting, for example the content of 
the implementation guide is adapted to the acute geriatric hospital ward. Secondly, most of the 
concerns regarding the use of the LCP raised in the UK were taken into account. For example, 
the terminology was changed from ‘Pathway’ to ‘Care Guide for the Last Days of Life’. This 
might prevent misconceptions about our programme, such as the misconceptions among health 





. The term ‘Care Guide’ suggests that the document is supposed to guide the 
health care staff in making individualized choices in caring for dying patients, without being a 
protocol that has to be followed. This change in terminology was later also recommended in 
the Neuberger review
6
. Furthermore, the importance of a thorough and correct implementation 
of the Care Guide, underpinned by education and training, is stressed in our implementation 
guide. The implementation guide incorporates nine components that have to be performed and 
includes a detailed and elaborate training package to help health care staff in educating and 
supporting their colleagues in using the Care Guide in a correct and compassionate way. This 
may counter as far as possible the identified problem of poor or improper implementation of 
the LCP in the UK leading to cases of inadequate end-of-life care in the hospital setting
61,62,63
. 
The Neuberger review indeed also confirmed that when the LCP is correctly applied it helps to 
achieve a dignified and pain-free death. Sufficient training and education should prevent staff 
from using the Care Guide as a ‘tick box’ exercise instead of as a guidance tool to assist them 




Barriers identified in the phase II study to implementing and using the Care Programme in the 
acute geriatric hospital ward were also found in earlier performed studies
23,64
. These identified 
barriers enabled us to further refine the Care Programme in light of the future phase III trial 
and potential dissemination. For instance, the term ‘care goal’ which was used in the Care 
Guide and was perceived as being too coercive was changed into ‘point of attention’.  
Secondly, we emphasized in our implementation guide that wards willing to implement the 
Care Programme must be supported by the management to invest in a steering group 
responsible for implementation and information of all involved health care staff. Managers of 
the ward should be aware that a motivated steering group and facilitators who can enthuse the 
staff are key factors for successfully implementation
23
. Finally, the feasibility study also 
learned that difficulties inherent in the organization and provision of end-of-life care need to 
be incorporated and discussed during the training sessions and audits. Therefore, we insist that 
all health care staff who will use the Care Guide attend these meetings. 
 
According to health care staff involved in the feasibility study the Care Programme has 
predominantly positive effects on end-of-life care, which confirms the findings of earlier 
qualitative studies
65,66,67
. An encouraging finding was that the Care Programme positively 
affects the quality and content of end-of-life care. Namely, using the Care Guide seemed to 
stimulate a multidisciplinary approach in care at the end of life, greater reflection among 
health care staff on end-of-life care and continuity of care. It may also help to structure care 
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delivery and promote a clearer policy regarding anticipatory prescribing of medicines. 
Moreover, as no additional resources or persons were needed to implement the Care 
Programme, positive effects could be achieved without any additional cost.  
 
After performing the phase II study, we performed a phase III RCT to evaluate the 
effectiveness of the Care Programme. By using this robust design, results will contribute 
substantially to the evidence for end-of-life care interventions. To our knowledge only one 
other cluster RCT in this area has studied the effects of the LCP programme on cancer patients 
dying in Italian hospitals
27,68
. Although a cluster RCT is a challenging design, results from a 
before-after cluster phase II trial support the need for multi-centre cluster RCTs
26
, as this is the 
only feasible method of assessing the effectiveness of end-of-life care interventions
27
.  
The data collection of this trial was completed in March 2015. Results of the phase III are not 

























8.4. Implications for practice, policy and research  
Following the summary and discussion of the main findings of this thesis, we formulated some 
important implications for health care staff, policy makers and researchers regarding end-of-
life care for older people in acute geriatric hospital wards. 
 
8.4.1. Implications for practice and policy 
As this thesis has identified some important challenges and issues in end-of-life care in acute 
geriatric hospital wards, we have delineated several implications for practice and policy. 
Health care staff working on acute geriatric wards and policy makers are capable of making a 
difference to end-of-life care for older people. Meeting the implications mentioned below 
might thus be a first step in the right direction.  
 
Changing attitudes and behaviors of health care staff on acute geriatric wards 
In order that a shift is made from a disease-modifying curative attitude to a more symptom-
focused palliative care approach within the hospital setting, the attitudes and behaviors of 
nurses and physicians towards end of life must be changed. As evidence suggests that 
education alone may be insufficient to engender a significant cultural change in hospital 
culture
69
, further research should seek to explore practical and policy-driven initiatives that 
more effectively moderate attitudes and behavior, namely interventions aiming at realizing a 
transition from ‘cure’ to a more palliative care approach
35
. 
This challenging recommendation is based on our findings that older patients dying in hospital 
are at a higher risk of receiving burdensome curative or life-prolonging interventions than 
patients dying in other settings. Additionally, results from our retrospective cross-sectional 
study performed in acute geriatric hospital wards have shown that anticipatory prescription of 
medication can be improved in comparison with the hospice setting. However, it may be that 
our developed Care Programme succeeds in its intent of improving the quality of end-of-life 
care delivery on the acute geriatric ward by shifting the attitudes and actions of clinical staff 
towards a more care-oriented approach and subsequently better care practices. 
 
Invest in education and training to enhance the knowledge and communication skills of nurses 
and geriatricians  
An additional step forward could be made by enhancing health care professionals’ knowledge 
of end-of-life care, including symptom management and comfort in the last days of life, in the 
basic curriculum, in post-graduate training, through training courses, workshops and seminars. 
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We for instance identified some problems such as the continuation of unnecessary 
interventions and medications in the last days of life. Furthermore, our study results and those 
from earlier performed studies have shown that the recognition and diagnosis of the dying 
phase in older hospitalized patients is also a challenging issue, mainly due to the difficulty of 
survival prediction in older patients dying from non-malignant diseases and physicians’ 
reluctance to acknowledge treatment failure
70–75
. 
Also communication between health care staff of geriatric hospital wards and patients/family 
carers can be improved. For the patient and/or family carers, to accept the fact that there is no 
treatment option other than palliative care can be hard to deal with. The burden of explaining 
the patient’s situation, which can be difficult and stressful, falls on the physicians and nurses. 
This might be different from the situation encountered in a hospice, where the patient usually 
goes after being informed of the fact that no further curative treatment is available. 
Furthermore, terminally ill patients and their families have serious and diverse issues to tackle, 
such as physical, psychological, social and spiritual problems. To deal with these issues, good 
communication skills are essential
75
. 
To address the identified problems and challenges in a population whose needs are complex 
and multifaceted, education and development of skills in health care professions caring for 
older dying patients is thus crucial.  
 
Encouraging and improving multidisciplinary collaboration 
In addition to education and training, good collaboration between all involved parties is 
strongly recommended in order to meet the complex and multifaceted needs of older 
hospitalized patients at the end of their life, e.g. geriatricians, oncologists, cardiologists, 
palliative care clinicians, pharmacists, psychologists, social workers, dieticians, nursing staff 
and chaplains
76
. Health care staff caring for older patients, such as on acute geriatric wards, 
should particularly be encouraged to seek the support of the palliative care team for dealing 
with the psychosocial and existential needs of dying patients. This is highly recommended as 
our study findings stress the magnitude of unmet psychosocial and existential needs at the end 
of life and the need to address these needs. Also for complex symptoms such as shortness of 
breath, or for deciding which nursing or medical interventions and which medications should 
be continued and which can be stopped the services of a palliative care team can provide a 
substantial contribution. 
 
Developing guidelines for optimal symptom control at the end of life in patients with dementia 
Our results showed that during the last 48 hours of life, 65.4% of the older patients dying in an 
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acute geriatric ward had an anticipatory prescription of medications, and 34.6% did not. 
Physicians should be made aware of the importance of ensuring no delay in responding to end-
of-life symptoms when they occur, particularly in dementia patients, as our study results 
showed that patients with dementia, especially those with early stage dementia, are less likely 
to have an anticipatory prescription than those without dementia.  
As patients with dementia are less likely to have an anticipatory prescription of medications, 
which may be due to the fact that physicians fear to prescribe for instance opioids in this 
population, it might be helpful to develop guidelines for optimal symptom control in patients 
with dementia. Guidelines could also help physicians in decision-making regarding the 
deprescription of unnecessary medications at the end-of-life. Physicians should take into 
account a patient’s individual needs and determine an appropriate medication policy. 
 
Structuring end-of-life care processes 
The structuring of care processes in the last days of life could help health care staff in 
delivering good end-of-life care, for instance by contributing to the management of symptoms 
in dying older patients. End-of-life care processes could be structured by using individualized 
end-of-life care plans based on best practices for care in the last days of life. These plans could 
be especially valuable in acute geriatric wards, where approximately half of the patients are no 
longer able to communicate their wishes and preferences for end-of-life care. Structuring end-
of-life care processes with individualized end-of-life care plans could enable health care staff 
to track the delivery of care easily and to see at one glance which care has been delivered by 
the different members of the multidisciplinary team and what still has to be done. This may 
contribute positively to the continuity of the care delivered. 
 
Dissemination of the developed Care Programme for the Last Days of Life if positive effects 
are shown 
Most of the abovementioned recommendations can be realized by implementing the Care 
Programme for the Last Days of Life. This Care Programme aims (1) to raise awareness about 
the importance of recognizing and diagnosing the dying phase, (2) to educate and train health 
care staff in order to enhance their knowledge about end-of-life care and their communication 
skills, (3) to encourage multidisciplinary collaboration and (4) to structure end-of-life care 
processes. 
However, only when the cluster RCT shows positive effects and no potential harm from the 
Care Programme for the Last Days of Life can be identified, should the intervention be 
disseminated on a larger scale. This further dissemination of the Care Programme would imply 
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among other things (1) publication(s) in peer-reviewed literature, (2) communication with 
policy makers using peer reviewed publications, conference presentations, public engagement 
activities, newsletters, and open access web deposition of publications at the end of the trial 
and (3) the surveillance and monitoring of long-term outcomes to measure long-term impacts 
of the Care Programme. 
 
8.4.2. Implications for future research 
Demographic, epidemiological and societal changes increasingly confront societies with 
challenges regarding the organization of end-of-life care and dying. As a number of these 
changes will persist in the future, challenges concerning the organization of end-of-life care 
and the pursuit of a good death should be dealt with in time, especially for the large group of 
older patients. Older patients frequently experience multiple and complex health problems and 
disabilities until death and will therefore have special care needs at the end of life
76,77
. Hence, 
more funding should be made available for future research in end-of-life care for older 
patients. 
 
Firstly, in order to better understand the needs of patients of different ages at the end of life 
and how age influences end-of-life care, further research should be encouraged. It may for 
instance be valuable to investigate why differences exist in the main goal of treatment in the 
last week of life between patients of 75-85 years and those older than 85. Getting more insight 
into the needs of older patients could be a first step towards future interventions aiming to 
improve end-of-life care. 
 
Secondly, as appropriate end-of-life care for older people should always be delivered in 
accordance with the patient’s individual needs and preferences, further research should focus 
on how a cultural change within the acute hospital setting may be achieved. By shifting from a 
disease-modifying curative attitude to a more symptom-focused palliative care approach, 
caregivers may be enabled to take into consideration and address individual end-of-life care 
needs and preferences. Therefore, further research should explore which interventions are 
effective in making transitions from ‘cure’ to a more palliative care approach. However, as 
there may be cases in which the health care staff is palliative care oriented whereas family 
caregivers and/or patients persistently insist on curation or life-prolongation, research should 
also focus on how family carers’ and patients’ attitudes could optimally be addressed. 
 
Thirdly, in order to provide evidence based guidelines for health care staff, it will be of great 
interest to explore the appropriateness of medical and nursing interventions during the last 
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hours of life and to investigate which medications are (in)appropriate at the end of life. 
Besides, future research should focus on how optimal symptom control could be ensured for 
patients with dementia and how the side effects of medication such as morphine could be 
avoided.  
 
Fourthly, further research should focus on tools to overcome prognostic paralysis especially in 
non-cancer terminal illnesses. 
 
In conclusion, an essential suggestion for future research is the continued investigation of the 
Care Programme for the Last Days of Life. As the phase III cluster randomized controlled trial 
on the effectiveness of the Care Programme has recently been finished, analysis of the results 
of this trial should be performed as soon as possible in order to judge whether or not the Care 
Programme for the Last Days of life has potential to improve end-of-life care in acute geriatric 
hospital wards.   
If it appears that the Care Programme provides a positive contribution to end-of-life care in the 
acute geriatric hospital setting, its implementation and use should be further monitored and 
ameliorated where needed. 
In addition and according to the results of the phase II study, further research to gain a better 
understanding of the barriers to implementing the Care Programme and how they could best 
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